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CHAPTER I 
GENERAL INTRODUCTION 
INTRODUCTION TO THE CHAPTERS 

GENERAL INTRODUCTION 
The isolation of sparsomycin 1^, next to tubericidin (sparsomycin A) 2 1, from a 
Streptomyoes Sparsogenes broth was reported by Argoudelis and Herr in 19622'3. 
More recently this compound has also been obtained from Stvevtomyaes 
Cuspidosporus1* »5. After its isolation it was roughly characterized (UV, IR, 
elementary analysis, specific rotation and molecular weight) by Argoudelis 
and Herr . 
ОН о "H2 
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1 Sparsomycin ( S c - R s ) 2 tubericidin 
Subsequently a first evaluation of its biological activity was carried out 
by Owen, Dietz and Camiener6. In their experiments sparsomycin was found to 
be active against KB human epidermoid carcinoma cells in tissue culture. 
The compound was very active against these mammalian cells (KB cell protein 
synthesis was inhibited 50% (ID50) at a concentration of 0.05 pg/ml), and 
moderately active against a variety of gram negative and gram positive 
bacteria as well as against fungi. In VÌVO data showed inhibition of growth 
of several tumors as assayed from tumor diameter measurements or from tumor 
weights. The toxicological screening of sparsomycin indicated an acute 
LD50 value of 2.4 mg/kg in mice. These data about the biological activity 
were probably the immediate cause to test sparsomycin in a phase I clinical 
study in 19647. In this study with 5 patients who had all advanced 
carcinomas or sarcomas, the drug was daily administered i.V. for an intended 
period of 42 days. The dose given ranged from 0.085 mgAg - 0.24 mg/kg. Two 
patients noted difficulty of vision, one after 13 days of treatment (total 
dose 12 mg) and one after 15 days of treatment (total dose 7.5 mg), where-
after treatment was stopped. 
It was conceived, that the primary biological activity of sparsomycin 
was due to a strong inhibition of the protein synthesis rather than inhi-
bition of DNA or RNA synthesis. Its effect on the protein synthesis was 
demonstrated by the decline of the protein synthesis of intact prokaryotic 
cells Ч 6/ 8- 1 2, eukaryotic cells13"^0 - including transformed6'0'9'19'20 
and/or virus infected cells » ; and in various cell-free systems (pro-
karyotes 1 3' 2 3 - 2 6' 3 4, eukaryotes27-41). 
The behavior of sparsomycin with regard to its inhibitory action and 
influence on the polyribosomes has also been investigated гп vivoi*2-~t*7. 
There is ample evidence4"»^9 that sparsomycin inhibits the protein 
synthesis by interacting with the peptidyltransferase center of ribosomes, 
the devices of the cell, where the protein synthesis actually takes place. 
The peptidyltransferase center is responsible for the cruxial event in the 
elongation step of the protein synthesis in which the peptidyl chain of 
the peptidyl-tRNA is transferred to the aminoacyl-tRNA. 
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The pronounced inhibition of the protein synthesis may be - at least partly -
responsible for several reported secondary actions of sparsomycin, such as 
the inhibition of the RNA-synthesis13, the DNA-synthesis16 and perhaps also 
for the reported ocular toxicity of sparsomycin6»50. Because sparsomycin is 
a selective and effective inhibitor of the protein synthesis, it has been 
used as a tool in a number of other biochemical studies15»51~60. 
Our interest in sparsomycin was roused by the discrepancy that existed 
between the wealth of information on the biological activity as well as the 
biochemical mechanism of action (vide supra) on one hand and the limited 
knowledge of the organic chemistry of the molecule on the other hand: when 
we started our research on sparsomycin there was no total synthesis of the 
molecule available. 
To our opinion the development of a flexible synthesis or synthetic 
methodologies for a molecule possessing an interesting biological activity 
is an absolute prerequisite for thorough studies on the biological activity 
and/or biochemical mechanisms of interaction. This can also be concluded 
from the work on - especially - puromycin (Chapter V), on chloramphenicol 
and on lincomycin, which interfere with the peptidyltransferase center too. 
As a consequence we started our investigations on sparsomycin, directing 
our first efforts towards a total synthesis of this molecule. A total 
synthesis was feasible since the structure of sparsomycin - excepting the 
chirality of the sulfoxide moiety - had been elucidated by Wiley and 
MacKellar61 in 1970. Our purpose was to develop a flexible synthesis that 
would enable us to prepare a wide variety of analogs. It was planned to use 
these analogs in structure activity relationship studies (see Chapter V) to 
determine : 
a^  the structural features and stereochemical requirements, essential 
for an optimal biological activity 
b the molecular mechanism of action of sparsomycin and its analogs. 
In addition, our aim was to study whether structural modifications in 
sparsomycin might yield a molecule with more selective biochemical and 
farmacological properties e.g. a molecule that will penetrate preferentially 
into a transformed cell. 
Furthermore, our experiences with the syntheses of analogs of sparsomycin 
will be used to develop a synthesis of a sparsomycin analog, containing a 
radioactive label as well as an affinity label. The latter may give rise to 
covalent bond(s) with (a) molecule(s) of its site of interaction. Studies 
with this affinity analog of sparsomycin might be valuable for an further 
understanding of ribosome structure and function. 
The guiding principle in structure-activity relation studies and in 
affinity label studies has to be the awareness of the existence of a close 
relation between the structure as well as the chemistry of a molecule and 
its biological activity. This implies a 'bio-organic chemical' attitude: 
hypotheses have to be formulated based on results obtained from studies on 
the biological activity of an effector molecule and on available information 
about the biochemical/biological structure of the effector's target (e.g. 
the ribosome). These hypotheses must lead to the design of molecular models. 
Although the biological activity of sparsomycin was an important reason 
for directing our synthetic efforts toward this molecule, there were other 
reasons for embarkment on a total synthesis. First, the development of a 
total synthesis would allow the determination of the absolute configuration 
of the sulfoxide-sulfur atom of sparsomycin. Second, the development of a 
total synthesis enabled us to get an impression about the organic chemistry 
of several of sparsomycin's separate functionalities (sulfoxide function, 
mono-oxodithioacetal moiety, hydroxy function). In the course of a total 
synthesis the molecule is composed from building bricks, fragments of the 
molecule. Each fragment contains less functionalities than the molecule as 
a whole, thus facilitating study of the chemistry of a particular function-
ality. 
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This information may be useful for speculating on the metabolic stability 
of the different fragments of the molecule. Among others, this is of im­
portance for the preparation of a radioactively labelled sparsomycin analog 
for in vivo experiments. Furthermore on basis of the chemistry of the various 
functionalities it will be possible to speculate about the molecular 
mechanism of the biological activity. 
As was mentioned above, there was no total synthesis of sparsomycin available. 
However, there have appeared some publications on the synthesis of analogs 
of sparsomycin ever since 6 2 - 6 5 (see also Chapter V ) . These analogs have been 
used in structure activity relationship studies66. Our efforts resulted in 
the first total synthesis of sparsomycin66, shortly thereafter followed by 
a total synthesis of Helquist and Shekhani67. Subsequently, we developed a 
second route69 to sparsomycin which required the development of exploratory 
chemistry. A new synthesis of functionalized γ-sultines was developed. The 
sultine approach is an attractive alternative route to the synthesis of 
sparsomycin and might be the method of choice for the preparation of certain 
analogs. The preparation of the sultine synthon allowed us to study its 
virtually unexplored chemistry. We have shown that functionalized sultines 
lead to compounds, that are otherwise accessible with difficulty. 
Finally, the part of the total synthesis dealing with the cysteinol mono-
oxo-dithioacetal moiety, offers a starting point as well as a handle for a 
total synthesis of γ-glutaraylmarasmin'0 3, a secondary fungus metabolite too. 
To our knowledge γ-glutamylmarasmin and sparsomycin are the only natural 
products containing the intruiging mono-oxodithioacetal function. 
•'•
 0
- OH 
H NH, u*^-^ 
HO' 
*NH2 H ^ ' ^ ' ^ M e 
3 γ-glutamyl marasmm 
A brief outline of the contents of the thesis seems opposite here. In 
Chapter II the absolute configuration of the sulfoxide-sulfur atom of sparso­
mycin is assigned, which completes the earlier described6^ structure 
elucidation. Chapter III and IV deal with total syntheses of sparsomycin and 
analogs. The total synthesis which is outlined in Chapter III features the 
employment of an a-halogensulfoxide as a cruxial synthon, whereas the 
synthesis in Chapter IV features the employment of a functionalized sultine. 
Subsequently, in Chapter V the site of interaction of sparsomycin, the 
peptidyltransferase center is discussed, followed by a study of structure-
activity relationships of sparsomycin and analogs as well as an evaluation 
of sparsomycin's antitumor activity. Chapter VI and VII consist of the first 
results of further studies on the chemistry of functionalized sultines. In 
Chapter VI a conformational analysis of functionalized sultines is presented; 
in Chapter VII the flash vacuum thermolysis of functionalized sultines is 
discussed. The contens of Chapter VIII consists of preliminary results of 
the synthesis of the marasmiη fragment of γ-glutamylmarasmin. 
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INTRODUCTION TO TEE CHAPTERS 
The elucidation of the structure of sparsomycin by Wiley and MacKellar on 
the basis of spectroscopic methods and chemical degradation studies did not 
include the chirality of the sulfoxide moiety. 
In Chapter II we describe the determination of the absolute configuration 
of sparsomycin's suifoxide-sulfur atom. The assignment is based on CD (Circular 
Dichroism) spectroscopic studies of synthetic precursors of the enantiomer of 
sparsomycin, and confirmation by an X-ray crystallographic study. The 
observation that the sign as well as the amplitude of the Cotton effect in 
the CD spectra are dependent upon the nature of the substituent, may be 
of value in determining the absolute configuration of other functionalized 
sulfoxides. 
In Chapter III the first total synthesis of sparsomycin and its three 
stereoisomers, as well as the synthesis of S-deoxy-sparsomycin, is described. 
This synthesis is the definitive proof of the structure of sparsomycin. Starting 
compounds in our approach are the simple, commercially available compounds 
6-methyluracil and D- or L-cystine. 
In this study several problems inherent to the reactivity of the various 
functionalities of the molecule, were encountered. The main challenge in the 
synthesis of sparsomycin was the presence of the cysteinol raono-oxodithio-
acetal fragment. It possesses several functionalities which require protection 
and deprotection at the right time and in the right way. In addition the 
lability of the mono-oxodithioacetal moiety limites the number of possible 
approaches. 
In the synthesis of the other fragment, the β-(6-methyl-uracilyl)acrylic 
acid and its subsequent coupling with the amine fragment the poor solubility 
of the uracil derivatives had to be overcome. 
Another approach to the synthesis of sparsomycin and analogs is presented 
in Chapter IV. This approach features an ß-amino-Y-sultine as intermediate 
for the preparation of the cysteinol mono-oxodithioacetal fragment. This 
second method for the preparation of sparsomycin, via an amino sultine, is 
based on the development of a useful synthesis of functionalized sultines, 
the separation of diastereomers and a study of their virtually unexplored 
chemistry. This study includes ring opening reactions, which can be performed 
by cleavage of either the C-0 or the S-0 bond, and the stereochemistry of 
the latter reaction. Other aspects of the chemistry of functionalized 
sultines are mentioned in Chapters VI and VII. 
Chapter V consists of four sections. 
The first section is devoted to back-ground information on sparsomycin's 
receptor site i.e. the peptidyltransferase center. A good understanding 
of the protein synthesis as well as of the role of the peptidyltransferase 
center in this process is a prerequisite to get insight into the activity 
of sparsomycin on a molecular level. The main function of the peptidyl-
transferase center, i.e. the actual attachement of subsequent amino acids 
to the growing peptide chain is explained. The peptidyltransferase activity 
in Vitvo can be assayed among others by the fragment reaction. 
In section 2, preliminary results of a study on structure-activity relation-
ships of sparsomycin and analogs employing this fragment reaction, are given. 
In section 2 these results are compared with those, obtained from testing 
the compounds against tumor cells (Leukemia L1210 cells) in an in vitro 
clonogenic assay. The latter results are described in section 3. 
In section 4 the available data on the antineoplastic activity of sparsomycin 
are evaluated. In addition, present and future investigations on the anti-
tumor activity of sparsomycin and analogs are discussed. 
The preparation and separation of diastereomeriс ß-amino-y-sultine deriva-
tives have been described (Chapter IV). It is known that chiral sulfur 
compounds generally have a high inductory power. In initial experiments 
(Chapter IV) we noticed that chiral induction occurred in a ring opening 
reaction with a prochiral nucleophile. 
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Study of the conformations, which are present in solution, may give insight 
into the chiral induction process. For that reason, among others, we deter-
mined the conformations in solution of the sultines at issue,by 500 MHz 
^-NMR spectroscopy and through use of a generalized Karplus equation as well 
as the pseudo-rotation concept. The results of this study are described in 
Chapter VI. 
In addition, the solid state conformation of one isomer, as determined by 
X-ray crystallographic analysis, is discussed. 
In Chapter VII the flash vacuum thermolysis (FVT) of ß-amino-y-sultines 
is described. We were intrigued by the possibility of preparing compounds 
by thermal extrusion of sulfur, which might be otherwise accessible with 
difficulty. 
Furthermore we were interested in the flash vacuum thermolysis reaction of 
functionalized sultines as compared to the reaction of non-functionalized 
sultines. As a first experiment we carried out the flash thermolysis of 4-
(benzamido)-γ-sultine. FVT of the compound led to a mixture of products, 
an allylamide being the main product. A mechanism that explains the formation 
of these products is proposed. Support for this proposal has been found by 
FVT of a deuterated sultine. 
In Chapter VIII preliminary results of four synthetic approaches to the 
marasmin part of the γ-glutamylmarasmin are described. So far, γ-glutamyl-
marasmin and sparsomycin are the only natural products containing a mono-
oxodithioacetal moiety related to cysteine. However, in γ-glutamylmarasmin 
the cysteine moiety possesses a carboxylic acid function, whereas sparso­
mycin has a methylene hydroxy group. We were interested whether we could 
apply the synthetic methodologies developed for the synthesis of the cysteinol 
mono-oxodithioacetal fragment of sparsomycin to the synthesis of marasmin. 
If so we might be able to prepare marasmin-sparsomycin, i.e. sparsomycin 
having a carboxylic acid function. In addition a synthesis of marasmin would 
enable us to elucidate the absolute configuration of the sulfinate sulfuratom. 
We have not yet completed the synthesis of marasmin; however, of the four 
approaches, the a-chlorosulfoxide approach seems promising. This approach 
originates from our total synthesis of sparsomycin (Chapter III),but cannot 
be simply applied to the synthesis of marasmin. 
CHAPTER II 
ABSOLUTE CONFIGURATION OF SPARSOMYCIN. 
A CHIROPTICAL STUDY OF SULFOXIDES. 
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Abstract Sparsomycin (1) is a naturally occurring compound possessing a wide range of biological activity, including antitumor 
and antibiotic activity. The Re enantiomer 1* and a diastereomer 2 have previously been synthesized. The absolute configuration 
of 1 was determined by CD spectroscopic studies of precursors of 1*. For several intermediates in the synthesis, the sign of 
the Cotton effect could be employed in the assignment of the configuration of the sulfoxide sulfur atom by extension of the 
principles established by Mislow and Snatzke. Sparsomycin was thus assigned the S
c
Ji
s
 configuration. The assignment was 
confirmed by single-crystal X-ray crystallographic studies of a precursor (5) of (ÄcJ-sparsomycin (1*). 
Sparsomycin (1), which was originally isolated as a metabolite 
of Streptomyces sparsogenes,1 has attracted considerable interest 
because of its biological activity against various tumors,3·4 bac-
teria,4·5 fungi,6 and viruses7 and because of its use in studying 
protein biosynthesis,8 a process which is inhibited by sparsomycin/ 
The structure (1), as first reported in 1970,'° contains one chiral 
carbon atom which was shown to possess the S configuration and 
a chiral sulfur atom of the sulfoxide group for which the con-
figuration was not determined. Structure-activity relationship 
studies have shown" that the activity of sparsomycin is dependent 
upon the configuration of the chiral carbon atom as well as on 
the presence of the sulfoxide function. However, the influence 
of the configuration of the sulfoxide sulfur atom has not been 
determined. Therefore we decided to establish the absolute 
configuration of sparsomycin's sulfoxide atom so that further work 
can proceed on studying its structure-activity relationships. 
There is a large number of naturally occurring sulfoxides for 
which the configurations have been determined.12 Particularly 
intriguing among these compounds are toxins obtained from 
poisonous mushrooms of the genus Amanita; whereas the com-
pounds of one sulfoxide configuration are very lethal, the com-
pounds of the opposite configuration are inactive up to rather high 
dose levels.13 
Recently, we have reported two routes for the total synthesis 
of the enantiomer (1*) and diastereomer (2) of sparsomycin. One 
approach is based14 upon the conversion of the a-chloro sulfoxides 
3 and 4 into a diastereomer (2) and the enantiomer (1*), re-
spectively, of sparsomycin. The other route involves15 sulfenylation 
of the methyl sulfoxides 6 and S to also yield 2 and 1*, respectively. 
We now wish to report the determination of the absolute con-
figuration of sparsomycin (1) by use of chiroptical studies and 
single-crystal X-ray analysis. We also wish to report our finding 
of a possible correlation between the sign of the Cotton effect 
exhibited by certain chiral sulfoxides involved in this work and 
the R£ designation of their configurations. 
CD Spectra of Sulfoxides. Mislow et al. have shown that a 
correlation exists between the absolute configuration of methyl 
alkyl sulfoxides and their optical activity; in the absence of strongly 
perturbing groups, a negative Cotton effect, centered at the ab-
sorption band near 200 ταμ in acetonitrile, correlates with the R 
configuration."·17 This rule was found to still be applicable when 
the alkyl group itself is also chiral but not strongly perturbing,18 
as is the case with 5-methylcysteine 5-oxide." 
We decided to study the Cotton effect of our sulfoxides through 
the use of CD spectra. In comparison with ORD spectra, CD 
* To whom correspondence should be addressed: H.C J.O., University of 
Nijmegen; P.H., State University of New York; J W L., State University of 
New York. 
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spectra have the advantage of giving information about individual 
electronic transitions without background effects.10 The CD 
(1) Part of this work was presented at the 178lh National Meeting of the 
American Chemical Society, Washington, D.C., Sept 1979; American 
Chemical Society: Washington, D.C., 1979; ORGN 127, and at the meeting 
of the Netherlands Foundation for Chemical Research (SON), Luntcren, 
November 5, 1979. 
(2) Argoudelia, A. D.; Herr, R. R. Anlimkrob. Agents Chemother. 19*2, 
780-786. 
(3) Slechta, L. Antibiotics (N.Y.) 19Í7, I. 410-414. 
(4) (a) Brodasky, T. F. J. Pharm. Sci. 1963, 52, 233-235. (b) Price, K. 
E.; Buck, R. E.; Lein, J. Antlmlcrob. Agents Chemother. 1964, 505-517. 
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Figure 1. CD spectra of compounds 3, 4, and 7-10 
spectra of the previously mentioned precursors 3 and 4 of the 
sparsomycin system as well as of the intermediates 7-10 are shown 
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,Л8) 10, Χ = SCH, (Л
с > 5 8 ) 
in Figure 1 The Ή NMR spectra of the compounds 9 and 10 
(5) Higashide, E , Hasegawa, Τ , Shibata, M , Mizuno, К , Akaikc, H 
Takeda Kenkyusho \empo 1966, 25. 1-14, Chem Abslr 1967, 66, 542Щ 
(6) Owen, S Ρ , Dielz, A , Caminer, G W Annmicrob Agents Che­
mother 19*2, 772-779 
(7) Thiry, L J Gen Virol 1968, 2, 143-153 
(8) (a) Smith, A E , Wigle, D Τ Eur J Biochem 1973, 35, 566-573 
(b) Carrasco, L, Baltaner, E , Vazquez, D Methods Enzymol 1974, 30. 
288—289 
(9) (a) Goldberg, I Η Cancer Chemoth Rep Part 1 1974, 58, 479-489 
(b) Vasquez, D FEBS Lett 1974, 40 (supplement), S63-S84 
(10) (a) Wiley, Ρ F , MacKellar, F Λ J Am Chem Soc 1970, 92, 
417 418 (b) Wiley, Ρ F , MacKellar, F A J Org Chem 1976, 41, 
1858 1862 
(11) Dubois, R J , Lm, С С L , Michel, В L J Pharm Sa 1975,64, 
825-829 (b) Vince, R , Brownell, J , Lee, С К Biochem Biophys Res 
Commun 1977, 75, 563-567 (с) Lin, С С L , Dubois, R J J Med Chem 
1977, 20, 337-341 (d) Lee. С К , Vince, R Ibid 1978, 21, 176-179 
(12) (a) Challenger, F Endeavour 1953, 12. 173-181 (b) Klyne, W , 
Day J , Kjaer, A Ada Chem Scand 1960, 14, 215-217 (c) Hine, R Acta 
trystallogr 1962,15,635-641 (d) Chnstensen, В W , Kjaer, A Acta Chem 
Scand 1963,17, 846-847 (e) Cheung, К К , Kjaer, A , Sim, G A J Chem 
Soc, Chem Commun 1965, 100-102 (0 Chislensen, В W , Kjaer, A ¡bid 
1965, 225-226 (g) Palmer, К J , Lee, К S Acta Crystallogr 1966, 20, 
790 795 (h) Laur, Ρ H In "Sulphur in Organic and Inorganic Chemistry", 
Sennmg, A , Ed , Marcel Dekker New York 1972, Vol 3, pp 168-210 (i) 
Klync, W "Atlas of Stereochemistrv". Oxford Press New York, 1978, Vol 
1, pp 235-236, Vol 2, pp 123-127 
(13) (a) Faulstich, H . Wieland, Τ "Peptides 1971", Nesvadba, Η , Ed, 
North Holland Publishing Co Amsterdam, 1973, pp 343-350 (b) Faulstich, 
Η Bloching, M , Zobeley, S , Wieland, Τ Experienlia 1973, 343-350 (с) 
Wieland Τ de Urnes, Μ Ρ J , Indes, H , Faulslich, H , Giren, A , Sturm, 
M , Hoppe, W Justus Uebigs Ann Chem 1974, 1570-1579 (d) Buku, A , 
Altmann, R , Wieland, Τ Ibid 1974, 1580-1586 
(14) (a) Otlenheijm, H С J . Liskamp, R M J Tetrahedron Lett 1978, 
2347 2438 (b) Ottenheijm, H С J , Liskamp R M J , Tijhuis, M W Ibid 
1979 387-390 
(15) Helquist, P , Shekhani, M S J Am Chem Soc 1979, 101, 
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(16) Mislow, К , Green, M M , Laur, Ρ , McLillo, J Τ , Simmons, Τ , 
Ternay, A L J Am Chem Soc 1965, 87, 1958-1976 
(17) Snatzke, G , Snalzke, F In "Fundamental Aspects and Recent De­
velopments in Optical Rotatory Disperaon and Circular Dichroism", Ciardclli, 
F , Salvador!, Ρ , Eds , Heyden and Son Ltd London, 1973, ρ 186 
(18) Axelrod, R , Bickart, Ρ , Goldstein, M L , Green, M M , Kjaer, A , 
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Figure 2. The molecular structure of 5 showing the Rc.Rs configuration 
m the presence of a chiral shift reagent showed that the enan­
tiomeric purity is greater than 95% 
Of principal importance are the sulfoxides 4 and 5 First of 
all, these compounds display ABX patterns for the NCHCHß(.0) 
segments in their Ή NMR spectra21 which are very similar to 
the corresponding portion of the spectrum of sparsomycin (1) but 
quite different from the corresponding portions of the spectra of 
compounds 3 and 6 Furthermore, compounds 4 and 5 can each 
be converted into the enantiomer (1*) of sparsomycin22 by use 
of our earlier synthetic sequences l 4 1 5 Therefore, if the absolute 
configuration of 4 and a derivative of 5, ι e , 8, were to be de­
termined, the absolute configuration of 1*, and thus of 1, would 
be revealed 
By application of Mislow's rule,16 the sulfur atom of 8, a methyl 
alkyl sulfoxide, can be assigned the R configuration because of 
the negative sign of the Cotton effect observed for this compound 
(see Figure 1 ) From this measurement, we can conclude that 
the precursor of 8, ι e , 5, also has the R configuration, and 
therefore 1*, derived from 5, has the S configuration at the 
sulfoxide sulfur atom This change in nomenclature is due to the 
reversal in the priority assignments for the sulfur substituents in 
going from 8 or 5 to 1* Consequently, the conclusion is reached 
that 1* has the Rc*Ss configuration and that sparsomycin (1) 
has the SC,RS configuration as depicted in the structural drawing. 
This assignment was confirmed by a single-crystal X-ray structure 
(21) For a discussion of NMR studies of diasleromenc sulfoxides, see 
Oae S In "Organic Chemistry of Sulfur", Oac. S , Ed , Plenum Press New 
York, 1977, pp 399-400 
(22) For the purpose of developing our initial roules to sparsomycin, we 
chose to prepare the RQ enantiomer which is derivable from commonly 
available L-cysteine Recently completed is the synthesis of 1, having the 
natural configuration from D-cysteine and from L serine 
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determination of 5 (vide infra) 
Intriguing is that the sign of the Cotton effect of the a-chloro 
sulfoxide 4 is the opposite of that of 8 Whereas the sulfur atoms 
of these two compounds have geometrically analogous arrange-
ments of their substituents, they have opposite R£ designations, 
merely because of reversed priority assignments of their sub-
stituents So that this point could be pursued further, the CD 
spectra of compounds 3, 7, 9, and 10 were also examined, note 
that in the compounds 7 - 1 0 the possibly perturbing benzyloxy-
carbonyl group is absent и From studying all of the spectra shown 
in Figure 1, the following conclusions may be reached. 
(i) For the sulfoxides 3,4, and 7-10 the sign of the Cotton effect 
centered at the absorption band in the region 220-230 πιμ is not 
influenced by the configuration of the α-carbon atom 2 4 
(ii) The sign of the Cotton effect changes by introduction of 
a chloro or alkylmercapto group on the methyl group which leads 
to a change in the R,S assignment of the sulfoxide 
The phenomenon of the correlation of the sign of the Cotton 
effect with configuration has been explained by Snatzke, at least 
for several other chromophores, through use of qualitative MO 
theory " 
Without further examples of the effect of heteroatomic sub­
stituents in addition to the two types studied here, we would 
certainly be premature in staling that the effect that we have 
observed to date in a few limited cases will ultimately be found 
to be a general phenomenon for substituted sulfoxides Clearly, 
more complete investigations are necessary to determine whether 
simple correlations exist between configurations and Cotton effect 
of nonmethyl sulfoxides Further studies of this nature are con­
tinuing in our laboratories 
X-ray Analysis. So that the assignment of configuration based 
upon C D ¡.pectra could be confirmed, a single-crystal X-ray 
structure determination of 5 was performed 26 This compound 
crystallizes from water as long, thin, orthorhombic needles in the 
form of a monoh>drate with 2 molecules/asymmetric unit A 
crystal was mounted in a sealed capillary filled with the super-
natant liquid from the recrystallization Mounting by more 
conventional techniques resulted in the rapid deterioration of the 
crystal, apparently due to loss of the water of hydration. The 
structure of one of the two unique molecules is shown in Figure 
2 By reference to the chiral carbon atom of the R configuration, 
the cínral sulfur atom can readily be seen to possess the R con-
figuration also 28 
Conclusion 
We have determined the absolute configuration of sparsomycin 
(1) by a combination of chiroptical, X-ray crystallographic, and 
chemical techniques Further work may now be directed toward 
determining the relationship between the sulfoxide configuration 
and the biological activity of sparsomycin Also, the principles 
delineated in this paper may be applied to the structural inves-
tigation of other compounds such as 7-glutamyl-marasmine29 that 
are related to sparsomycin 
(23) Amide and urethane bonds have an n,*· transition at 220-250 m, so 
that Ihe Collón effects observed for 3 and 4 musi be the result of two chro-
mophores, one inherently chiral, the other inherently symmetric but chiral 
perturbed 
(24) This conclusion is in accordance with the observations made with 
5-methylcysteine-S-oxide, sec ref 19 
(25) Snatzke G Ange'* Chem 1979, 91. 380-393 
(26) Crystals of 5 belong to the orthorhombic space group Pl\l\2{ with 
a = 13 4448 (3) A, * = 41 950 (6) А, с = 5 102 (2) A, and Ζ = 8 There 
are two C|2H|7SN04*H20 formula units per asymmetric unit Data were 
collected on an Enraf Nonius С AD4A diffractometer with use of Cu Κα 
X-radialion in the range 0 < 26 < 90° The structure was solved by using 
the MULTAN direct method programs and refined to values of 0 029 and 0 036 
for the 343 variables and 1237 observations with F
a
 > 3ff(F0) The computing 
was earned out on a PDP 1145 computer with use of the Enraf-Nomus 
Structure Détermination Package developed by Okaya and Frenz " 
(27) Okaya, Y In "Computing in Crystallography", Schenk H , Olthof-
Hazekamp, R , van Koningsveld, Η Bassi, G С , Eds , Delfi Lnivcrsity Press 
The Netherlands, 1978, pp 153-165 Frenz, В A Ibid, pp 64-71 
(28) Supplementary material 
(29) Gmelin, R , Luxa, H H , Rolh, К . Hôfle, G Phyiochem I97é, /5, 
1717-1721 
Experimental Section 
Circular dichroism spectra were measured with a Dichrograph II 
apparatus (Roussel-Jouan, France) The concentrations varied between 
7 0 x IO"1 mol L ' and 5 9 x 10 ' mol L"1, acetomtnle was used as 
solvent м For the Ή NMR spectra a Bruker WH-90 was used with 
Me4Si as an internal standard Thin-layer chromatography (TLC) was 
earned out with the use of Merck plates which were precoated with silica 
gel F-254 or silica gel 60 F-254 silanised, thickness 0 25 mm Spots were 
visualized with a UV hand lamp, iodine vapor, and, in the case of amines 
and amides, with nmhydrin TDM,3' respectively 
N-((Benzyloxy)carboayl)-S-(cbloroiiKtbyl)cystelDol S-Oxldes 3 and 
4 and N-((Bmzyloxy)carbonyl)-S-inethylcyst«nol S-Oxidcs 5 ind 6. 
The syntheses of compounds 3-6 have been described before,1*··15 detailed 
experimental descriptions are presented elsewhere 3 ! " 
S-Melhylcysteinol S-Oxides 7 and 8 and S-((MethyIthlo)in«thyl)-
cysteinol S-Oxldcs 9 and 10. Protection of the alcohol function of 3 or 
4 with the THP group and subsequent treatment with sodium methyl-
mercaptide gave the Ν,Ο-prolected derivatives of 9 and 10, respectively, 
these conversions have been described previously "* 
Removal of the N-Protecting Group. Ammonia was condensed until 
complete dissolution of the compound occurred After removal of the 
external cooling bath, sodium was added carefully to the rcfluxing am­
monia solution'4 until the blue color persisted for a few minutes The 
solvent was evaporated subsequent to the addition of a few crystals of 
ammonium chloride The residue thus obtained was extracted twice with 
chloroform Evaporation of the solvent gave a yellow oil, which was 
chromatographed under slightly increased pressure (10 cmHg) on silica 
gel (Merck 60-H) When CH2Cl2/CHjOH (v/v) was used as eluent in 
a ratio of 9 1 the O-protected derivatives of 9 or 10 were isolated in 
10-38% yield Subsequent elution with СН2СІ2/СН,ОН (85 15, v/v) 
gave the O-prolected derivatives of 7 or 8 in 20-30% yield The product 
ratios 7 9 and 8 10 varied from experiment to experiment All com­
pounds were homogeneous on TLC (СНгСІз/МеОН, 75 25, v/v Ή 
NMR (CDClj) 7-OTHP ä 1 62 (m, 6 H, OCHjíCWj),, 2 66 (s, 3 H, 
5 (O)Ctfj), 2 83 (d, 2 H, CHß(0)), 3 52 (m, 3 H, CHCHJO), 3 78 (m, 
2 H, OCH2CH2), 4 59 (br s, 1 H, OC(H)O), 8 OTHP 6 1 62 (m, 6 H, 
OCH2(CH2),), 2 63 (s, 3 H, S(0)CW,), 2 80 (m, 2 H, CW2S(0)), 3 53, 
(m, 3 H, CHCH20), 3 74 (m, 2 H OC#2CH2), 4 60 (br s, I H, OC-
( / 0 0 ) , 9-OTHP ä 1 60 (m, 6 H, OCH2(C//2),), 2 33 (s, 3 H, SCtfj), 
2 60-3 27 (m, 2 H. С Я ^ О ) ) , 3 47 (m, 3 H, CHCHjO), 3 71 (m, 2 H, 
ОСЯ2СН2), 3 67 and 3 89 (AB spectrum, 2 H, J = 13 5 Hz, S(O)-
CH2S), 4 58 (br s, 1 H, OC(H)O), 10-OTHP Í 1 60 (m, 6 H, OCH2-
(СЯЛз), 2 33 (s, 3 H, SCtfj), 2 85-2 89 (AB part of ABX spectrum, 2 
H, C>jS(0)), 3 55 (m, 5 H, CCH 20, H2NC//, ОСЯ2СН г), 3 67 and 
3 84 (AB spectrum, 2 H, J = 13 5 Hz, S(0)CW2S), 4 60 (br s, 1 H, 
ОС(Я)О) 
Removal of the О-Protecting Group. A solution of the O-protected 
dithioacetal-5-oxides 7, 8, 9, or 10 in ethanol, the pH of which was 
adjusted at 3 with 0 I N aqueous HCl, was refluxed The reaction, which 
took about 1 5 h, was monitored by TLC (silanised silica gel, eluent 
CHCl3/MeOH saturated with NH,, 9 1, v/v) When the reaction was 
complete, solid carbonate was added, and the resulting suspension was 
stirred overnight at room temperature Filtration and subsequent con­
centration to dryness gave a colorless oil which was extracted twice with 
acetomtnle Evaporation of the solvent gave the unprotected amino 
alcohol in quantitative yield All four compounds thus prepared were 
homogeneous on TLC (silanised silica gel, eluent as used for monitoring 
the reaction) The enantiomeric purity of 9 and 10 was determined by 
Ή NMR spectroscopy in CDClj A racemic mixture22 of 9 showed in 
the presence of tns[3-((trinuoromethyl)hydroxymethylene)-D-campho-
(30) Although CD Spectra of ammo-containing compounds are commonly 
obtained from solutions to which acid has been added, we were precluded from 
following this procedure because of the acid-sensinvity of our compounds, 
especially the alkylmercapto sulfoxides which, as a general class, arc very 
well-known to undergo facile acid-catalyzed hydrolysis (a) Ogura, Κ , 
Tsuchihashi, G , Tetrahedron Leu 1971,3151-3154 (b) Richman, J E, 
Herrmann, J L , Schlessmger R H ibid 1973, 3267-3270 (c) Schill, G , 
Jones, Ρ R Synihesis 1974, 117-118 If we had been able to use acidic 
conditions, a complication may have been the quite different basicities of the 
amines 7-10 compared to those of the carbamates 3 and 4 Furthermore, we 
have already commented on the apparent absence of effects arising from the 
configuration of the cr-carbon atom and, to a limited extent, changes in the 
nature of substituents about this position 
(31) Arx, E von, Faupel, M, Brugger, M J Chromatogr 1976, 120, 
224-228 
(32) Ottenheijm, H С J , van Nispen, S Ρ J M Tijhuis, M W , Lis-
kamp, R M J , submitted for publication 
(31) Hclquist, Ρ , Hwang, D -R , Shekhani, M S , manuscript m prepa­
ration 
( 34) The procedure of Nesvadba and Roth was applied, using a simplified 
apparatus Nesvadba, H , Roth, H Monclsh Chem 1967, 98, 1432-1436 
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rato]ytterbium(III) two well-separated signals for the SCH, group The 
more downfield shifted signal could be assigned to the AcAs enantiomer, 
the other one to the S
c
£
s
 compound The same phenomenon was ob­
served with a racemic mixture of 10 According to this method, com­
pounds 9 and 10 were found to be optically pure With the methyl 
sulfoxides 7 and 8, no chemical shift difference could be observed in the 
presence of the shift reagent used or with the Pr or Eu analogues Ή 
NMR (CDClj/CD2Clj) 7 S 2 64 (s, 3 H, S(0)C#j), 2 84 (d, 2 H, 
CHß(0)), 3 30-3 71 (m, 3 H, CHCH20), 8 5 2 63 (s, 3 H, 8(0)СЯз) 
2 55-3 02 (m, 2 H, CH£{0)), 3 30-3 80 (m, 3 H, СЯС//20), 9 Í 2 33 (s, 3 H, SCH,), 2 87 and 3 05 (8 lines, AB part of ABX spectrum, 2 H, 
/AB - 13 Hz, Удх - 5 Hz, ^ B X = 6 Hz, СНСЯзЗСО)), 3 33-3 71 (m, 
3 H, CHCH20), 3 72 and 3 86 (AB spectrum, 2 H, J = 13 5 Hz, S-{0)CH£), 10 6 2 34 (s, 3H, SCH,), 2 80-3 00 (AB part of ABX spec­
trum, 2H, CHCHjSiO)), 3 33-3 71 (m, 3H, CHCHJO), 3 73 and 3 81 
(AB spectrum, 2H, J = 13 8 Hz, S(0)C#iS) 
Compounds 7 and 8 from 6 and 5, Respectively, The N-protected 
alcohol 5 or 6 " 3 J were treated with sodium in liquid ammonia as de­
scribed for the preparation of the O-protected derivatives of 7-10 When 
the reaction was complete and no sodium consumed anymore, slightly 
more than 1 equiv of ammonium chloride was added, after which the 
solvent was evaporated 1 he residue was extracted twice with aceto-
nitnle, and subsequently the solvent was evaporated The amino alcohols 
8 and 7, both obtained in 80% yield, were identical (TLC, Ή NMR) 
with those obtained above 
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The total syntheses of sparsomycin (1), a naturally occurring antibiotic and antitumor substance, and its three 
stereomers 65-67 are described for the first time In a convergent approach, the carboxyhc acid 2 and the amine 
3 were synthesized followed by amide formation (Scheme I) The acid 2 was prepared (23% yield) from 
6-methyluracil (12) by coupling the aldehyde 19 with the phosphorane 20 (Scheme III). The synthesis of the 
amine 3, especially challenging because of the monoxodithioacetal moiety, was accomplished by the reaction of 
a cysteine α-halo sulfoxide derivative 8 with sodium methylmercaptide (Scheme Π, route B). Alternatively, oxidation 
of the dithioacetals 23-26 was unsatisfactory, yielding predominantly the undesired regioisomers 27B-30B (Table 
I). Procedures are given for the preparation and separation of the α-halo sulfoxide diastereomers 33,35, 36-41, 
and 52-54. By use of these procedures, the amino alcohol monoxodithioacetals 3 and 60 were prepared in five 
steps (40% yield) from the D-cystine derivative 59 having the S
c
 chirality of sparsomycin (Scheme VII) Finally, 
sparsomycin (1) and the S
c
 diastereomer 67 were prepared (40% yield) by mixed anhydride coupling of 2 with 
3 and 60, respectively (Schemes I and X) In addition, syntheses of the RQ enantiomer 65 and corresponding 
diastereomer 66 are described (Scheme IX) The CD spectra of 1 and its three stereomers are also discussed 
Sparsomycin (1), a metabolite of Streptomyces spar-
sogenes1 or Streptomyces cuspidosporus,2 has attracted 
much attention because of its activity against various tu-
rnors,
3
·
4
 bacteria2 4 I fungi,
5
 and viruses6 and for studies7·8 
on inhibiting protein biosynthesis. On the basis of spec­
troscopic and degradation studies9 the presently accepted 
structure 1 was proposed by Wiley and MacKellar. The 
chiral carbon atom was shown to have the S configuration; 
however, the chirahty of the sulfoxide sulfur atom was not 
determined. 
Although sparsomycin in limited amounts is accessible 
from natural sources,10 a total synthesis would be desirable 
for several reasons. First, a synthesis would confirm the 
assigned structure and would allow the chirality of the 
sulfoxide to be determined. Second, an efficient synthesis 
would provide sparsomycin in quantities sufficient for 
further clinical testing and other studies of its biological 
activity. Third, small alterations in a flexible synthesis 
might permit the preparation of a number of analogues 
for structure-activity studies. Finally, a synthesis of 1 
constitutes a challenge, because among its several func­
tionalities is that of the formaldehyde monoxodithioacetal 
function К8(0)СН28СНз. This moiety is rarely encoun­
tered" in nature but has recently attracted much attention 
because of its synthetic utility.12 
The synthesis of (S)-deoxosparsomycin by us1 3 and 
others14,15 had substantiated structure 1; however, no total 
synthesis of this antibiotic was reported until recently 
when Helquist16 and we17,19 each described in preliminary 
reports different routes to the йс enantiomer of sparso­
mycin. In addition, the sulfoxide could be assigned19 the 
R configuration as depicted in structure 1 (Scheme I). 
This assignment is based on chiroptical studies and X-ray 
crystallographic analysis of precursors of sparsomycin (vide 
infra). The present publication presents in detail our 
synthetic approaches to sparsomycin and its three ste­
reoisomers. These syntheses confirm the Wiley and 
MacKellar structure and should provide a practical source 
of sparsomycin and its analogues for further study of its 
biological activity. 
Strategy. Sparsomycin (1) may be considered as an 
amide derived by the coupling of the 0-(6-methyl-
' Dedicated to Professor Dr R J F Nivard on the occasion of his 
60th birthday 
Reprinted from The Journal of Organic Chemistry, 1981,46, Ί273 
Copyright © 1981 bv the American Chemical Society and reprinted by permission of the copyright owner 
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uracilyl)acrylic acid (2) and the amine 3 (Scheme I). The 
latter can be viewed as a derivative of D-cysteine (5) having 
( D A D Argoudelis, R R Herr, Antimicrob Agents Chemother ,760 
(1962) 
(2) E. Higashide, Τ Hasegawa, M Shibita, К Mizuno, and H Akaike, 
Takeda Kenkywtho Nempo, 25,1 (1966), Chem Abstr, 66,54328 (1967). 
(3) L Slechta, "Antibiotics Г D Gottbeb, Ρ D Shaw, Eds, Springer 
Verlag, New York, 1967, ρ 410 
(4) Τ F Brodasky, J Pharm Sci, 52, 233 (1963), Κ Ε Pnce, R E 
Buck, and J Lein, j4n¿tmtcro6 Agents Chemother , 505 (1964) 
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a reduced CO2H function and its sulfhydryl function al­
kylated and oxidized. 
Component 2 could be prepared in two ways by using 
a Wittig condensation of a C(5)-substituted 6-methyluracil 
(4) More challenging was the synthesis of component 3, 
since the unsymmetrical monoxodithioacetal moiety is acid 
labile12 and is also capable of undergoing the thermal- or 
base-induced β eliminations for which sulfoxides are prone. 
Two fundamentally different approaches are reported 
here. Initially we studied the regioselective oxidation of 
a dithioacetal (7) derived from cysteme 6 (Scheme II, route 
A). Our second approach (route B) employed the reaction 
of an a-chloro sulfoxide derivative of cysteine (8) with 
sodium methylmercaptide. A third approach (route C), 
featuring sultines 9 as intermediates, will be subject of a 
future report.20 A fourth approach (route D) has been 
explored successfully by Helquist,1621 who employed the 
sulfenylation of an a-sulfinyl carbanion 10. Routes B-D 
have in common the introduction of the /3-sulfur atom 
subsequent to the oxidation of the α-sulfur atom. Inci-
(5) S Ρ Owen, A Dietz, and G W Caminer, Antimtcroò Agents 
Chemother, 772 (1962) 
(6) L Thiry, J Gen Virol, 2 (paît 1), 143 (1968) 
(7) А Б Smith and D Τ Wigle, Eur J Bloche m , 35, 566 (1973) 
(8) I Η Goldberg, Cancer Chemoth Rep , Part 1 58, 479 (1974), D 
Vaaquez, FEBS Lett, 40 (Suppl), S63 (1974) 
(9) (a) Ρ F Wiley and MacKellar, J Am Chem Soc ,92, 417 (1970), 
(b) Ρ F Wiley and MacKellar, J Org Chem, 41, 1858 (1976) 
(10) The isolation of sparsomycin by cultivation of fungi has been 
patented From Streptomyces sparsogenes, see Upjohn Co, British 
Patent 974 541 (1964), Chem Abstr , 62, 5855d (1965) From Strepto 
myces cuspidosporus, see E Higashide, M Shibata, Τ Hasegawa, and 
К Mizuno, Japanese Patent 7134196 (1971), Chem Abitr, 76, 2549 
(1972) 
(11) The only other natural «ample is 7 glutamylmarasmme К 
Gmelin, Η -Η Іліжя, К Roth, and G Höfle, Phytochemistry 15, 1717 
(1976) 
(12) The dithioacetal monoxide is a masked carbonyl compound, 
whose carbanion can serve as an acyl anion equivalent See F I K 
Ogura and G Tsuchihashi, Tetrahedron Lett, 3151 (1971) In addition, 
their acidolytic cleavage can be used to prepare unsymmetnc disulfides, 
see Y Kishi, Τ Fukuyama, and S Nakatsuka, J Am Chem Soc , 95, 
6490 (1973), В Zwanenburg and Ρ Kielbasinski, Tetrahedron, 35,169 
(1979) 
(13) For a prehnunaiy report, see Η С J Ottenheijm, S Ρ J M van 
Nispen and M J Sinnige, Tetrahedron Lett, 1899 (1976) 
(14) С С L. Lin and R J Dubois, J Med Chem , 20, 337 (1977) 
(15) С К Lee and R Vince, J Med Chem , 21, 176 (1978) 
(16) Ρ Helquist and M S Shekhani, J Am Chem Soc , 101, 1057 
(1979). 
(17) H С J Ottenheijm and R M J Liskamp, Tetrahedron Lett, 387 
(1978) 
(18) H С J. Ottenheijm, R M J Liskamp, and M W Tijhuis, Tet­
rahedron Lett 387 (1979) 
(19) H С J Ottenheijm, R M J Liskamp, Ρ Helquist, J \\ Lauher, 
and M Shekhani, J Am Chem Soc , 103, 1720 (1981) 
(20) R M J Liskamp, H J M Zeegers, and H С J Ottenheijm, 
manuscript in preparation. 
(21) Ρ Helquist, M S Shekhani, and D -R. Hwang, manuscript in 
preparation. 
R 1 N H » r < H 
(«I (1) 
21 R = CO2H Ri = H 
22 R = СОгМе R, = H 
23 R = COjMe R, = Boc 
24 R = СОгН Ri = Вое 
25 R = CH2QH R, = Вое 
2*6 R = CH2OH R, = Ζ 
>* , ^ ^ " 
27 Д 
26 A 
30 A 
27 В 
¿"βΒ 
ÍS В 
зов 
Table I. Conversion of 23-26 into 
27A-30A and 27B-30B 
overall 
yield," % 
rel yield,6 
A 
% 
2 3 -
2 4 -
2 5 -
2 6 -
• 27 
•28 
•29 
- 3 0 
9 2 
7 8 
9 6 
9 2 
20 
16 
3 3 
25 
8 0 
84 
67 
7 5 
" After column chromatography * Based on Ή NMR 
spectroscopy before chromatography 
dentally these four approaches also represent general 
methods for the preparation of carbonyl compounds.12 
Acid Component 2. The two procedures developed13 
for the preparation of the /3-(6-methyluracilyl)acrylic acid 
(2) commenced from 5-(hydroxymethyl)-6-methyluracil 
(13, Scheme III). This alcohol was prepared from com­
mercial 6-methyluracil (12) with formaldehyde and aque­
ous NaOH by a variation of Kircher's method.22 Yields 
of 70-80% could be reached if these reagents were used 
in molar ratios of 1:3:2. Treatment of 13 with HBr in 
glacial acetic acid gave ii23 (79% yield), which upon re­
action with (СбН
в
)зР in DMF yielded quantitatively the 
phosphonium salt 15. η-Butyl glyoxylate (16) was pre­
pared in variable yields from ra-butyl dimethoxyacetate by 
distillation from РгОд. A more satisfactory preparation 
of 16 was the oxidation24 of dibutyl tartrate with NaI04 
according to Atkinson.25 In contrast to their report, 
however, we find that the hemihydrate of 16 is actually 
isolated. From this, 16 may be obtained by distillation 
from P 2 0 5 . The Wittig coupling of 15 with 16 in DMF gave 
17 in low yields (5-15%), regardless of the reaction con­
ditions and bases used. This low yield might be explained 
by deprotonation of either the uracil nitrogen or the C-
(6)-СНэ group of 15 to give an eio-methyleneuracil de­
rivative and (CeHsJaP. Indeed, the latter could be detected 
on TLC, along with the expected (CgHs^PO. The overall 
yield by the route 12 —» 15 -• 17 was only 6%. 
In a variation of the Wiley-MacKellar procedure9 we 
employed the inverse of the previous Wittig reaction, i.e., 
coupling of 19 with 20, for a more satisfactory synthesis 
of 2. The aldehyde 19 was prepared by us from 13 (63% 
yield) by reaction with КзЗгОв and a trace of AgNOs.26·27 
(22) W Kircher, Justus Liebigs Ann Chem , 385, 293 (1911) See also 
ref 9b In addition, it was found that Chne's procedure for this reaction 
gave only polymeric material R E Cline, R M Fink, and К Fink, J 
Am Chem Soc , 81, 2521 (1959) 
(23) Υ Ρ Shvachkin and L A Syrtsova, Zh Obshch Khim, 34,2159 
(1964), Chem Abstr , 61, 9575h (1964) 
(24) In our hands preparation of a pure sample of 16 according to F 
J Wolf, J Wyland, N J Leonard, and L A Miller, Org Synth , 35,18 
(1966), failed 
(25) С M Atkinson, С W Brown, and J С Б Simpson, J Chem 
Soc , 26 (1956) 
(26) R Brossmer and D Ziegler, Chem Ber, 102, 2877 (1969) 
(27) Most of the conventional reagents for the conversion of alcohols 
into aldehydes were found to be unsatisfactory, for instance, the chromic 
oxide oxidation used by Wiley and MacKellar0*1 gave a 20% yield only. 
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Coupling of 19 with 20 gave 18 (41% yield); the overall 
yield by this route (12 — 19 — 18) is 23%. 
Alkaline hydrolysis of 17 or 18 gave quantitatively the 
acid 2, identical with the product obtained by Wiley and 
MacKellar.9 
Amine Component 3. Routes A and В (Scheme II) 
were explored initially by using the more readily available 
L-cysteine {R configuration) as the starting material. 
Route A. L-Cystine was reduced with sodium in liquid 
NH 3, treated with chloromethyl methyl sulfide
28
 and 
acidified to give 21 (Chart I) in 61% yield. The amino acid 
ester 22 was prepared in 87% yield by treatment with 
CH3OH and SOCI2, followed by deprotonation with (C2-
ЬУэМ. Compound 22 was used for the preparation of 
enantiomeric (S)-deoxosparsomycin (62) via 61 as is de­
scribed below. The ester 61 and the alcohol 62 are difficult 
to purify because of their high polarity. Therefore, the 
regioselective oxidation 7 —-11 was studied on the more 
easily handled cysteine derivatives having the conventional 
(benzyloxy)carbonyl (Z) or (tert-butyloxy)carbonyl (Boc) 
N-protecting groups. In order to study the influence of 
group R on the regioselectivity of the oxidation, we pre­
pared the acid 24 and the alcohols 25 and 26 in addition 
to 23. Compound 23 was prepared from 22 by standard 
techniques. Protection of the amino function of 21 and 
reduction (LÌBH4) of 23 afforded 24 and 25, respectively. 
The alcohol 26 was prepared from the corresponding N-
protected ester by reduction (LÌBH4). Treatment of the 
dithioacetals 23-26 with 1 equiv of NalO« gave a mixture 
of the corresponding monoxodithioacetals 27A-30A and 
27B-30B. Table I shows that the less hindered /9-sulfur 
atom is attacked preferentially. In addition, it can be 
concluded that on oxidation of compounds 23-25, the ratio 
of A to В varies slightly but significantly depending upon 
the nature of R, reaching a maximum for R = CHjOH.29 
(28) This u a general method for the preparation of S-alkylated cys­
teine derivatives according to P. J Б Brownie«, M E Coi, В О 
Handford, J С. Manden, and G T. Young, J Chem Soc , 3832 (1964). 
4 2 -
S c h e m e V 
OTHP ^ О Т Н Р 
«· Η2Ν»·|··Η 
0 ' * 
46 Х = 5 С Н з 
48 X = H 
43 »•Η2Ν»·Ξ·«Η 
Rc-Ss ij X = S C H 3 . R c - R s 
49 Χ = Η 
Structures 27A-30A and 27B-30B were assigned by means 
of spectroscopy and an independent synthesis of 29A (vide 
infra). As a mixture of all possible stereoisomers of A and 
В were formed, e.g., 25 (ñc) — 29A {Rc-Rs) + 29 Wcr-Ss) 
+ 29B (ßc-Äs) + 29В (Йс-Ss), in which the desired re-
gioisomers A were by far the minor components, this route 
was temporarally abandoned.30 
Route B. The a-chloro sulfoxide 8 was prepared31 by 
reaction of CH2N2 with a sulfmyl chloride,32·33 synthesized 
from the corresponding disulfide with Cl2 and acetic an­
hydride.3 4 Thus, treatment of iV-[(benzyloxy)-
carbonyl]-L-cystine methyl ester (31) with 3 equiv of CI2 
in the presence of АсгО gave the sulfmyl chloride 32 (Chart 
11) as a stable, white solid. Reaction of 32 with dry CH2N2 
gave, according to 'H NMR spectroscopy, a mixture of the 
two diastereomeric a-chloro sulfoxides 33 (R
c
Ji
s
) and 33 
(ßc,Ss). If an undried etheral CH2N2 solution was used, 
up to 30% of the sulfinate ester 34 could be isolated be-
sides 33 The above procedure with a slight but crucial 
modification was applied to the preparation of the α-bromo 
sulfoxides 35 (Rc,Rs) and 35 (nc-^s) m that 32 was added 
dropwise to a solution of CH2N2 and LiBr in ether-THF.3 5 
The reverse order of addition gave mainly dimeric products 
of unknown structure. 
The nucleophilic displacement of halogen in 33 or 35 by 
СНз8~ was expected to proceed normally as it is a known 
reaction3* for a-chloro sulfoxides. However, treatment of 
33 or 35 with CHaSNa gave the dehydroamino acid de­
rivative 44 as the main product (Scheme IV). This β 
(29) We are inclined to contribute this effect to anchunenc aasiatance, 
if R = CH2OH, a cyclic intermediate can be formulated, which is s u or 
eight membered, depending upon the involvement of S(a) or S(ß), re-
spectively As the six-membered ring is favored, this should lead to 
Oxidation at S(a) Similar cyclic intermediates have been formulated for 
the oxidation of 1,2 diols with КаЮд, e g, Η Ο House in "Modern 
Synthetic Reactions", 2nd ed , W A Benjamin, New York, 1972, ρ 354. 
(30) A search for a method for the regio- and diastereoselective oxi­
dation of dithioacetals 25 and 26 is in progress In addition, we are 
studying the regioselective reduction of dithioacetal S(o),S(/3)-dioxides, 
so far this approach has failed since the reaction conditions used induced 
β eliminations to yield 44 
(31) Attempts to convert a suitably protected S-methyl-L-cysteme 
S-oxide derivative into the corresponding compound 8 by a known pro­
cedure [S Inuchimja and G Tsuchihashi, Synthesis 558 (1970); N 
Kumeda, J Nokanu, and M Kinoshito, Bull Chem Soc Jpn, 49, 256 
(1976)] failed Nor was it possible to prepare a S(ha]omethyl)-L-cysteme 
derivative from CH2X2 (X = CI or Br) and cysteine, regardless of the 
reaction conditions used, the corresponding dithioacetal RSCHgSR was 
formed A G van Veen, Reel Trav Chim Pays Bas, 54, 493 (1935). 
(32) E. Ayca, Istanbul Umv Fen Fak Мест , Sen С, 22, 371 (1957) 
(33) We thank Professor Venier for bringing this reaction, developed 
for the preparation of simple α-halosulfoxides, to our attention. С G. 
Vemer, H -H Hsieh, and H J Barager, J Org Chem , 38, 17 (1973) 
(34) Ι В Douglass and R V Norton, J Org Chem, 33, 2104 (1968). 
(35) С G Venier and H J Barager HI, J Chem Soc, Chem Com­
mun , 319 (1973) 
(36) К Ogura and G Tehuchihashi, J Chem Soc , Chem Commun, 
1689 (1970) 
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elimination reaction could be prevented by reduction of 
the ester function of 33 or 35 with LiBH4 in monoglyme 
to yield a mixture of the diastereomenc alcohols 36, 37 and 
38, 39, respectively Whereas the diastereomers of 33 or 
35 could not be separated, the alcohols 36 (21% yield) and 
37 (34% yield) could be separated easily by column 
chromatography. The yields given are based on 31. The 
assignment of the absolute configurations will be discussed 
below. 
Direct conversion of 36 39 into the desired corre­
sponding monoxodithioacetals 42 and 43 failed treatment 
with CHaSNa in C2H5OH gave the cyclic urethane 45 
(Scheme IV) as the main product (30% yield). To cir­
cumvent this cyclization, we protected the alcohol function 
of 36 or 37 with the tetrahydropyranol group37 and ob­
tained 40 or 41, respectively. Finally, treatment of 40 and 
41 with 1.2 molar equiv CH^SNa18 gave the monoxodi­
thioacetals 42 and 43, respectively, in quantitative overall 
yield. 
At this stage the N-protecting group, introduced to avoid 
side reactions in the preceding steps, had to be removed ю 
We had noted that 42 and 43 were stable to liquid NHj,4 0 
so du Vigneaud's procedure41 for removal of the Ζ group 
was applied. When 42 or 43 in refluxing NH3 was treated 
carefully42 with Na in liquid NH3, the desired amines 46 
and 47 were isolated (Scheme V), though in low yields 
(20-30%). These amines were used for the first synthesis 
of the enantiomer 65 and diastereomer 66, respectively, 
of sparsomycin (1) (vide infra). 
Regardless of conditions used for the deblocking of 42 
or 43, a ninhydrin-positive compound was isolated as the 
main product (30-40% yield). Structure 48 and 49, re­
spectively, were assigned to these byproducts on the basis 
of independent syntheses (see Experimental Section). 
These products, formed by a reductive scission of the C-S 
bond, were found to be identical with the intermediates 
used by Helquist16 in approach D (Scheme II). Monitoring 
the Na/NHs reaction by TLC revealed that Ζ removal and 
C-S bond cleavage are competing reactions. Because of 
the inefficiency and poor reproducibility of this reaction, 
we decided to prepare a derivative of 42 and 43 having an 
N-protecting group, whose cleavage conditions are more 
compatible with the monoxodithioacetal moiety. 
The base-labile [[(methylsulfonyl)ethyl]oxy]carbonyl 
(Msc) group43 and the (trichloroethoxy)carbonyl (Toe) 
group,44 removable under neutral conditions, were found 
to be unsuitable; their removal was accompanied to a large 
extent by β elimination. We had noticed, however, that 
the THP group of 63 and 64 could be removed under 
mildly acidic conditions (vide infra), indicating that the 
(37) J Η van Boom and J D M Herscheid, Synthesis, 3,169 (1973) 
(38) The quality of the CHaSNa was found to be crucial for the success 
of this reaction Of all the procedures used, only the reaction of MeSSMe 
with Na m liquid NH3 according to F Б Williams and Б Giebauer-
Fuelnegg, J Am Chem Soc , 53,352 (1931), gave CH3SNa that fulfilled 
our requirements The purity was checked gravimetncally by reaction 
of 2,4-dinitrofluorobenzene with the mercaptide to yield its 2,4-dinitro-
benzene derivative 
(39) For removal of the Ζ group the usual acid cleavage had to be 
avoided, because of the acid-labile monoxodithioacetal group In addi 
tion, catalytic hydrogénation of compounds containing bivalent sulfur 
generally fails, due to catalyst poisoning 
(40) Palladium-catalyzed hydrogénation in liquid NHj according to J 
Meienhofer and К Kuromizu, Tetrahedron Lett, 3259 (1974), gave only 
starting material 
(41) R H Sifferd and V du Vigneaud, J Biol Chem, 108,753 (1935) 
(42) The procedure of H Nesvadba and H Roth, Monatsh Chem , 98, 
1432 (1967), was applied with a simplified apparatus 
(43) G Tesser and I С Balvert-Geers. ¡nt J Pept Protein Res , 7, 
295 (1975) 
(44) Τ В Windholz and D В R. Johnston, Tetrahedron Lett, 2555 
(1967). 
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RStOCHjSCHa function had a greater acid stability than 
we had originally anticipated. Therefore we chose to 
synthesize the amine fragment by employing the (tert-
butyloxy)carbonyl (Boc) group which is removable in 
CF3COOH at 0 "C. Thus, [(tert-butyloxy)carbonyl]-L-
cystine methyl ester 50 (Chart III) was converted into the 
a-chloro sulfoxides 53 and 54 (47% yield, ratio 1:2) via 
intermediates 51 and 52 as has been described for the 
syntheses of 36 and 37. It is noteworthy that the Boc group 
is stable under the reaction conditions employed for the 
synthesis of 51, i.e., treatment with АсгО and CI2 and the 
attendant formation of AcCl. Compounds 53 and 54 could 
be separated easily and were each converted nearly 
quantitatively into the previously prepared (Chart I, 29A) 
monoxodithioacetals 55 and 56 by treatment with CHsSNa. 
Finally, the amino alcohols 57 and 58 were prepared 
quantitatively by treatment of 55 and 56, respectively, with 
СГчСООН at 0 "C and subsequent deprotonation with an 
ion-exchange resin (Scheme VI). 
The conversions 53 -• 55 -» 57 and 54 —• 56 -• 58 de­
serve further comment. First, when the reactions are done 
in reverse order, i.e., removal of the Boc group prior to the 
substitution reaction, unidentified side products are 
formed in addition to the desired compound during the 
last reaction. A possible side reaction might be the in­
tramolecular displacement of chloride by the amine 
function. Second, it is unnecessary to protect the alcohol 
groups of 53 and 54 prior to treatment with CHaSNa, as 
these alcohols, unlike 36 and 37, do not form 45. Third, 
care has to be taken to avoid epimerization of the sulfoxide 
sulfur atom. It was noticed that during silica gel chro­
matography of the crude reaction mixture of 54 —• 56, the 
diastereomer 55 is formed. As compounds 55 and 56 are 
not interconvertable by chromatography on silica gel in 
the absence of NaCl, the formation of 55 evidently arises 
by a silica gel/NaCl-catalyzed epimerization of the sulf­
oxide sulfur atom.45 Finally, 'H NMR spectra of the 
(45) Whereas the HCl-catalyzed racemization of sulfoxides is well 
established, we are not aware of a precedent for this reaction E Ciuf-
faiin, et al, J Chem Res, Synop , 270 (1978) 
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amino alcohols 57 and 58 in the presence of a chiral shift 
reagent showed that their enantiomeric purity is greater 
than 95%. From this we concluded that no racemization 
or epimerization had occurred during the reactions leading 
to 57 or 58. 
Having established this, the amino compounds 3 and 60 
were prepared in five steps, starting from the D-cystine 
derivative 59 having the S
c
 chirality (Scheme VII) as oc­
curs in sparsomycin (1). The overall yield of this sequence 
of five reactions is 40%. 
The absolute configuration of the sulfoxide sulfur atom 
of 1 was determined1' by CD studies of the intermediates 
36, 37, 57, and 58 as well as compounds 48-49 after THP 
removal. This assignment has been confirmed19 by X-ray 
analysis of the ]V-carbobenzyloxy derivative 48, lacking the 
THP group. 
Coupling of the Fragments. (S)-Deoxo-
sparsomycin. Coupling of 2 with 22 was achieved by 
means of dicyclohexylcarbodiimide (DCC) and hydroxy-
benztriazole (HOBT) in DMF, yielding 61 in 60% yield 
(Scheme VIII). Selective reduction of the ester function 
with L1BH4 in monoglyme gave the enantiomer of deoxo-
sparsomycin 62 in 63% yield after column chromatography 
(Sephadex LH-20). The Ή NMR spectrum was similar 
to that reported for 1, except for the presence of a singlet 
at δ 3.96, due to the SCHjS protons. 
Sparsomycin (1) and Its Three Stereoisomers 65-67. 
The reagents DCC and HOBT again were used for the 
coupling of the O-protected amino alcohols 46 and 47 with 
2, providing 63 and 64, respectively, in 40-50% yields 
(Scheme IX). The THP group could be removed by re-
fluxing a slightly acidified ethanol solution of 63 and 64 
for 15 min to give 65 and 66, respectively, in 70-80% yields 
after column chromatography (Sephadex LH-20). To 
avoid tedious purification of the polar compounds 65 and 
66, the precursors 63 and 64, respectively, were carefully 
chromatographed (silica gel). Compound 65 proved to be 
identical in all respects with sparsomycin46 (1), but, as 
expected, it exhibits a negative specific rotation. Thus 65 
is the enantiomer and 66 the R
c
 diastereomer of 1. Com­
pounds 65 and 66 are easily distinguished by different R/ 
values on TLC and by their Ή NMR spectra: 65 shows 
three lines for the CHCH2S(0) protons, whereas 66 dis­
plays the eight lines typical of the AB part of an ABX 
spectrum. Both compounds show the four lines of an AB 
spectrum for the S(0)CH2S protons, however, their 
chemical shift values differ slightly but significantly. 
(46) We a « grateful for Dr Ρ F Wiley (Upjohn Co ) for bupplying 
us with a sample of authentic sparsomycin 
H N 
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According to these criteria, and to the specific rotation of 
65, no epimerization occurs during the coupling and de-
protection reactions. 
An alternative route to 65 and 66 is the coupling of 2 
with the amino alcohols 57 and 58, respectively (Scheme 
IX). While this approach avoids the protection of the 
alcohol function, it has the disadvantage that reactants and 
product are poorly soluble in typical organic solvents; in 
addition, purification of the end products 65 and 66 is a 
cumbersome task. A variety of coupling procedures in­
cluding EEDQ,47 IIDQ,48 Woodward's L reagent,« p-
nitrophenyl trifluoroacetate,50 DCC/HOBT,5 1 DCC/ 
HONSu,52 and ethyl chloroformate53 were studied in em 
attempt to improve the yield of this step. The last two 
gave optimal results, in that yields were acceptable 
(33-40%) and that complete separation of side products 
was possible by reverse-phase HPLC or chromatography 
on Sephadex LH-20. 
Finally, sparsomycin (1) and the iS
c
 diastereomer 67 
were prepared in 33% and 40% yields, by coupling 2 with 
the amino alcohols 3 and 60, respectively, by the mixed 
(47) В Belleau and G Malek, J Am Chem Soc , 90, 1651 (1968). 
(4β) Y KiBo, Y Kai, ала H Yayima, Chem Pharm Bull, 21, 2507 
(1973) 
(49) D J Woodman and A I Davidson, J Org Chem, 38, 4288 
(1973) 
(50) S Sakakibara and N Inukai, Bull Chem Soc Jpn , 37, 1231 
(1964) 
(51) W König and R Geiger, Chem Ber, 103, 788 (1970), G С. 
Windridge and E С Jorgensen, J Am Chem Soc, 93, 6318 (1971). 
(52) G W Anderson, J Б Zimmerman, and F M Callahan, J. Am. 
('hem Soc , 86, 1839 (1964) 
(53) Τ Wieland and Η Bernard, Justiu Ueblgs Ann. Chem., S72, ISO 
(1951) 
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Figure 1. CD spectra of compounds 1 and 65-67 in acetonitrile. 
anhydride method (Schemes I and X). Compound 1 thus 
obtained was identical in all respects with an authentic 
sample46 of sparsomycin, whereas 67 was identical with 
diastereomer 66, differing only in the sign of specific ro­
tation. The yield of this six-step synthesis of 1 is 16% 
based on 59. 
The CD spectra of sparsomycin (1) and its stereomers 
65-67 are shown in Figure 1. It appears that the sulfoxide 
and amide chromophores can be considered separately; the 
sign of the Cotton effect at 230 nm (sulfoxide function) 
is not influenced by the sign of the band at 265 nm (amide 
function). The sign of the Cotton effect in the region 
230-240 nm is a criterion of the chirality of the sulfoxide 
function: a positive sign correlates with an S
s
 configuration 
and a negative sign with an Rg configuration. This agrees 
with our earlier findings19 on precursors for 1. The Cotton 
effect at 260-270 nm is due to an n,ir* transition of the 
amide bond. The sign of this band is determined by the 
chirality of the carbon atom; a positive sign correlates again 
with an S
c
 configuration and a negative sign with an ß c 
configuration. 
Discussion 
The syntheses of 1 and its stereoisomers 65-67 described 
herein provide definite proof of sparsomycin's structure. 
In addition, they made possible the assignment of the 
chirality of the sulfoxide sulfur atom. The most efficient 
route involved coupling 2 with the amino alcohol 3, pre-
pared from [(tert-butyloxy)carbonyl]-D-cystine methyl 
ester 59. The overall yield (16%) of this six-step approach, 
while being acceptable, is lowered chiefly by the ineffici-
ency (40% ) of the coupling of 2 with 3. Unfortunately, all 
of the coupling reactions of 2 with the amines described 
in this report proceeded in low yields. This might be due 
to a decrease in nucleophilicity of the «.^-unsaturated 
carboxylate anion of 2 and to acylation of the uracil ring. 
Work is presently in progress to improve the coupling 
procedure (e.g., using diethyl cyanophosphate64), to 
streamline the synthesis of 11 via the sultine approach 
(route C), to prepare a series of analogues of 1, and to 
synthesize Y-glutamylmarasmine.11 
Experimental Section 
Ή NMR spectra were measured on Varían Associates Model 
T-60 or a Bruker WH-90 spectrometer with Me4Si or t-BuOH as 
an internal standard. CDCI3 was used as the solvent unless stated 
otherwise. IR spectra were measured with a Perkin-Elmer 
spectrophotometer. Model 997, and UV spectra on a Perkin-Elmer 
(64) S. Jew, S. Terashima, and K. Koga, Tetrahedron, 35,2337 (1979). 
Ottenheijm et al. 
spectrophotometer, Model 555. For determination of the specific 
rotation, a Perkin-Elmer 241 Polarimeter was used. Circular 
dichroism spectra were measured with a Dichrograph II apparatus 
(Roussel-Jouan, France). 
Mass spectra were obtained with a double-focusing Varían 
Associates SMI-B spectrometer. Melting points were taken on 
a Kofler hot stage (Leitz-Wetzlar) and are uncorrected. Thin-layer 
chromatography (TLC) was carried out by using Merck precoated 
silica gel F-254 plates (thickness 0.25 mm). Spots were visualized 
with an UV lamp, iodine vapor, ninhydrin, and TDM. For column 
chromatography, Merck silica gel H (typ 60) was used. A Miniprep 
LC (Jobin Yvon) was used for preparative HPLC. 
5-(HydroxymethyI)-6-methyluracil (13). This synthesis is 
a modification of Kircher's procedure,22 which was found to be 
highly erratic. 
6-Methyluracil (12; 5.2 g, 40 mmol) was dissolved in 64 mL of 
a 5% aqueous NaOH solution with stirring and gentle heating; 
to this solution was added 10 g of a 37% aqueous formaldehyde 
solution. This reaction mixture was stirred for 16 h at room 
temperature. The resulting precipitate was filtered off and washed 
with cold water; subsequently the precipitate was dissolved in 
the minimal amount of water of 80 "C. If necessary, the resulting 
solution was filtered in order to remove polymeric byproducts. 
To the clear solution was carefully added concentrated sulfuric 
acid until neutral pH. 
Finally, the solution was kept at 4 "C for 4 h during which the 
alcohol 13 crystallized. Filtration, washing with ice-cold water, 
recrystallization from water, and drying in vacuo for 6 h at 80 
"C yielded 73% of 13 (4 5 g). The compound was homogeneous 
on TLC (Я/ 0.43, sec-BuOH saturated with water): NMR 
(MeîSO-de) δ 2.1 (s, 3 H, СНэ), 4.0 (s, 2 H, CH2OH); IR (КВт) 
3400,1700,1665,1110 cm-1. Anal. Caled for CeHeNA: C, 46.15; 
H, 5.16; N, 17.94. Found: С, 45.93; H, 5.15; Ν, 17.71. 
5-(Bromoraethyl)-6-methyluraciI23 (14). A solution of 
pulverized 13 (2.0 g, 13.0 mmol) in 40% НВг/АсОН (40 mL) was 
stirred with the exclusion of atmospheric moisture at 100 °C for 
16 h. Subsequently, the reaction mixture was kept at 4 "C for 
16 h during which 14 crystallized. The precipitate was collected 
and washed with dry ether to yield 14 (2.2 g, 78%) which is very 
hygroscopic and had to be stored in a desiccator over KOH: mp 
310 "C dec; Ή NMR (AsCy 6 2.1 (β, 3 Η, С{6)СЩ· 4.1 (s, 2 H, 
СНгВг); positive Beilstein test. 
5-(Methyltriphenylphosphonium)-6-methyluracil Brom­
ide (15). A solution of Р(РЬ)э (3.0 g, 11 mmol) in dry DMF (10 
mL) was added at room temperature to a stirred solution of 14 
(2.0 g, 9 mmol) in 18 mL of dry DMF; the temperature of the 
reaction mixture increased to 35-40 "C. Stirring was continued 
at room temperature for 2 h and finally at 70° С for 1 h. The 
reaction mixture was cooled at room temperature, and subse­
quently dry ether was added dropwise while the solution was being 
stirred. The resulting precipitate was sticky at the beginning but 
upon continued stirring turned into a crystalline mass. Filtration 
and washing with dry ether gave 15: 98% yield (4.3 g); mp 270 
e C dec; Ή NMR (Me2SO-cí6) í 1.6 (s, 3 H, С(б)СНз), 3.8 (d, 2 
H, CH2P), 6.2 (m, 15 H, (РЬ)з); IR (KBr) 1715 and 1665 cm"1. 
Anal. Caled for СмНиВг^ОгНгО: С, 57.79; H, 4.84; Ν, 5.61. 
Found: С, 57.28; Η, 4.94; Ν, 5.60. 
η-Butyl Glyoxalate (16). From π-Butyl Dimethoxy-
acetate. Sodium dimethoxyacetate was prepared from di-
chloroacetic acid as has been described by Moffett et a l ." The 
solvents were evaporated in vacuo, and the residue was dissolved 
in ether and 5% aqueous KHSO, solution. The water layer was 
extracted two times with ether, and then the organic layers were 
dried (N82804) and concentrated in vacuo. The residue was 
dissolved in n-BuOH containing HCl, and the resulting solution 
was stirred at room temperature for 16 h. The reaction mixture 
was then cooled to 0 "C, and the excess acid was neutralized to 
approximately pH 7 by addition of solid NaHC0 3. The mixture 
was filtered, and then ether and 5% aqueous NaHC0 3 solution 
were added. The organic layer was dried (N82804), and subse­
quently the ether was removed by distillation. Finally the residue 
was distilled under reduced pressure by using a Vigreux column 
to yield n-butyl dimethoxyacetate: bp 100 °C (20 mm); Ή NMR 
(55) R. В. Moffett, С. С. Pnce, and С. Б. Scott, Org. Synth., 35, 59 
(1955). 
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Í 1 3 (m, 7 H, OCH2C3H7), 3 3 (s, 6 H, 2 OCH3), 4 15 (t, 2 H, 
OCH2), 4 8 (s, 1H, HC(0Me)2) This compound was distilled over 
P2O5 (approximately 1 g/g of the aceta!) to give 16 in yields ranging 
from 10% to 30%, bp 65-68 "C (20 mm) The ester is not stable 
and polymerizes within 24 h, even when stored at 20 0C Ή 
NMR 6 1 4 (m, 7 H, OCHAH,), 4 3 (t, 2 H, OCH2), 8 3 (s, 1 H, 
HC(O)) 
From Dibutyl Tartrate. Di η-butyl tartrate [bp 150 °C (2 
mm)] was prepared from the acid and η BuOH with a catalytic 
amount of boron tnfluonde etherate The ester was converted 
into the hemihydrate of 16 according to Atkinson et al ,Ά fractions 
m the boiling range 60-75 "C (20 mm) [lit bp 55 0C (14 mm)] 
were collected IR (CHCI3) 3500 cm ' (OH), Ή NMR (only 
characteristics) ¿ 4 4-5 5 (m, 2 H, HOC(H)OC(H)OH) The 
hemihydrate, which is a stable compound, was converted into 16 
by distillation over P2O5 (1 4 g/1 0 g of hemihydrate), 16 was 
isolated in 48% yield as a light yellow liquid 
в Butyl ( £ ) 3-(2,4-Dioxo-6 methyl-5 pyrmudmyl)acrylate 
(17). A solution of KO-t Bu (2 4 g, 20 mmol) m DMF (40 mL) 
was added dropwise to a stirred and cooled (-30 °C) solution of 
15 (4 8 g, 10 mmol) as well as 16 (2 6 g, 20 mmol) in DMF (60 
mL) at such a rate that the temperature of the reaction mixture 
stayed at -30 "C Stirring was continued for 5 h at -30 °C and 
then 24 h at room temperature, after which the excess base was 
neutralized to ca pH 7 by addition of AcOH Subsequently the 
solvent was removed under reduced pressure to leave a sticky 
residue Chromatography on a Sephadex LH-20 column with 
MeOH/H20 (85/15 v/v) as eluent gave 17 10% yield (250 mg), 
mp 265 0C dec, Ή NMR (Me^O d
e
) ä 12 (m, 7 H, OCHAH,), 
2 3 (s, 3 H, 0(6)011;,), 4 1 (t, 2 H, OCHj), 6 7 and 7 3 (AB spectrum, 
2 H, J = 16 Hz, (£)-НО=СН), IR (КВг) 1730,1710,1645, 1615, 
and 1590 cm '. 
5-Formyl 6 methyluracil (19). To a stirred, hot (90-100 0C) 
solution of 13 (6 24 g, 40 mmol) in 150 mL of water /ач added 
potassium persulfate (10 8 g, 40 mmol) all at once The resulting 
clear solution was allowed to cool slowly to 40 °C, after which a 
catalytic amount of silver nitrate (0 1 g, 0 6 mmol) was added 
The reaction mixture was stirred at room temperature for 16 h, 
within 30 mm of stirring the first crystalls of the aldehyde 19 
appeared The precipitate was collected and recrystallized from 
water to yield 4 g (63% ) of 19 after drying m vacuo for 6 h at 80 
"C The compound was homogeneous on TLC (R/ 0 60, 
МеОН/СНгСІз, 1/4 v/v) and gave the same spectroscopic data 
as reported by Wiley and MacKellar9b Anal Caled for 
CeHoNA-HjO C, 4186, H, 4 68, N, 16 27 Found C, 41 62, H, 
4 61, N, 16 03 
Ethyl (.E)-3-(2,4-Dioxo-6-methyl 5-pyrimidinyl)acrylate 
(18). This compound was prepared by a slight modification of 
Wiley s procedure e b (Carbethoxymethylene)triphenyl-
phoephorane (20; 15 8 g, 45 mmol) was added to a stirred solution 
of the aldehyde 19 (7 0 g, 45 mmol) m 110 mL of dry DMF 
Stimng was continued for 3 days at room temperature after which 
a solution of 20 (1 6 g, 4 5 mmol) m i l mL of dry DMF was again 
added Finally the solution was stirred at room temperature for 
24 h Then ca. 2 mL of glacial acetic acid was added, and the 
solution was evaporated to dryness m vacuo at 60 "C The residue 
was dissolved in the mmimal amount of boiling methanol The 
solution was cooled and kept at 0 "C The crystalls were collected 
and washed with cold methanol to give the ester 18 40% yield, 
mp 302-303 "C (ht1* mp 299-302 eC), TLC R, 0 70 (MeOH/ 
CHjClj, 1/4 v/v) Anal Caled for C K H ^ N J O , С, 53 57, H, 5.39, 
Ν, 12 49 Found С, 53 34, Η, 5 40, Ν, 12 47 
(.E)-3-(2,4-Dioxo-6-methyl-5-pynmidinyl)acrylic Acid (2). 
The ester 18 (6 5 g, 29 mmol) was dissolved in ca 250 mL of 
methanol and 250 mL of dioxane Upon addition of 30 mL of 
an aqueous 4 N NaOH solution a precipitate appeared, therefore, 
water was added until complete dissolution The reaction mixture 
was stirred at 40 0C for 16 h After completion of the reaction, 
which was monitored by TLC (eluent MeOH/CH2Cl2,1/4 v/v), 
the pH of the mixture was adjusted to 1-2 with 4 N aqueous HCL 
Subsequently, the volume was reduced to ca 50 mL by evapo­
ration of the solvent in vacuo at 40 °C The precipitate was 
collected by filtration or centrifugaron to give 2 90% yield (5 1 
g), mp 270 e C dec (ht* mp 265 "С), TLC R, 018 (MeOH-CHjClj, 
1/4 v/v), spectroscopical data were essentially identical with those 
reported by Wiley e b Anal Caled for CgH
e
N204 C, 48 98, H, 
4 11, N, 14 28 Found C, 48 93, H, 4 13, N, 14 03 
5 [(MethyHhio)methyl]-L-cysteine (21). To a stirred so­
lution of L-cystine (24 0 g, 0 1 mol) in 500 mL of liquid ammonia 
( 33 °C) were added small pieces of sodium metal until the blue 
color persisted for a few minutes Then freshly distilled chlo-
romethyl methyl sulfide (19 3 g, 0 2 mol) was added dropwise 
After this the ammonia was evaporated at room temperature and 
the residue dissolved in the minimal amount of water The 
solution was adjusted to pH 5 with a 6 N aqueous solution of HCl 
The formed precipitate of 21 was filtered off and washed with 
cold water, ethanol, and ether successively Drying in vacuo 
afforded the cysteine derivative 21 70% yield (12 7 g), TLC R, 
0 44 (я BuOH/HOAc/H20,4/1/1 v/v), NMR (DjO/LiOD) Í 2 25 (s, 3 H, SCHa), 2 95 (m, 2 H, CHCHJ, 3 25-3 65 (m, 1 H, СНСЩ, 
3 75(s,2H,SCH2S),mp220oCdec Anal Caled for CsHnNOjS,. 
С, 33 13, H, 6 12, Ν, 7 73 Found С, 32 75, Η. 5 98, Ν, 7 81 
S [(Methylthio)methyI]-LcyeteineMethyl Ester (22). The 
hydrochloride of 22 was prepared from 21 by the well-known 
method of treatment with methanol and thionyl chloride The 
product was obtained m 87% yield Free amino ester 22 was 
prepared in situ by treatment with 1 equiv of triethylamine. 
Hydrochloride of 22 TLC R, 0 72 (sec-BuOH/NH4OH, 55/22 
v/v), NMR (MejSO-de) S 21 (β, 3 Η, SCHj), 315 (d, 2 H, CHCHj), 
3 7 (s, 3 H, COjCHa), 3 8 (s, 2 H, S C H Î S ) , 4 2 (t, 1 H, CHCHj) 
N-[(tert Butyloxy)carbonyl]-S-[(methylthio)methyl]-L-
cysteine Methyl Ester (23). This compound was prepared in 
84% yield from the hydrochloride of 22 as described for the 
synthesis of 50 TLC R, 0 85 (MeOH/CH2Cl2,3/97 v/v), NMR 
{ 145 (s, 9 Η, C(CHj)j), 215 (s, 3 H, SCH3), 3 1 (m, 2 H, CHCHJ, 
3 65 (s, 2 H, ЗСНгб), 3 75 (s, 3 H, СО&Щ, 4 5 (br s, 1 H, CHCH¡), 
5 35 (br d, 1 H, NH) 
IV [(tert-Butyloxy)carbonyl] S-[(methylthio)methyl] L-
cysteine (24) This compound was prepared in 89% yield from 
21 as described for the synthesis of 50 TLC fy 0 53 (MeOH/ 
CH2C12,15/85 v/v), NMR δ 1 45 (s, 9 H, С(СНэ)
э
), 2 15 (s, 3 H, 
SCHj), 3 00-3 15 (m, 2 H, CHCHjS), 3 65 (s, 2 H, SCH2S), 
4 35-4 65 (m, 1 H, CHCH2S), 5 35-5 65 (br, 1 H, NH), 9 80 (s, 
1 H, C02H) 
JV-[(iert-Butyloxy)carbonyl] S-[(methylthio)methyl] L-
cysteinol (25). Compound 25 was prepared m 64% yield from 
23 by reduction with lithium borohydnde as described for the 
preparation of 53 and 54 TLC fy 0 56 (MeOH/CHjClj, 6/94 v/v), 
NMR ί 1 44 (s, 9 H, С(СНз)з), 218 (β, 3 Η, SCH3), 2 73-2 93 (m, 
2 Η, CHCH2S), 3 67 (β, 2 Η, SCHjS), 3 69-3 89 (br β, 3 Η, 
CHCH2OH), 5 07 (br s, 1 Η, NH) Anal Caled for CjoH^NOaS* 
С, 44 92, H, 7 92, Ν, 5 14 Found С, 44 56, Η, 7 87, Ν, 5 14. 
Ν [(Benzyloxy)carbonyl] S-[(methylthio)methyl]-L-cye-
teinol (26). Starting from the hydrochloride of 22, we introduced 
the (benzyloxy)carbonyl group using its N-hydroxyphthalimide 
derivative ж The N-protected ester thus obtained was reduced 
in 56% yield as described for the preparation of 53 and 54 TLC 
R/ 0 65 (MeOH/CH2Cl2,1/9 v/v), NMR δ 2 13 (s, 3 H, SCH3), 
2 84 (d, 2 H, CHCHjS), 3 64 (s, 2 H, SCHjS), 3 76 (d, 2 H, 
CHCH2OH), 3 87 (m, 1 H, CHCH2OH), 5 11 (s, 2 H, CeHjCHj), 
5 35 (br d, 1 H, NH), 7 33 (s, 5 H, C
e
H6) Anal. Caled for 
C^jNOaS* С, 5180; H, 6 35, N,4 65 Found С, 51 67, H, 6 33, 
Ν, 4 65 
Compounds 27A-30A and 27B-30B. Oxidation of 23-26 was 
performed with 1 equiv of sodium metapenodate by usmg the 
following procedure To a stirred, cooled (0 aC) solution of the 
cysteine derivative 23, 24, 25, or 26 (4 mmol) in 12 mL of ace· 
tonitrile was added dropwise a solution of sodium metapenodate 
(856 mg, 4 mmol) in 12 mL of water The reaction mixture was 
stirred at 4 "C until completion of the reaction, as was monitored 
by TLC (about 16 h) The precipitate consisting of sodium iodato 
was removed by filtration, and ethyl acetate was added After 
separation of the organic layer the aqueous layer was extracted 
three times with ethyl acetate The collected organic layers were 
washed with bnne, dried (Na^O^, and evaporated in vacuo 
Relative yields of A and В compounds are based on the NMR 
spectra of the mixtures, determined were the ratios of integration 
of the SíOCHíSCHa signal (ca J 2 3) and the SCH^OJCHa 
signal (ca. δ 2 7), each of which appeared as a singlet The overall 
(56) E Th M Woltern, Thesis, NJmegen, 1973 
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yields were determined after purification by HPLC 
JV-[(Benzyloxy)carbonyl] ι cysteine Methyl Ester Sul· 
Пну] Chloride (32). (Ζ) L Cystine methyl ester (31, 3 22 g, 6 
mmol), prepared according to a procedure of Gustus,57 and acetic 
anhydride (1 22 g, 12 mmol) were dissolved in 25 mL of etha­
nol free dichloromethane The solution was stirred and cooled 
at -10 0 C In a separate 100-mL flask, containing 25 mL of dry, 
ethanol-free dichloromethane cooled to -10 "C, was introduced 
dry gaseous chlorine until about 1 3-1 4 g of chlorine had been 
dissolved (the theoretically necessary amount of chlorine was 1 28 
g, 18 mmol) This solution of chlorine was added dropwise to the 
former solution via a connecting tube The temperature of the 
reaction mixture was kept below 0 °C After the addition had 
been completed, the cooling was removed and the reaction mixture 
was stirred at room temperature for 1 h Subsequently, di­
chloromethane and excess of chlorine were evaporated at room 
temperature at water pump pressure and the acetyl chloride at 
oil-pump pressure The sulfmyl chloride 32 thus isolated appeared 
as colorless oil, which eventually solidified NMR 6 7 36 (s, 5 H, 
C6H5), 6 0 (Ьг, 1 H, NH), 5 15 (s, 2 H, С6Н5СН2), 4 82 (m, 1 H, 
НСС02СНэ), 4 0 (m, 2 H, CHîStOJCl), 3 8 (s, 3 H, С02СНэ), IR (CHClj) 1745, 1720, 1125 cm l 
iV-[(Benzyloxy)carbonyl]-S-oxo-S-(chloromethyl)-L-
cysteine Methyl Ester (33), A solution of the sulfmyl chloride 
32 (2 43 g, 8 mmol) in the minimal amount of dichloromethane 
or DME was added dropwise to a stirred, dried (over KOH pellets) 
solution of excess diazomethane in ether During this the reaction 
mixture was kept at 0 °C After completion of the addition of 
the sulfmyl chloride the reaction mixture was stirred for 1 h at 
room temperature The excess of diazomethane was removed by 
adding a few drops of acetic acid, after which the solvent was 
removed in vacuo The product thus obtained was used without 
purification for the next experiment Purification could be 
achieved by column chromatography (eluent МеОН/СНгСІг, 
25/975 v/v) to yield 33 (80%) TLC R, 0 38 (МеОН/СН2СІ2,4/96 
v/v), NMR δ 7 36 (s, 5 H, C6H6), 5 9 (br, 1 H, NH), 5 14 (s, 2 H, 
CeHjCHj), 4 76 (m, 1 H, HCCOjCHj), 4 49 (AB spectrum, 2 H, 
S(0)CH2C1), 3 80 (s, 3 H, С02СНз), 3 42 (AB part of ABX 
spectrum, 2 H, CHCH^ÍO)), IR (CH2C12) 1740,1720,1055 cm ', 
mass spectrum, m/e 335, 333 (M+) 
N-[(Benzyloxy)carbonyl] S-oxo-S methoxy L-cysteine 
Methyl Ester (34). If the above-mentioned reaction was carried 
out with an undned diazomethane solution, the sulfinate ester 
34 was isolated (0 77 g, 30% yield) after column chromatography 
besides the a-chloro sulfoxide 33 (0 88 g, 35% yield) For 34 TLC 
R, 0 55 (MeOH/CH2Cl2,4/96 v/v), NMR Ò 7 36 (s, 5 H, CeHs), 
5 85 (br, 1 H, NH), 5 14 (s, 2 H, CeHsCHj), 4 76 (m, 1 H, 
СНС02СНэ), 3 76 (s, 3 H, 8(0)ОСНэ), 3 29 (AB part of ABX 
spectrum, 2 H, CHCH2S(0)), IR (CH2C12) 1120 cm ', mass 
spectrum, m/e 315 (М+) 
Af-[(Beiizyloxy)carbonyl]-S-oxo-S-(bromomethyl)-L-
cysteine Methyl Ester (35). Lithium bromide (552 mg, 6 4 
mmol), dried m vacuo at 110 °C, was dissolved in THF, freshly 
distilled from sodium hydride To this solution a dried (KOH) 
solution of diazomethane (7 2 mmol) in ether was added To the 
resulting stirred solution was added a solution of 32 (1 9 g, 6 mmol) 
in ethanol-free dichloromethane dropwise at 0 °C After com­
pletion of the addition excess diazomethane was removed by a 
stream of argon, and subsequently water and dichloromethane 
were added The aqueous layer was extracted twice with di­
chloromethane The combmed organic layers were dried (Na^Oj) 
and evaporated to dryness m vacuo at room temperature to yield 
the crude α-bromo sulfoxide 35 (1 87 g, 82%), which was used 
without further purification TLC Л, 0 58 (МеОН/СН2С12,1/9 
v/v), NMR 4 7 38 (s, 5 H, C6H5), 5 9 (br, 1 H, NH), 5 16 (s, 2 H, 
CeH6CH2), 4 76 (m, 1 H, CHC02Me), 4 36 (m, 2 H, S(0)CH2Br), 
3 83 (s, 3 H, С02СНэ), 3 4 (m, 2 H, CHCHjSÍO)), mass spectrum, 
m/e 377, 379 (M+) 
N-[(Benzyloxy)carbonyl]-S-oxo-S-(chloromethyl)-L-
cyeteinol (36 and 37). To a stirred, cooled (-78 °C) solution of 
sodium borohydnde (0 91 g, 24 mmol) as well as lithium iodide 
(3 21 g, 24 mmol) m 200 mL of dry DME was added the ester 33 
(2 67 g, 8 mmol) all at once The reaction mixture was allowed 
(57) E L Gustus, J Org Chem, 32, 3425 (1967) 
Ottenheijm et al 
to warm up at room temperature and then was stirred f-v 2 h 
After completion of the reaction, as was monitored uy TLC 
(MeOH/CH2Cl2,1/9 v/v), the solution was neutralized to pH 7 
with an aqueous solution of 1N HCl under ice cooling After this, 
stirring was continued for 1 h at room temperature Subsequent 
to evaporation of the DME in vacuo, water and dichloromethane 
were added The aqueous layer was extracted three times with 
dichloromethane and twice with ethylacetate The combined 
organic layers were dried (Na¿S04) and evaporated in vacuo The 
residue was chromatographed on silica gel (eluent MeOH/CH2CI2, 
6/94 v/v) to give the alcohols 37 (807 mg, 33%) and 36 (513 mg, 
21%) The yields are based on 3! Both compounds were ho-
mogeneous on TLC (37, Λ, 0 27, ЗЬ, Я, 0 24, MeOH/CHjClj, 1/9 
v/v) 
For 36 NMR S 3 16 (d, 2 H, CHCH2S(0)), 3 87 (d, 2 H, 
CH2OH), 4 16 (m, 1 H, СНСНзОН), 4 40 and 4 54 (AB spectrum, 
J = 11 1 Hz, 2 H, S(0)CH2C1), 5 11 ís, 2 H, C6H5CH2), 5 67 (br 
d, 1 H, NH), 7 34 (s, 5 H, СсН
ъ
), IR (КВг) 3330,1680,1020 cm ', 
mass spectrum, m/e 305, 307 (M+) Anal Caled for 
C12H16C1N04S С, 47 14, Η, 5 27, Ν, 4 58 Found С, 47 49, Η, 
5 25, Ν, 4 40 
For 37 NMR δ 3 09 and 3 31 (AB part of ABX spectrum, 8 
lines, J A X = 5 4 Hz, J B X = 5 7 Hz, JAB = 13 3 Hz, 2 H, 
СНСНгЗЮ)), 3 78 (AB spectrum, J^ = 12 5 Hz, 2 H, CH2OH), 
4 13 (m, 1 H, CHCH2OH), 4 47 and 4 57 (AB spectrum, JAB = 
11 2 Hz, 2 H, S(0)CH2C1), 5 11 (s, 2 H, C6H6CHn), 5 84 (br, d, 
1 H, NH), 7 34 (s, 5 H, C6H5), IR (КВг) 3340, 1695, 1040 cm"1, 
mass spectrum, m/e 305, 307 (M+) Anal Caled for 
Ci2Hi6ClN04S C, 47 14, H, 5 27, N, 4 58 Found C, 46 48, H, 
5 21, N,4 43 
N [(Benzyloxy)carbonyl]-S-oxo-S-(bromomethyl)-L-
cysteinol (38 and 39). Reduction of the ester 35 (1 4 g, 3 7 mmol) 
was carried out as described for the preparation of 36 and 37 to 
yield a crude mixture of 38 and 39 (1 12 g, 86%) Purification 
by column chromatography (eluent, МеОН/СН2С12, 7/93 v/v) 
gave the mixture of 38 and 39 in 63% yield (0 82 g), the two 
diastereomers could not be separated, in contrast to the corre­
sponding chloro sulfoxides 38 and 39 TLC Rf 0 41 (MeOH/ 
CH2C12,1/9 v/v), NMR (CDjOD) « 7 36 (s, 5 H, CeHs), 5 09 (s, 
2 H, C6H5CH2), 4 6 (m, br, 2 H, S(0)CH2Br) Ò 4 07 (br m, 1 H, 
CHCH2OH), 3 62 (d, 2 H, CH2OH), 3 10 (m, 2 H, CHCH,S(0)), 
mass spectrum m/e 349, 351 (M*) 
JV-[(Benzyloxy)carbonyl] S-oxo-S-(chloromethyl)-0-
(tetrahydropyranyl) L-cysteinol (40). Dihydropyran (666 mg, 
7 9 mmol) was added dropwise to a stirred solution of 36 (764 mg, 
2 5 mmol) and p-toluenesulfonic acid monohydrate (38 mg, 0 2 
mmol) m 17 mL of diesane After the mixture was stirred at room 
temperature for 90 mm, the reaction was complete, as judged by 
TLC (MeOH/CH2Cl2, 6/94 v/v) The pH of the mixture was 
adjusted to about 8-9 by additio.i of a solution of ammonia in 
methanol after which the solvent was evaporated in vacuo The 
residue was dissolved in dichloromethane, and this solution was 
washed with 20 mL of an aqueous saturated sodium bicarbonate 
solution The organic layer was dried (Na^OJ and evaporated 
in vacuo to dryness to yield 40 as a pale yellow semisolid in 
quantitation yield TLC Я, 0 28 (МеОН/СН2С12,4/96 ν/- „ NMR 
ä 1 6 (m, 6 Η, ОСН2(СН2)э), 2 9-3 2 (br d, 2 H, CHCH^O)), 
3 2-4 1 (m, 5 H, OCH2CH2 and CHCH20), 4 3 (d, 2 H, S(O)-
CH2C1), 4 5 (br s, 1 H, OC(H)O), 5 0 (s, 2 H, Г^СЩ), 5 3-6 1 (br, 1 H, NH), 7 2 (s, 5 H, C
e
H
s
) 
JV-[(Benzyloxy)carbonyl]-S-oxo-S (chloromethyl)-O-
(tetrahydropyranyl) L-cysteinol (41). O-Protection of 37 was 
carried out as described for the synthesis of 40 to yield 41 
quantitatively TLC R, 0 28 (MeOH/CH2Cl2, 4/96 v/v), NMR 
¿ 16 (m, 6 H, OCHjíCH^j), 2 7-3 8 (m, 2 H, CHCHjSíO), 3 8-4 2 
(m, 5 H, OCH2CH2 and CHCH20), 4 5 (br s, 3 H, S(0)CH2C1, 
OC(H)O), 5 0 (s, 2 H, CeH6CH2), 5 4-6 0 (br, 1 H, NH), 7 1 (s, 
5 H, CçHs) 
Sodium Methylmercaptide. Sodium methylmercaptide was 
prepared by treatment of dimethyl disulfide with sodium m liquid 
ammonia according to a published procedure ж Before each 
experiment the quality was assayed gravimetncally as follows 
To a solution of 1 equiv of sodium methylmercaptide m the 
minimal amount of dry ethanol was added all at once a solution 
of 15 equiv of l-fluoro-2,4-dinitrobenzene (FDNB) in the minimal 
amount of dry ethanol Immediately the l-(methylmercapto)-
21 
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2,4-dinitrobenzene crystallized. Subsequently the mixture was 
refluxed for 30 min, after which the l-(methylmercapto)-2,4-di-
nitrobenzene was allowed to crystallize at 4 °C for 16 h. Finally 
the bright yellow crystals were collected and weighted; mp 128 
eC. Preferentially the reagent is stored in a desiccator over KOH 
in an argon atmosphere. Batches containing less than 95% sodium 
methylmercaptide were discarded. 
JV-[(Benzyloxy)carbonyl]-S-oxo-S-[(methylthio)-
methyl]-0-(tetrahydropyranyl)-L-cysteinol (42). A solution 
of sodium methylmercaptide (693 mg, 9.9 mmol), the purity of 
which was checked as described above, in 100 mL of dry ethanol 
was added at once to a stirred solution of the α-chloro sulfoxide 
40 (3.24 g, 8.3 mmol) in 100 mL of dry ethanol. Argon had been 
passed through both solutions for 15 min. The reaction mixture 
was stirred at 50 °C and monitored by TLC (MeOH/CH2Cl2,1/9 
v/v). The reaction took about 2.5-5 h, depending on the quality 
of the sodium methylmercaptide. If the reaction did not proceed 
to completeness, an additional quantity of sodium methyl­
mercaptide (175 mg, 2.5 mmol) was added. After completion, the 
solvent was evaporated, and water and dichloromethane were 
added. The organic layer was washed with water to neutral pH 
and dried (NajSO^. Removal of a slight turbidness, due to finely 
devided sodium chloride, could be achieved by stirring with 
N82804 for 1 h. Filtration and removal of the solvent afforded 
quantitatively (3.33 g) the monoxodithioacetal 42, which was 
homogeneous on TLC (Я, 0.22, МеОН/СН2С12,6/94 v/v): NMR 
i 4.6 (m, 6 H, ОСН2(СН2)з), 2.3 (s, 3 H, SCH,), 2.8-3.3 (br t, 2 
H, CHCH2), 3.7 (br s, 2 H, SiOCH^CHa), 3.3-4.3 (m, 5 H, 
CHCHjO, OCHjCHj), 4.5 (br s, 1 H, OC(H)O), 5.0 (s, 2 H, 
CHsCHj), 7.2 (s, 5 H, Ó W ; mass spectrum, m/e 401 (M+). Anal. 
Caled for CieH^NOsSî: С, 53.84; H, 6.78; Ν, 3.49. Found: С, 
63.70; Η, 6.79; Ν, 3.68. 
Af-[(Benzyloxy)carbonyl]-S-o¥o-S-[(methylthlo)-
methyl]-0-(tetrahydropyranyl)-L-cysteinol (43). This com­
pound was prepared quantitatively from 41 (2.38 g, 6.1 mmol) 
as has been described for the preparation of 42. Its R/ value was 
identical with and the 'H NMR spectrum very similar to those 
of 42: R, 0.22 (MeOH/CH2Cl2, 6/94 v/v); NMR 6 1.6 (m, 6 H, 
OCH2(CH2)3), 2.3 (s, 3 H, SCH3), 2.8-4.3 (m, 7 H, CHCH20, 
CHCH2, OCHJCHJ), 3.7 (br d of AB spectrum, 2 H, S(0)-
СН28СНэ), 4.5 (br s, 1 H, OC(H)O), 5.0 (s, 2 H, CeHjCHj), 7.2 (s, 5H, CgHg); mass spectrum, m/e 401 (M+). Anal. Caled for 
C^H^NOsS* С, 53.84; H, 6.78; Ν, 3.49. Found: С, 53.40; Η, 6.70; 
Ν, 3.58. 
Methyl iV-[(Benzyloxy)carbonyl]-2-aminoacrylate (44). 
A two-phase system consisting of a solution of sodium methyl 
mercaptide (54 mg, 0.75 mmol) and tetraethylammomum chloride 
(124 mg, 0.75 mmol) in the minimal amount of water and a 
solution of 36 or 37 (50 mg, 0.15 mmol) in the minimal amount 
of chloroform was stirred at room temperature for 4 h, after which 
the organic layer was separated and dried (Na^OJ. According 
to NMR and TLC (Я, 0.91; MeOH/CHjCla 4/96 v/v) the a-chloro 
sulfoxide was quantitatively converted to the dehydroamino acid 
derivative 44: NMR « 3.83 (s, 3 H, С02СНз), 5.16 (s, 2 H, 
CHjCHj), 5.79 (d, 1 H, C=CH), 6.24 (s, 1 H, C=CH), 7.37 (s, 
5 H, C
e
H6). 
2-Ozo-4-[[[(methylthio)methyl]sulfoxo]methyl]oxazoli-
dïne (45). Sodium methylmercaptide (96 mg, 1.4 mmol) was 
added all at once to a stirred solution of 38 (210 mg, 0.6 mmol) 
in the minimal amount of acetonitrile/water (1/1 v/v). After the 
mixture was stirred for 24 h at 40 "C, dichloromethane was added, 
and the aqueous layer was extracted twice with dichloromethane. 
The combined organic layers were dried (MgS04) and concen-
trated in vacuo. After column chromatography (eluent 
MeOH/CHjCl2,7/93 v/v) benzyl alcohol was isolated in addition 
to the cyclic urethane derivative 45: yield 38 mg (30%); NMR 
(CD2C12) Í 2.29 (s, 3 H, SCHj), 3.04 (m, 2 H, №¡¡8(0)), 3.82 (AB 
spectrum, 2 H, SiOJCHjSCHj), 4.51 (m, 2 H, CH2OC(0)), 6.13 
(br s, 1 H, NH); IR (CHjÔy 1755,1060 cm"1, mass spectrum, m/e 
209 (M+). 
S-Oxo-S-[(methylthio)methyl]-0-(tetrahydropyranyl)-
L-cysteinol (46). The Ν,Ο-protected dithioacetal S-oxide 42 (321 
mg, 0.8 mmol) was placed in a three-walled reaction vessel, which 
was cooled with chilled methanol (-33 eC). Ammonia was con­
densed until complete dissolution of the compound. After removal 
of the external cooling, a solution of sodium in ammonia was added 
dropwise to the refluxing ammonia solution by using a simplified 
version of a published procedure.42 Once the blue color persisted 
for a few minutes, the source of sodium was removed. The solvent 
was evaporated subsequent to addition of a few crystals of am­
monium chloride. The residue thus obtained was extracted twice 
with chloroform. Evaporation of the solvent gave a yellow oil, 
which was chromatographed. Elution with MeOH/CH2Cl2 (1/9 
v/v) gave 46 in 10-38% yield. Subsequent elution with 
MeOH/CH2Cl2 (15/85 v/v) gave 48 in 20-30% yield. The product 
ratio varied from experiment to experiment. Both compounds 
were homogeneous on TLC. 
For 46: TLC Я,0.29 (МеОН/СН2С12,1/9 v/v); NMR δ 1.60 (m, 6 Η, ОСН2(СН2)з), 2.33 (s, 3 H, SCH3), 2.85-2.89 (AB part 
of ABX spectrum, 2 H, СВДО)), 3.55 (m, 5 H, CHCH20, H2N-
CH,OCHJCHJ),3.67 and3.84 (ABspectrum, 2H,JAB = 13.5Hz, 
SíOÍCHjSCHa), 4.60 (br s, 1 H, OC(H)O); IRÍHCCy 3400,1120, 
1020 cm1 . 
For 48: TLC Я, 0.12 (МеОН/СН2С12,1/9 v/v); NMR « 1.62 (m, 6 H, ОСН2(СН2)з). 2.63 (s, 3 H, 8(0)СНз), 2.80 (m, 2 H, 
CHîSiO)), 3.53 (m, 3 H, CHCH20), 3.74 (m, 2 H, ОСИ£Щ, 4.60 
(br s, OC(H)O)); IR (HCCI3) 3400, 1120, 1020 cm"1. 
S-Oxo-S-[(methylthio)methyl]-0-(tetrahydropyranyl)-
L-cysteinol (47). This compound was prepared from 43 as has 
been described for the preparation of 46. The yields of 47 
(10-38%) and of the byproduct 49 (20-30%) varied from ex­
periment to experiment. 
For 47: TLC Я, 0.24 (МеОН/СН2С12,1/9 v/v); NMR í 1.60 (m, 6 H, OCHJÍCHJ^) , 2.33 (s, 3 H, SCHa), 2.60-3.27 (m, 2 H, 
CHjSiO)), 3.47 (m, 3 H, CHCHjO), 3.71 (m, 2 H, OCHjCHj), 3.67 
and 3.89 (AB spectrum, 2 H, J/a = 13.5 Hz, SiOJCHjSCHj), 4.58 
(br s, 1 H, OC(H)O)); IR (HCCI3) 3400, 1120, 1020 cm"1. 
For 49: Я/ 0.10 (MeOH/CH2Cl2,1/9 v/v); NMR 6 1.62 (m, 6 
H, ОСН2(СН2)з), 2.66 (s, 3 H, 8(0)СНз), 2.83 (d, 2 H, CH^ÍO)), 
3.52 (m, 3 H, CHCH20), 3.78 (m, 2 H, OCH2CH¿, 4.59 (br s, 1 
H, OC(H)O); IR (HCCI3) 3400, 1120, 1020 cm"1. 
S-Oxo-S-methyl-0-(tetrahydropyranyl)-L-cysteinol (48 
and 49). From JV-[(benzyloxy)carbonyl]-iS-methyl-L-cysteine 
methyl ester, oxidation to the sulfoxide was performed as follows. 
A solution of sodium metaperiodate (4.28 g, 20 mmol) in 35 mL 
of water was added dropwise to a stirred solution of iV-[(ben-
zyloxy)carbonyl]-S-methyl-L-cysteine methyl ester in 25 mL of 
acetonitrile. Subsequently the reaction mixture was stirred at 
room temperature for 48 h, after which the solvents were evap-
orated in vacuo. Dichloromethane was added and the precipitate 
consisting of sodium iodate was removed by filtration. The solvent 
was evaporated in vacuo, and the residue was crystallized from 
methanol ether to give N-[(benzyloxy)carbonyl]-S-oxo-S-
methyl-L-cysteine methyl ester: 92% yield; NMR i 2.62 (s, 3 H, 
8(0)СНэ), 3.26 (m, 2 H, CHCHJO)), 3.75 (в, 3 H, COsCHj), 4.63 
(m, 1 H, CHCHJO)), 5.13 (s, 2 H, С^СЯ^, 6.30 (br d, 1 H, 
NH), 7.33 (s, 5 H, CSH6). 
The thus prepared sulfoxide (567 mg, 2 mmol) was added to 
a stirred and cooled (0 °C) solution of sodium borohydride (113 
mg, 3 mmol) and lithium iodide (400 mg, 3 mmol) in 15 mL of 
dry DME. The reaction mixture was stirred at room temperature. 
After completion of the reaction, as was shown by TLC 
(МеОН/СН2СІ2,1/9 v/v), the solution was neutralized with an 
aqueous 2 N HCl solution under ice-cooling. Stirring was con­
tinued for 1 h at room temperature. The solution was concen­
trated in vacuo to a small volume and extracted twice with di­
chloromethane. The combined organic layers were dried (Na^SOJ, 
and the solvent was removed to give the two diastereomeric 
N-[(benzyloxy)carbonyl]-S-oxo-S-methyl-L-cystemolB: 56% yield 
(288 mg); NMR í 2.55 and 2.58 2 s, 3 H, 8(0)СНз), 2.83-3.13 (m, 
2 H, CHCH2S(0)), 3.53-3.83 (m, 3 H, CH2OH), 3.83-4.33 (m, 1 
H, CHCHjSÍO)), 5.0 (s, 2 H, CeHjCHJ, 5.97 (br d, 1 H, NH), 7.23 
(s, 5 H, CgHji). The crude product was used as such in the reaction 
with dihydropyran, yielding quantitatively the diastereomers of 
the O-protected derivatives. This reaction was carried out aa 
described for the preparation of 40: NMR S 1.6 (m, 6 H, 
ОСН2(СН2)з), 2.55 and 2.60 (2 s, 3 H, 8(0)СНз), 2.83-3.13 (m, 
2 H, CHCHjSÍO)), 3.2-4.2 (m, 5 H, CHCH20, OCHJCHÎ), 4.5 (br 
s, 1 H, ОСдаЮ), 5.01 (s, 2 H, CeHjCHj), 7.22 (s, 5 H, CH,). 
Removal of the Ζ group was accomplished as described for the 
preparation of 46. The two diastereomeric S-methyl sulfoxides 
thus prepared were separated on a silica gel column (MeOH/ 
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CH2CI2,1/9 v/v) The stereomer having the highest Rf value on 
TLC (СН2СІ2/МеОН, 4/1 v/v) was found to be identical (TLC, 
Ή NMR) with compound 48, obtained in the Ζ removal reaction 
leading to 46 The second stereomer was identical with 49 
JV-[(tert-Butyloxy)carbonyl] L-cystine Methyl Ester (50). 
Starting from L-c>stine methyl ester hydrochloride, we prepared 
50 with di Cert-butyl pyrocarbonate analogous to the method 
described58 for unestenfied amino acids To a stirred and cooled 
(0 0C) solution of L cystine methyl ester hydrochloride (3 41 g, 
10 mmol) and an aqueous 1 N NaOH solution (20 mL, 20 mmol) 
in 30 mL of dioxane/water (2/1 v/v) was added di feri-butyl 
pyrocarbonate (4 8 g, 22 mmol) Subsequently the cooling was 
removed and the reaction mixture stirred for 24 h at room tem­
perature After concentration of the reaction mixture to a small 
volume, ethyl acetate was added, and the solution was carefully 
acidified with Em aqueous 2 N potassium hydrogen sulfate solution 
to pH 3 The organic layer was separated and the aqueous layer 
extracted twice with ethyl acetate The collected organic layers 
were washed with water and with brine and dried (NBÜSO«) 
Evaporation of the ethyl acetate in vacuo and recrystalhzation 
from ethyl acetate/hexane gave 50, in 85% yield, which was 
homogeneous on TLC (Rf 0 40, MeOH/CHzClj, 3/97 v/v) mp 
9e-97 0C, NMR δ 145 (s, 9 H, t-Bu), 316 (d, 2 H, CHCHsS), 3 78 
(s, 3 H, С02СНз), 4 60 (m, 1 H, CHCHjS), 5 38 (br d, NH) Anal 
Caled for CI8H32N208S2 C, 46 14, H, 6 88, N, 5 98 Found С, 
46 39, H, 6 96, Ν, 5 93 
Af-[(íert-Butyloxy)carbonyl] S-oxo-S chloro L cysteine 
Methyl Ester (51). Compound 51 was prepared from 50 (7 96 
g, 17 mmol) as described for the synthesis of 32 The product 
obtained, a light yellow oil, was used without further purification 
for the preparation of 52 NMR (CDüClj) δ 1 44 (s, 9 H, (-Bu), 
3 81 (s, 3 H, С02СНз), 3 96 (t, 2 H, CHCH^O), 4 75 (m, 1 H, 
CHCHîSiO)) 
7V-[(tert-Butyloxy)carbonyl] S-oxo S-(chloromethyl)-L-
cysteine Methyl Ester (52). A solution of the sulFinyl chloride 
51 (14 0 g, 34 mmol) in 200 mL of dichloromethane or THF was 
added dropwise over a period of 3 h to a cooled (0 "С) dried (KOH) 
solution of diazomethane (ca. 39 mmol) m ether After the workup 
as described for the preparation of 33, the oily substance thus 
obtained (R, 0 27, MeOH/CH2Cl2, 3/97 v/v) was used without 
further purification for the preparation of 53 and 54 NMR 6 145 
(s, 9 H, t-Bu), 3 38 (AB part of ABX spectrum, 8 lines, 2 H, 
CHCHíSÍO)), 3 80 (s, 3 H, С02СНэ), 4 50 (AB spectrum, 2 H, 
SÍOCHjCl), 4 63 (m, 1 H, CHCH^O)) 
JV-[(tert-Butyloxy)carbonyl]-S-oxo S-(chloromethyl)-L-
cysteinol (53 and 54). The ester 52 (34 mmol) was reduced with 
lithium borohydnde, which was prepared from sodium boro-
hydnde (3 86 g, 102 mmol) and lithium iodide (13 65 g, 102 mmol), 
as described for the preparation of 36 and 37 The workup had 
to be changed the pH was adjusted to 5 by addition of an aqueous 
1 N citric acid solution to the stirred and cooled (0 "С) solution 
Before neutralization was complete a sticky mass precipitated 
sometimes In that case the solvent was evaporated m vacuo, after 
which the residue could be dissolved m methanol/water (1/1 v/v) 
and the neutralization could be completed After extraction 
followed by drying and evaporation of the solvent, separation of 
the diastereomers was performed by column chromatography on 
silica gel with MeOH/CH2Cl2 (7/93 v/v) as the eluent to yield 
17 % (1 57 g) of 53 and 30% (2 77 g) of 54 Both compounds were 
homogeneous on TLC (53, R/ 0 33, 54, R, 0 36, MeOH/CH2Cl2, 
1/9 v/v) 
For 53 NMR δ 145 (s, 9 H, t-Bu), 2 91-3 42 (AB part of ABX 
spectrum, 2 H, CHCHjStO)), 3 64-3 93 (br t, 2 H, CH2OH), 
3.93-4 29 (m, 1 H, CHCH2OH), 4 44 and 4 55 (AB spectrum, JAB 
= 111 Hz, S(O)CHjCl), 5 24-5 58 (br d, 1 H, NH), IR (KBr) 1690, 
1170, 1040, 670 cm ·, mass spectrum, m/e 271, 273 (M+), mp 
139-140 "С (CH2Cl2-hexane) Anal Caled for CeH18ClNO«S С, 
39 78, H, 6 68, Ν, 5 15 Found С, 39 79, Η, 6 38, Ν, 5 13 
For 54 NMR δ 145 (s, 9 H, t-Bu), 3 11 and 3 41 (AB part of 
ABX spectrum, 8 lines, 2 H, J^ = 13 5 Hz, J^x = JBX = 5 6 HZ, 
CHCHÜSÍO)) , 3 60-3 93 (m, 2 H, CH2OH), 3 93-4 33 (m, 1 H, 
CHCH2OH), 4 54 and 4 61 (AB spectrum, J = 11 3 Hz, 2 H, 
StOCH^D, 5 22-5 64 (br d, 1 H, NH), IR (KBr) 1700,1170,1040, 
(58) L Moroder, A Hallet, Б Wunsch, О Keller, and G Wersin, 
Hoppe-Seyler a Ζ Physiol Chem, 357,1651 (1976) 
22 
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670 cm l, mass spectrum, m/e 271, 273 (M+), mp 108-109 "С 
(CH2Cl2-hexane) Anal Caled for CsH.eClNO^S C,39 78, H, 
6 68, N, 5 15 Found C, 39 79, H 6 71, Ν, 4 94 
JV-[(tert-Butyloxy)carbonyl] S oxo S [(methylthio)-
methyl] L-cysteinol (55). The monoxodithioacetal 55 was 
prepared from the α chloro sulfoxide 53 (1086 g, 4 mmol) as has 
been described for the synthesis of 42 The reaction was now 
carried out at room temperature and monitored by TLC 
(MeOH/HCClj, 1/9 v/v) In addition, the workup was changed 
after 24 h, the reaction was complete, and the mixture was filtrated 
over Celite The solvent was evaporated in vacuo after which the 
residue was dissolved in dichloromethane Residual sodium 
chloride was removed by washing with ca 5 mL of water The 
organic layer was dried by being stirred for 2 h with Na^O* By 
doing this, residual NaCl could be filtered off together with the 
desiccant Evaporation of the solvent gave 55 in 85% yield, which 
was homogeneous on TLC (Ä/ 0 34, MeOH/CH2Cl2, 1/9 v/v). 
NMR δ 1 45 (s, 9 H, t Bu), 2 33 (s, 3 H, SCH3), 3 03 and 3 28 (AB 
part of ABX spectrum, 8 lines, J^ = 13 3 Hz, JAX = «JBX = 6 3 
Hz, 2 H, CHCHjSiO)), 3 73 and 3 83 (AB spectrum, J = 13 5 Hz, 
2 H, 3(0)СН28СНз), 3 67-3 76 (m, covered by AB spectrum, 2 
H, CH2OH), 3 76-4 31 (m, 1 H, CHCH2OH), 5 36 (br d, 1 H, NH), 
IR (KBr) 1690, 1250, 1170, 1030 cm ', mass spectrum, m/e 227 
(M+ - isobutene) Anal Caled for C10H21NO4S2 С, 42 38, H, 
7 47, Ν, 4 94 Found С, 42 56, Η, 7 53, Ν, 5 22 
JV-[(terí-Butyloxy)carbonyl]-S oxo-S-[(methylthio)-
methyl]-L-cysteinol (56). The monoxodithioacetal 56 was 
prepared from 54 as has been described for the preparation of 
55 If the crude product was chromatographed over silica gel 
instead of being worked up as described for 55, an epimenzation 
of the sulfoxide sulfur atom was observed (see text) Compound 
56 was obtained m 85% yield and was homogeneous on TLC (Rf 
0 38, MeOH/CH2Cl2,1/9 v/v) NMR δ 1 45 (s, 9 H, í-Bu), 2 33 
(β, 3 Η, SCHj), 2 98 and 3 47 (AB part of ABX spectrum, 8 Imes, 
JAB = 13 5 Hz, JAX = 3 8 Hz, J
m
 = 5 8 Hz, 2 H, CHCHjSÍO)), 
3 76 and 3 88 (AB spectrum, J = 13 8 Hz, 2 H, SíOCHüSCHa), 
3 65-3 95 (m, 2 H, covered by AB spectrum, CH2OH), 5 44 (br 
d, 1 H, NH), IR (KBr) 1700,1260,1170,1060 cm 1, mass spectrum, 
exact mass calculated for CeHuNO^j, (M+ - C^g) m/e 227 2096, 
found m/e 227 2118 Anal Caled for C^jH^NC^Ss С, 42 38, 
H, 7 47, Ν, 4 94 Found С, 42 38, Η, 7 39, Ν, 4 88 
S-Oxo-S [(methylthio)methyl]-L-cyeteinol (57). A solution 
of 55 (1 273 g, 4 5 mmol) in 50 mL of TFA was stirred at 0 "C 
for 30 mm, after which the TFA was evaporated in vacuo at room 
temperature The residue was dried in vacuo over KOH for 1 
h and then dissolved m a minimal amount of water The solution 
was placed on an ion-exchange column (Amberlite IRA 410,20-50 
mesh, OH form) Elution with water and removal of the solvent 
by freeze-drying gave 57 in a quantitative yield (823 mg) The 
product thus obtained was homogeneous on TLC (R/ 0 31, sec-
BuOH/NH4OH, 5/2 v/v) NMR (CDCyCDjCy δ 2 34 (s, 3 H, 
SCHj), 2 88-3 00 (AB part of ABX spectrum. 2 H, CHCH2S(0)), 
3 33-3 71 (m, 3 H, CHCH20), 3 73 and 3 81 (AB spectrum, 2 H, 
J = 13 8 Hz, SÍOJCHüSCHa) The enantiomeric purity of 57 was 
determined in CDCI3 as follows a racemic mixture, prepared by 
mixing 57 and 3 (vide intra), showed in the presence of tns-
[3-[(tnfluoromethyl)hydroxymethylene]-d-camphorato]ytterbi-
um(III) two well-separated signals for the SCH3 group According 
to this method, 57 was found to be optically pure Anal Caled 
for CsHuNOjSü С, 32 76, H, 7 15, Ν, 7 64 Found С, 32 52, Η, 
7 19, Ν, 7 63 
S-Oxo-S [(methylthio)methyl]-L-cysteinol (58). The ammo 
alcohol 58 was prepared quantitatively from 56 (636 mg, 2 25 
mmol) as has been described for the preparation of 57 The 
product obtained was homogeneous on TLC (Rf 0 30, sec-
BuOH/NfyOH, 5/2 v/v) The enantiomeric purity was checked 
as reported for 57 and was found to be larger than 95% NMR 
δ 2 34 (β, 3 Η, SCHj), 2 87 and 3 05 (AB part of ABX spectrum, 
8 Unes, JAB = 13 Hz, JAX = 5 Hz, JBX = 6 Hz, 2 H, CHCH^O)), 
3 33-3 71 (m, 3 H, CHCH20), 3 72 and 3 86 (AB spectrum, 2 H, 
J = 13 5 Hz, SíOJCHjSCHa) Anal Caled for Ο ^ Ν Ο ^ С, 
32 76. Η, 7 15, Ν, 7 64 Found С, 32 79, Η, 7 15, Ν, 7 52 
5 Oxo-S [(methylthio)methyl]-l>cyeteinol (3 and 60). 
[(tert-Butyloxy)carbonyl]-D-cyBtine methyl ester (59) was prepared 
from D-cystine methyl ester hydrochloride as described for the 
synthesis of the enantiomeric compound 50 Compound 59 (2 75 
Total Synthesis of the Antibiotic Sparsomycin 
g, 8.1 mmol) was converted in five steps into the amino alcohols 
3 and 60 as described for the synthesis of their enantiomers 57 
and 58, respectively. The overall yields were 149! and 26%, 
respectively, based on 59. Both compounds were identical (TLC, 
Ή NMR) with their antipodes and were enantiomerically ho­
mogeneous. Anal. Caled for C S H ^ N O J S J : C, 32.76; H, 7.15; N, 
7.64. Found for 3: C, 32.31; H, 7.20; N, 7.53. Found for 60: C, 
32.48; H, 7.23; N, 7.48. 
Methyl 2-[/?-(6-Methyl-5-uracilyl)acrylamido]3-[[(meth-
ylthio)methyl]suirido]propionate (61). Triethyl.jnine (0.53 
mL, 3.8 mmol) was added to a solution of the hydrochloride of 
22 (880 mg, 3.8 mmol) in 6 mL of dry DMF. The precipitated 
triethylamine hydrochloride was filtered off, and th< filtrate was 
added to a stirred solution of the acrylic acid 2 (500 тц, 2.5 mmol) 
and hydroxybenztriazole (415 mg, 3.1 mmol) in 5 ml. ι if dry DMF. 
Then DCC (525 mg, 2.5 mmol) was added all at once t о the cooled 
(-15 " O reaction mixture. Stirring was continued at room tem­
perature for 16 h. Subsequently the reaction mixture was cooled 
to -10 "C and then filtered. The solvent of the lîltrate was 
removed in vacuo at 50 "C, after which column chromatography 
(eluent MeOH/CH2Cl2, 4/96 v/v) of the residue gave the amide 
61: 60% yield; TLC R, 0.64 (MeOH/CH2Cl2, 2/8 v/v); NMR 
(MejSO-de) « 2.22 (s, 3 H, SCH3), 2.44 (s, 3 H, С(б)СНэ), 3.15 (m, 
2 H, CHCHjS), 3.8 (s, 3 H, С02СН,), 3.9 (s, 2 H, SCHjS), 4.72 (m, 1 H, СНС02СНэ), 7.25 and 7.45 (AB spectrum, J = 16 Hz, 
2 H, HC=CH), 8.7 (br d, 1 H, HN); IR (KBr) 1730,1690,1670, 
1615 c m 1 ; mp 180-182 "С (water). 
S-Deoro-(H)-8parsomycin (62). The ester 61 (150 mg, 0.4 
mmol) was reduced with lithium borohydride as described for the 
preparation of 36 and 37. After removal of the solvent in vacuo, 
the product was purified by gel filtration over Sephadex LH-20 
(eluent H20/MeOH, 15/85 v/v) to yield 62 (63%). The product 
was homogeneous on TLC (R, 0.51, MeOH/CH2Clj, 1/4 v/v): 
NMR (Me2SO-d6) Í 2.32 (s, 3 H, SCH·,), 2.5 (s, 3 H, CtëJCHa), 
3.0 (m, 2 H, CHCHjS), 3.75 (m, 2 H, CH2OH), 4.0 (s, 2 H, SCH^), 
4.25 (m, 2 H, CHCH2OH), 7.30 and 7.54 (AB spectrum, J = 16 
Hz, 2 H, HC=CH), 8.25 (br d, 1 H, HNCH); IR (KBr) 1725,1655, 
1605 cm1 ; mp 221-222 "C. Anal. Caled for C^H^Njí^Sj: C, 
45.40; H, 5.45; N, 12.04. Found: С, 45.20; H, 5.4; N, 12.16. 
Sparsomycin Enantiomer 65. From 46. The coupling 
procedure was analogous to the procedure which has been de­
scribed for the preparation of 61. A coupling of O-protected amino 
alcohol 46 (200 mg, 0.75 mmol) with the add 2 (164 mg. 0.84 mmol) 
gave after workup and column chromatography (eluent 
MeOH/CH2Cl2,8/92 v/v) the amide 63: 45% yield TLC R/0.34 (MeOH/CHjClj, 1/9 v/v). A solution of this product (130 mg, 
0.29 mmol) in 7 mL of ethanol to which was added 70 /iL of an 
0.1 N aqueous HCl solution was refluxed for 15 min. Then the 
solution was neutralized with ammonium hydrogen carbonate and 
the solvent evaporated in vacuo. Gel filtration over Sephadex 
LH-20 (eluent H 20/MeOH, 15/85 v/v) gave 65, in 75% yield, 
which was homogeneous on TLC (Я, 0.28; МеОН/СН2С12,1/4 
v/v): NMR (D20) i 2.30 (s, 3 H, SCH3), 2.41 (s, 3 H, С(б)СНз), 
3.21 (d, 2 H, CHCH2S(0)), 3.77 (m, 2 H, CHCH2OH), 3.95 and 
4.11 (AB spectrum, J = 13.8 Hz, 2 H, SÍOCHjSCHa», 4.47 (m, 
1 H, CHCH2OH), 7.06 and 7.40 (AB spectrum. J = 15.6 Hz, 2 H, 
HC=CH); IR (KBr) 1715, 1660, 1600, 1015 cm1 ; UV (MeCN) 
Хм, 297 nm; [<»PD -60° (c 0.47, water). Anal. Caled for 
СиН^зОбЗг: С, 43.20; H, 5.30; N, 11.63. Found: С, 43.61; H, 
5.20; N, 11.43. 
From 57. To a stirred, cooled (0 "С) solution of the acid 2 (383 
mg, 1.95 mmol) and triethylamine (218 mg, 2.15 mmol) in 25 mL 
of THF/DMF (1/1 v/v) was added ethyl chloroformate (212 mg, 
1.95 mmol). Stirring was continued at 0 "С for 4 h. Subsequently, 
a solution of the amino alcohol 57 (275 mg, 1.5 mmol) in 25 mL 
of THF/DMF (1/1 v/v) was added dropwise. The reaction 
mixture was stirred at room temperature for 48 h, ard then the 
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solvents were removed in vacuo at room temperature. The product 
thus obtained was purified by gel nitration with Sephadex LH-20 
(eluent H 20/MeOH, 15/85 v/v) to yield 65 (48%). 
Sparsomycin Diastereomer 66. From 47. The coupling 
procedure was analogous to the procedure used for the preparation 
of 61. Reaction of the O-protected amino alcohol 47 (104 mg, 0.38 
mmol) and the uracilylacrylic acid 2 (82 mg, 0.42 mmol) gave after 
workup and column chromatography (eluent MeOH/CHjC^, 8/92 
v/v) 64: 45% yield; TLC Д, 0.38 (MeOH/CH2Cl2, 1/9 v/v). 
Deprotection of the alcohol function and purification of the re­
action mixture was done as has been described for the synthesis 
of 65. The diastereomer 66 was obtained in 74% yield: TLC R/ 
0.32 (MeOH/CHîClj, 1/4 v/v); NMR (D20) ä 2.30 (s, 3 H, SCH,,), 
2.38 (s, 3 H, С(б)СНз), 3.15 and 3.39 (AB part of ABX spectrum, 
8 lines, JAB = 14 Hz, ^АХ = 4.6 Hz, J
m
 = 7.2 Hz, 2 H, 
CHCHÜSÍO) ) , 3 78 (d, 2 H, CHCH2OH), 3.98and 4.15 (AB 
spectrum,«/ = 14 Hz, 2 H, S(O)CHjS), 4.46 (m, 1 H, CHCH2OH), 
7.03and 7.41 (AB spectrum, J = 15.6 Hz, 2 H, HC=CH); IR (KBr) 
1710,1660,1600,1010 cm"1; UV (MeCN) λ,,*. 298 nm; [α]\ -59' 
(с 0.59, water). Anal. Caled for d s H ^ O A : C, 43.20; H, 5.30; 
N, 11.63. Found: C, 43.57; H, 5.45; N, 11.17. 
From 58. Diastereomer 66 was prepared in 35% yield from 
the amino alcohol 58 (357 mg, 1.95 mmol) and the uracilylacrylic 
acid 2 (392 mg, 2.0 mmol) as described for the preparation of 65. 
Sparsomycin (1). Sparsomycin was prepared in 33% yield 
from the amino alcohol 3 (46 mg, 0.25 mmol) and the uracilyl­
acrylic acid 2 (64 mg, 0.325 mmol) as described for the preparation 
of 65; [a]2 5!, +75° (c 0.245, water) (Ut1 [
a
]*D +69° (c 0.5, water)). 
The product thus obtained showed the same spectral charac­
teristics ('H NMR, IR, UV) as 65 except for the CD curve (see 
Figure 1), whereas it was identical with an authentic sample of 
sparsomycin.*1 Anal. Caled for C^H^NaOsSî: С, 43.20; H, 5.30; 
Ν, 11.63. Found: С, 43.51; Η, 5.43; Ν, 11.27. 
Sparsomycin Diastereomer 67. Compound 67 was prepared 
from the amino alcohol 60 (92 mg, 0.5 mmol) and the acid 2 in 
40% yield as has been described for the preparation 65. The 
product thus obtained was identical with 66, except for the sign 
of the specific rotation and the CD curve (see Figure 1); la]aD 
+48° (c 0.175, water). Anal. Caled for C1sH19N306S2: C, 43.20; 
H, 5.30; N, 11.63. Found: C, 42.89; H, 5.36; N, 11.34. 
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An efficient route leading to the functionalized five-membered cyclic sulfinate esters (7-sultme8) 14a,b and 
21a,b is described on the basis of the reaction of the N-protected Cystinol derivatives 11 and 20, respectively, 
with N-chlorosuccimmide (NCS) and AcOH Ring-opening reactions of the sultines can be performed in two 
ways Treatment of 14 with Clj or NCS/HC1 gives the sulfonyl chloride 15 by cleavage of the C-0 bond Selective 
cleavage of the S-OR bond occurs when 14 or 21 is treated with MeSCHjLi, n-BuLi, or C
e
H6C(Li)(H)CN to yield 
the hydroxyalkyl sulfoxides 22-26 These nucleophihc ring-opening reactions are stereospecific and proceed with 
inversion at the sulfoxide sulfur atom. The synthesis of 23a constitutes a new approach to the antibiotic sparsomycin 
(1) Circular dichroism measurements can be employed m the assignment of absolute configurations to the sulfoxide 
sulfur atom of the sultines 14a,b and 21a,b (patents pending). 
The antibiotic sparsomycin (I ) 1 may be considered as 
an amide derived from the acid component 2 and the 
amine component 3 (Scheme I). The latter can be viewed 
as a derivative of D-cysteine (4), having its CO2H function 
reduced and its SH function alkylated and oxidized. 
Recently, in the course of total syntheses of 1, two ap­
proaches were developed to prepare protected derivatives 
of 3, as represented by formula 9 (Scheme II). Helquist2 
applied successfully the sulfenylation of the a-sulfinyl 
carbanion 6, prepared, in turn, from D-cysteine 4 (route 
A), while we3 , 4 employed the reaction of the cysteinol a-
halo sulfoxide derivative 7 with sodium methylmercaptide 
(route B). 
An attractive alternative to these routes might feature 
the nucleophilic ring opening of a cyclic sulfinate ester or 
7-sultine, 8 (approach C). Such an intermediate has a 
sulfur atom activated toward nucleophilic attack and si­
multaneously provides protection for the alcohol function. 
We report the viability of this approach: we have syn­
thesized sultines of type 8 and have studied their ring-
opening reactions with nucleophiles. In the course of our 
synthetic work on sulfur-containing natural products we 
have become interested in sultines for several reasons. In 
contrast to their lactone counterparts they are inherently 
chiral, so that in reactions with racemic nucleophiles (e.g., 
R ^ R j C r ) ring opening will be a diastereoselective pro­
cess. As will be shown below, these ring-opening reactions 
may proceed by cleavage of either the S - 0 bond or the 
C-0 bond. Oxidation of sultines gives sultones which have 
a utility of their own in synthetic organic chemistry.6 
S y n t h e s i s of 7-Sult inee 8 
In contrast to the extensive literature which exists on 
the preparation of sulfinate esters6 only a limited number 
of sultines have been described.7 To our knowledge, no 
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(1) Aigoudelie, A D , Herr, R R Antimicrob Agents Chemother 
1962, 78α Higaehide, E, Hasegawa, Τ , Shibita, M, Minino, К, Akaike, 
Η Takeda Kenhyusho Nempo 1966,25,1, Chem Abstr 1967,66, 54238 
(2) Helquist, Ρ , Shekani, M S J Am Chem Soc 1979,101,1057 
(3) Ottenheijm, H С J , Liskamp, R M J , Tijhuie, M W Tetrahe­
dron Lett 1979,387 
(4) Ottenheijm, H С J , Liskamp, R M J , van Nispen, S Ρ J Μ , 
Boote, Η Α., Tijhuis, U VI J Org Chem 1981, 46, 3273 
(5) Hanefeld, W , Kluck, D Synthesis 1981, 229 Smith, M В , Wo-
Ішаку, J. J Org Chem 1981, 46, 101 Franer-Reid, В , Sun, Κ Μ , 
Teang, R Υ -К , Sinaij, Ρ Pietraezkiewicz, Μ Can J Chem 1981, 59, 
260 Kondo, К, Aoi, H , Takemoto, К Synth Commun 1980,10, 267 
(6) Nudelman, A Phosphorus Sulfur 1980, 9, I 
(7) Sharma, N К, De Reinach-Hirtzbach, F, Dunt, Τ Can J Chem 
1976, 54, 3012 and reference cited therein 
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synthesis of functionalized sultines, e.g., 8, have yet been 
reported. 
For the preparation of 8 we examined first the method 
used8·9 for the conversion of l-mercaptopropan-3-ols into 
(8) Givene, Б N , Hamilton, L A J Org Chem 1967, 32, 2857 
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7-sultines as it allowed us to use cysteinol as the starting 
material Thus, the N-protected L-cystinol derivative 11, 
prepared from 10 by LÌBH4 reduction followed by I2 ox-
idation, was treated with 3 equiv of CI2 and an excess of 
AcOH (Scheme III). However, instead of the expected 
compound 14 the sulfonyl chloride IS was formed (78% 
yield). The structure of 15 was secured by spectroscopic 
data and the formation of the derivatives 16-18. We then 
reexamined the reaction conditions. When the reaction, 
which was monitored by TLC, was stopped just as 15 
began to appear, in addition to starting material 11, the 
sultines 14a and 14b could be isolated, albeit in low yields 
(7% and 28%, respectively). The molecular structures of 
14a and 14b were assigned by spectroscopy and the 
preparation of derivatives; the absolute configuration of 
the sulfoxide sulfur atoms10 was assigned by X-ray analysis 
of a homologue (vide infra). The two diastereomers 
showed a surprisingly large difference in Л/ value on 
chromatography and were readily separated by silica gel 
chromatography, compound 14a being the more polar 
component.11 
Treatment of the isolated sultines with С\
г
 resulted in 
quantitative formation of 15. The formation of 14 and 15 
from 11 can be rationalized by the following sequence. 
Chlorine oxidation of 11 produces first the sulfonium ion 
12, which, by subsequent intramolecular displacements by 
the hydroxy! functions, leads to 2 mol of the sultene 13. n 
This, on oxidation with СІг/АсОН, gives the sultines 14a 
and 14b. Finally, 15 is formed by cleavage of the C-0 
bond, a reaction known to proceed with sulfinate esters13 
and with some sultines7 in the presence of halogens. This 
ring-opening reaction might be rationalized as depicted in 
19. 
Apparently, ring opening of 14 to 15 and the oxidation 
steps that lead to 14 are competing reactions with similar 
rates in the Cl2/AcOH procedure. We reasoned that the 
(9) Dodson, R. M, Hammen, P. D., Davie, R A. J. Chem. Soc., Chem. 
Commun 1968, 9 
(10) The R/S nomenclature ш adopted for euUinate esters (Mislow, 
К , Green, M M, Laur, Ρ , Melillo, J Τ , Simmons, Τ , Ternay, A L. J. 
Am. Chem Soc 1965,87,1958) has been followed here, m that the S-0 
"double" bond has a lower priority than the S-OR bond 
(11) The conformations of 14a and Mb are being studied by NMR and 
may provide some explanation for the large difference in polarity 
(12) While sultines have been proposed before as reactive interme­
diates, only recently has the first stable sultene been prepared, see 
Astrology, G W ; Martin, J. С J. Am Chem. Soc 1977, 99, 4390 and 
references cited therein 
(13) Douglass, Ι В J. Org. Chem 1965. 30, 633; 1974, 39, 563 
H / W :;0 
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use of another oxidizing agent, generating Cl+ and having 
a less nucleophilic counterion, might prevent the ring 
opening. Consequently, we studied, in turn, SOjClj and 
iV-chlorosuccimmide (NCS).14 Reaction of 11 with 3 equiv 
of SO2CI2 gave an intractable reaction mixture. Oxidation 
with NCS, however, was more successful; treatment of 11 
with AcOH and 3 equiv of NCS gave 14a and 14b (1:1 
ratio) in 90% yield. Thus it appears that under these 
reaction conditions no Cl2 is being formed. With an excess (10 equiv) of NCS, compound 15 was again isolated as the 
sole product. The sultines were found to be unreactive 
toward NCS alone. Thus the production of 15 must be 
caused by reaction of the sultines with СГ/NCS or CI2. 
Reaction of 11 with 3 equiv as well as with an excess (10 
equiv) or N-bromosuccinimide (NBS) gave the sultines 14a 
and 14b (1.1 ratio) in 86% yield. Here the use of an excess 
of NBS gave no detectable amounts of the ring-opened 
product.15 
Earlier we had shown4 in the synthesis of sparsomycin 
(1) that the tert-butoxycarbonyl (Boc) group was preferred 
for the N-protection of 9. Therefore, we also prepared the 
sultines 21a and 21b (88% yield, 1:1 ratio) by treatment 
of 20 with 3 equiv of NCS, an excess of AcOH, and, to 
avoid removal of the acid-labile Boc group, 3 equiv of 
pyridine (Scheme IV). Structures 21a and 21b were as­
signed to the more polar and less polar diastereomeric 
products, respectively, by means of spectroscopy and an 
X-ray crystallographic analysis of 21a.17 These structures 
were also supported by conversion of the products into 
derivatives (vide infra). 
The Ή NMR spectra of 14a,b and 21a,b deserve some 
comment. Previous studies have shown that protons in 
a 1,3-eyn-diaxial relationship to a sulfinyl oxygen atom 
experience deshielding, which has been referred to as the 
syn-axial effect.18 This effect has been discussed for 
four-,19 five-,7 and six-membered18·20 ring systems and 
caused a Δ6 of 0.6-1.1 ppm. This effect was not observed 
in 14a,b and 21a,b; the 1H NMR spectra showed nearly 
the same S value for the C(4) proton in either a syn rela­
tionship with the sulfinyl oxygen (21a, & 4.79) or an anti 
position (21b, i 4.85). This indicates that the syn-axial 
effect may not be applicable to substituted γ-sultines, 
where substituents assume pseudoaxial and pseudoequa-
torial positions.21 
(14) Both reagents have been used for the conversion of tert-butyl 
hydroxyalkyl sulfoxides into sultines (see ref 7) 
(15) This interesting difference m reactivity of the sultines 14 toward 
NBS and NCS might be explained by a polarization difference between 
their N-halogen bonds, the N-Br bond is less polarized than the N-Cl 
bond,16 so that NBS may not be reactive enough to cause ring opening 
of 14. We noticed that during the NBS reaction Brj was formed From 
this it may follow that the sultines 14 are stable toward Br? but reactive 
toward d j 
(16) Lumbrceo, H., Gaseo, L.; Malin, С Bull Chem Soc Fr 1951, IS, 
823. 
(17) A detailed discussion of the X-ray crystallographic analysis of 21· 
and a conformational analysis of 21a and 21b based on NMR spectros­
copy will be the subject of a future report 
(18) Harpp, D N., Gleason, J G J Org Chem 1971, 36, 1314 and 
references cited therein 
(19) Johnson, С R., Siegl. W О Tetrahedron Lett 1969, 1879 
(20) Buchanan, G W , Sharma, N К , De Reinach Hirtzbach, F , 
Durst, Τ Con J Chem 1977, 55, 44 
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Nucleophilic Ring-Opening Reactions of Sultinee 
The moet widely used procedure for the synthesis of 
sulfoxides of high optical purity involves the reaction of 
an optically active sulfinate ester with a Grignard reagent, 
the Andersen synthesis.22 Recently, this method has been 
used by Colombo et al.23 for the synthesis of optically active 
thioacetal monosulf oxides by reaction of an optically active 
sulfinate ester with (alkylthio)methyllithium. These re­
actions are stereospecific and proceed with inversion at 
sulfur.24 Nucleophilic ring opening of sultinee has been 
reported only twice. Grignard reagents26 as well as orga-
nocopper-lithium reagents28 gave the corresponding sul­
foxide alcohols. Although the stereochemistry of these 
ring-opening reactions has not been rigorously established, 
it has been discussed and assumed25 by analogy to open-
chain eulfinates to proceed also with inversion at sulfur. 
We found that Colombo's approach23 was also applicable 
for the conversion of 8 into 9. Thus, reaction of 14 and 
21 at -78 "С with 3 equiv of (methylthio)methyllithium, 
prepared according to Peterson,27 gave the desired di-
thioacetal monoxides 22 and 23 (Scheme V; the yields for 
22 have not been optimized). The known4 compounds 27a 
and 27b were found as side products (19% and 11% yields, 
respectively) when the reaction mixtures of 14 -• 22 were 
not acidified rapidly after completion. 
The formation of 22 and 23 was found to be stereospe­
cific; no trace of the corresponding diastereomers was 
found. Since the absolute configuration of sultine 21a17 
as well as of the ring-opened products 22 and 2328 has been 
rigorously established, we can now conclude that in analogy 
to open-chain eulfinates, sultines undergo nucleophilic 
ring-opening reactions with inversion at sulfur.2* 
The reactivity of 14 and 21 toward other nucleophiles 
was also studied. Reaction of 14a and 21b with n-butyl-
(71) This >yn-axial effect was applied incorrectly by Sharma et al.,7 
who assigned erroneous structures to r-aultines having a phenyl sub­
stituent at C(4). 
(22) Andersen, K. K. Tetrahedron Lett. 1962, 93. Andersen, K. K.; 
Foley, J.; Perkins, R.; Gaffield, W.; Papanikalaou, N. J. Am. Chem. Sot. 
1964,86,6637. Andersen, K. K. Int. J. Sulfur Chem. Part B, 1971,6,69. 
(23) Colombo, L.; Gennare, C; Narisano, E. Tetrahedron Lett. 1978, 
Э861 
(24) Azelrod, M.; Bickart, P.; Jacobus, H.; Green, M. M.; Mislow, K. 
J. Am. Chem. Soc. 1968, 90, 4835. 
(26) Pirkle. W. H.; Hoekstra. M. S. J. Am. Chem. Soc. 1976,98,1832. 
(26) Harpp, D. N.; Vines, S. M.; Montillier, J. P.; Chan, T. H. J. Org. 
Chem. 1976, 41, 3987. 
(27) Peterson, D. J. J. Org. Chem. 1967, 32, 1717. 
(28) Ottenheijm, H. C. J.; Liekamp, R. M. J.; Helquist, P.; Lauher, J. 
W.; Sbekhani, M. J. Am. Chem. Soc. 1981,103, 1720. 
(29) Whereas the ring-opening reactions of 14 and 21 proceeded with 
inversion, the R/S nomenclature does not change in those cases where 
there is a reversal in the priority assignments for the sulfur substituents, 
e^., in going from 14 to 22, or 21 to 23, and 26. See also ref 10. 
Figure 1. CD spectra of 21a,b and 23a,b in acetonitrile. 
lithium gave the sulfoxides 24 and 25, respectively. In an 
attempt to prepare other a-functionalized sulfoxides in 
addition to 22 and 23, compounds 21a and 21b were 
treated with lithium benzylcyanide30 to give the a-cyano 
sulfoxides 26a and 26b, respectively. In each case dia­
stereomers having different configurations at the C(H)-
(CN) carbon atom were formed in unequal amounts: for 
26a the ratio was 1/2; for 26b the ratio was 9/11 (the 
stereochemistry is undetermined). This shows that asym­
metric induction by the chiral sulfur atom is at work. So 
far, optically active a-cyano sulfoxides have been virtually 
unexplored.31 
Treatment of 21b with 2 equiv of NaOMe in MeOH gave 
a mixture of the starting material and 21a in a 1:1 ratio. 
This epimerization can be explained by a trans-
esterification reaction of the ring-opened RC-RB methyl 
sulfinate ester;32 ring closure of the latter gives 21a. None 
of the ring-opened methyl sulfinate esters could be isolated. 
CD Spectra of 21 and 23 
Previously we showed that for sparsomycin4 as well as 
for several a-functionalized sulfoxides used as synthetic 
intermediates ^ that CD can be employed in the assign­
ment of the configuration of the sulfoxide sulfur atom; a 
negative sign of the Cotton effect centered at the S(O) 
absorption band in the 220-230-nm region correlates with 
an R configuration (as in 22a and 23a) and a positive sign 
with an 5 configuration (as in 22b and 23b). Examples 
in which CD spectra have been applied to eulfinates or 
sultines are so few28 as to allow no generalizations. The 
CD spectra of the sultines 21a and 21b were measured and 
compared with those of 23a and 23b (Figure 1). 
For 21a and 21b a striking difference is observed in the 
magnitude of rotational strength, whereas the bands for 
the sulfoxides 23a and 23b have nearly the same ampli­
tude. This may be rationalized as follows. In the region 
of 220-240 nm each spectrum consists of a composite 
(30) Kaiser, E. M.; Hauser, С. R. J. Am. Chem. Soc. 1966,88, 2348. 
(31) After completion of our study on the reaction of sultines with a 
prochiral nitrile, the preparation of α-суало sulfoxides from sulfinate 
esters was reported: Annunziato, R.; Cinquini, M.; Colonna, S.; Cozzi, 
F. J. Chem. Soc., Perkin Tran». 1 1981, 614. 
(32) For the methanolysis of sulfinate esters, see: Darwish, D.; No-
reyko, J. Can. J. Chem. 1965, 43,1366. 
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chromophore, which includes an inherently symmetric but 
chirally perturbed amide band as well as an inherently 
chiral sulfoxide band. With the sulfoxides 23a and 23b 
and other sulfoxides we have studied before,4 t h e contri­
bution due to the chiral carbon atom is small, so that their 
CD curves are nearly mirror images. This behavior con­
trasts with t h a t of the sultines 21a and 21b, where the 
contribution of the chiral carbon is evidently considerably 
larger and on the same order of magnitude as t h a t of the 
sulfoxide atom. As yet we have no explanation for this 
increase of rotational strength of the amide chromophore. 
Nevertheless, the CD curves of 21a and 21b allow the 
conclusion t h a t the sign of the band which is due to the 
sulfoxide chromophore is positive and negative, respec­
tively. From this it follows t h a t the correlation between 
the sign of the Cotton effect and the absolute configuration 
of the sulfoxide sulfur atom in unsubst i tuted sultines is 
identical with t h a t mentioned above for a-functionalized 
sulfoxides: compounds that have a geometrical ar­
rangement as depicted m 21a and 23b have a positive sign 
of the Cotton effect, and their stereomers 21b and 23а а 
negative one.28 This implies t h a t the nucleophilic ring-
opening reactions of sultines 14 and 21 t h a t lead to a-
functionalized sulfoxides are accompanied by a change in 
the sign of the Cotton effect.33 In addition, it can be 
concluded that at least for 7-sultines, CD can be employed 
in the assignment of the absolute configuration of the 
sulfoxide sulfur atom. Whereas this method is as direct 
and reliable as the method of Ή N M R using chiral fluoro 
alcohols, 2 5 we have to urge caution when sultines having 
an additional chiral center are studied; the strong effect 
of coupling of both chromophores could lead to an alter­
ation in the sign of t h e 220-240-nm band; i.e., both sulf­
oxide diastereomers could have cotton effects of the same 
sign. 
In summary, we have shown t h a t sultines can undergo 
ring-opening reactions either by cleavage of the C - 0 bond 
or by cleavage of the S-OR bond. Previously, we have 
shown4 tha t 23a is easily converted into (η
ε
)-3 and can be 
subsequently coupled with 2 to give (i?
c
)-sparsomycin 
T h u s , t h e sequence of reactions 20 -• 21a - * 23a consti­
tutes a new approach to sparsomycin (1). 
Work is in progress on determining the inductive power 
of the chiral sulfur a tom of the sultines in ring-opening 
reactions with racemic nucleophiles. Also, the general 
appplicability of the CD rule for sultines as delineated in 
this paper will be studied. 
Exper imenta l Sect ion 
Ή NMR spectra were measured on a Vanan Associates Model 
T-60 or a Braker WH-90 spectrometer with Me4S¡ or t-BuOH as 
an internal standard CDCI3 was used as the solvent unless stated 
otherwise. 13C NMR spectra were measured on a Bruker WP-60 
spectrometer IR spectra were measured with a Perkin-Elmer 
spectrophotometer, Model ΘΘ7, and UV spectra on a Perkm-Elmer 
spectrophotometer, Model 555 Circular dichroism spectra were 
measured with a Dichrograph II apparatus (Roussel-Jouan). 
Mass spectra were obtained with a double-focusing Vanan 
Associates SMI-B spectrometer. Melting points were taken on 
a Köfler hot stage (Leitz-Wetzlar) and are uncorrected Thin-layer 
chromatography (TLC) was earned out by using Merck precoated 
silica gel F-254 plates (thickness 0 25 mm), with the following 
solvent systems. (A) MeOH/CH^lj, 1/9 v/v, (В) МеОН/СН2СІ2, 
6/94 v/v, (C) M e O H / C H Ä 4/96 v/v, (D) M e O H / C H A 3/97 
v/v. Spots were visualized with an UV lamp, iodine vapor, mn-
(33) We anticipate that ring-opening reactions that lead to aJkyl sul-
foxides will proceed with conservation of the sign of the Cotton effect 
This prediction is based upon our observation28 that the sign of the 
Cotton effect of alkyl sulfoxides (118(0)11,. is opposite that of the cor-
responding a-functionabzed derivatives (RS(0)CH(X)(R2) 
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hydrin, or CI2-TDM м For column chromatography Merck silica 
gel H (type 60) was used The Mimprep LC (Jobin Yvon) was 
used for preparative HPLC 
Z-L-Cystinol (11). To a stirred, cooled (-78 0C) solution of 
sodium borohydnde (6 81 g, 180 mmol) and lithium iodide (24 09 
g, 180 mmol) in 600 mL of dry dimethoxy ethane (DME) was 
added methyl ester 10, prepared according to the procedure of 
Gustus,35 in one portion The reaction mixture was allowed to 
warm to room temperature and then stirred until the reaction 
was complete, as monitored by TLC (system A) The solution 
was neutralized to pH 7 with an aqueous solution of 1N HCl with 
ice cooling Stirring was continued for 1 h at room temperature, 
after which time the volume was reduced to half its volume A 
methanolic solution 0 1 M m iodine and 0 2 M in pyridine was 
added until a faint yellow color of iodine persisted The excess 
of lodme was destroyed by adding a few crystals of N828205 After 
evaporation of DME and methanol in vacuo, water and di-
chloromethane were added The aqueous layer was extracted three 
times with dichloromethane and twice with ethyl acetate The 
combined organic layers were dried (NajSOJ, and the solvent was 
evaporated in vacuo After recrystallization of the residue from 
ethyl acetate, 12 53 g (87% yield) of 11 was obtained. This 
material was homogenous on TLC (R/ 0 17, solvent system B): 
NMR (CDaOD) δ 2.67-3.13 (m, 2 H, CHjS), 3 63 (br d, 2 H, CHjO), 
3 80-4 10 (m, 1 H, CHCH2), 5 07 (s, 2 H, С^СЩ, 7 32 (s, 5 H, 
CeHs), IR (КВг) 3300, 1695, 1680, 1535 cm"1 Anal. Caled for 
CsHjeNjOeSj С, 54 98; H, 5.87, Ν, 5 83 Found С, 55.27, Η, 
5 84, Ν, 5 65. 
4-[(Benzyloxycarbonyl)amino]-l,2-oxathiolane 2-Oxide 
(14a,b). To a stirred solution of Z-cystinol (11, 4 80 g, 10 mmol) 
in 100 mL of glacial acetic acid was added a solution of І -
chlorosuccimmide (4 01 g, 30 mmol) in 150 mL of glacial acetic 
acid dropwise at room temperature The reaction mixture was 
stirred overnight After completion of the reaction as monitored 
by TLC (solvent system B) the acetic acid was evaporated m vacuo 
at room temperature The residue was dissolved in 400 mL of 
dichloromethane and 15 mL of water The organic layer was 
separated and dried, and the solvent evaporated in vacuo The 
residue was dried and then chromatographed over silica (eluant 
MeOH/CHjClj, 0 5/99 5 v/v) to yield 14a (45%) and 14b (45%) 
The synthesis of 14a and 14b with N-bromosuccinimide (3 equiv 
or more) was earned out as described above After evaporation 
of acetic acid, residual bromine was removed by dissolving the 
residue in methanol and evaporation of the solvent in vacuo, this 
was repeated twice. Column chromatography of the residue gave 
14a (43% yield) and 14b (43% yield) 
14a· mp 87 CC (AcOEt-hexane) R, 0 43 (solvent system B); 
NMR 6 3 34 and 3 07 (AB part of ABX spectrum, 8 lines, J
№
 = 
13 9 Hz, JAX = 6.2 Hz, J B X = 2 4 Hz, 2 H, CHzSÍO)), 4 38-4.52 
and 4 62-4 88 (m, 3 H, CHCHjO), 5 09 (s, 2 H, C6H5CH2), 5 45 
(br d, 1 H, NH), 7.33 (s, 5 H, С ^ ) , IR (КВг) 3310,1720, 1530, 
1110 cm"1; exact mass caled for CUH 13N0 4S 255 147, found 
255149. Anal Caled for С
и
НізШ 4 8 · С, 51.75, H, 5 13; Ν, 5 49 
Found. С, 51 89, Η, 5.11; Ν, 5 35 
14b Я, 0 64 (solvent system В), NMR δ 2.91 and 3 20 (AB part 
of ABX spectrum, 8 lines, JAB = 13.9 Hz, t/AX = 6.2 Hz, J B x = 
2 4 Hz, 2 H, CHjSÍO)), 4 58 and 4 75 (AB part of ABX spectrum, 
8 lines, JAB = 9 6 Hz, JAX = 5 7 Hz, JBX = 1 9 Hz, 2 H, CHjO), 
4 98 (m, 1 H, CHCH2O), 5 10 (s, 2 H, C6H5CH2), 6.36 (br d, 1 H, 
NH), 7 33 (s, 5 H, CeH5); IR (KBr) 3320,1690, 1545,1108 cm"1; 
exact mass caled for CnHijNO^S 255 147, found 255 147. Anal. 
Caled for CuHjaNC^S. C, 51 75; H, 5 13; N, 5.49 Found; C, 51 42, 
H, 5 20, N, 5 35 
3-Chloro-2-[(benzyloxycarbonyl)amino]-l-propane-
sulfonyl Chloride (15). To a stirred solution of Z-cystinol (11, 
1.44 g, 3 mmol) m 40 mL of glacial acetic acid was added a solution 
of chlorine (1 59 g, 22 mmol) in 15 mL of dry, ethanol-free di-
chloromethane in small portions at room temperature After the 
addition was complete, the reaction mixture was stirred for 2 h 
at room temperature, after which time the excess of chlorine was 
removed by a stream of argon Evaporation of the solvent at room 
temperature m vacuo gave 15 78% yield, R/0 25 (solvent system 
(34) Von Απ, E , Faupel, M , Brugger, M J Chromatogr 1976,120, 
224 
(35) Gustus, E L J Org Chem 1967, 32, 3425 
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B), NMR Ò 3 67-4 00 (m, 2 H, СНгЗОгСІ), 4 00-4 10 (br d, 2 H, 
CH2C1), 4 44-4 82 (m, 1 H, CHCH2C1), 5 13 (s, 2 H, CJHSCHJ), 
5 59 (br d, 1 H, NH), 7 35 (s, 5 H, C6H6), IR (Nujol) 3340, 1695, 
1380,1360,1350,1175 cm1, mass spectrum, m/e 325,327, 329 (M+) 
Methyl 3 Chloro-2-[(benzyloxycarbonyl)amino]-l-
propanesulfonate (16). The sulfonyl chloride 15 was converted 
in 43% yield to 16 by chromatography over silica gel with solvent 
system С R/0 82 (solvent system С), NMR δ 3 45-3 52 (AB part 
of ABX spectrum, 2 H, CHJSÍOÍ)), 3 75 and 3 92 (AB part of ABX 
spectrum, J^ = 4 2 Hz, </
Β
χ = 5 4 Hz, JXB = 114 Hz, CH2C1), 
3 90 (s, 3 H, OCH3), 4 41 (m, 1 H, CHCH2C1), 5 12 (s, 2 H, 
CeHsCHj). 5 69 (br d. 1 H, NH), 7 35 (s, 5 H, C
e
H5), IR (Nujol) 
3320, 1695, 1545, 1350, 1330, 1180 cm"1, exact mass caled for 
djHieClNOsS 321 252, found 321 251 Anal Caled for 
С12Н1вС1Ж>58 C, 44 79, H, 5 01, N, 4 35 Found C, 44 55, H, 
4 80, N,4 11 
Ethyl 3-Chloro-2-[(benzyloxycarbonyl)amino]-l-
propanesulfonate (17). The sulfonyl chloride 15 (1 52 g, 4 7 
mmol) was dissolved m 200 mL of chloroform containing ethanol 
and solid sodium carbonate The reaction mixture was stirred 
overnight Subsequently the precipitate was removed and the 
solvent evaporated in vacuo The residue was recrystalhzed from 
chloroform/hexane to give the ethyl sulfonate 17 40% yield, mp 
133-134 0C, NMR 6 140 (t, 3 H, SOjCHjCHs), 3 44-3 51 (AB part 
of ABX spectrum, 2 H, CH^Oj), 3 75 and 3 92 (AB part of ABX 
spectrum, J^ = 4 3 Hz, JBX = 5 5 Hz, J ^ = 11 4 Hz, 2 H, CH,Cl)t 
4 32 (q, 2 H, СН2СНз), 4 46 (m, 1 H, CHCH2C1), 5 12 (s, 2 H, 
C
e
H6CH2), 5 65 (br d, 1 H, NH), 7 35 (s, 5 H, C6H6), IR (Nujol) 
3315,1690,1545,1345,1330,1180,1170 cm"1, mass spectrum, m/e 
335,337 (M+) Anal Caled for CuH^ClNOsS С, 46 50, H, 5 40, 
Ν, 4 17 Found С, 46 11, Η, 5 26, Ν, 4 35 
JV-Methyl-3-chloro 2 [(benzyloxycarbonyl)amino]-l-
propaneeulfonamide (18). To a stirred and chilled (0 SC) 
solution of the sulfonyl chloride 15 (200 mg, 0 61 mmol) in dry, 
ethanol-free chloroform was added a solution of methylamine in 
benzene (1 22 mmol) The solution was stirred at room tem­
perature overnight, the salt was removed by nitration, and the 
solvent was evaporated in vacuo The crude product was neit 
purified by column chromatography (solvent system D) to give 
the sulfonamide 18 62% yield, fyO 61 (solvent system B), NMR 
δ 2 74 (d, 3 H, NHCH3), 3 34 (d, 2 H, CHJSOJ), 3 71 and 3 87 (AB 
part of ABX spectrum, J^x = 4 0 Hz, J^x = 5 0 Hz, «/^ = 113 
Hz, 2 H, CH2C1), 4 41 (m, 1 H, CHCH2C1), 4 71 (br, 1 H, NHCH3), 
5 12 (s, 2 H, C6H6CH2), 5 51 (br d, 1 H, NH), 7 36 (s, 5 H, C6HS), 
IR (KBr) 3320, 1690,1535,1330, 1155 cm"1, exact mass caled for 
Ci2Hi7ClN204S 320 2675, found 320 266 Anal Caled for 
C12H17C1N204S С, 44 93, H, 5 34, Ν, 8 73 Found С, 44 83, Η, 
5 21, Ν, 8 46 
Ν (tert-Butoxycarbonyl)-L-cyetinol (20). iV-(ter£-butoxy-
carbonyl)-L cystine methyl ester (7 03 g, 15 mmol), prepared as 
described earlier,4 was reduced with lithium borohydrate [sodium 
borohydnde (3 41 g, 90 mmol) and lithium iodide (12 05 g, 90 
mmol) in 200 mL of dry DME] as described for the preparation 
of 11 The workup, however, was modified due to the acid lability 
of the N-protecting group the pH was adjusted to 5 by addition 
of aqueous 1 N KHSCX, to the stirred and cooled (0 °C) solution 
Sometimes a sticky mass precipitated before neutralization was 
complete In that case the solvent was evaporated in vacuo, the 
residue dissolved in methanol/water (1/1 v/v), and the neu­
tralization then completed The oxidation with iodine was earned 
out as described for the preparation of 11 Subsequently, the 
methanol was evaporated in vacuo, and water and ethyl acetate 
were added The aqueous phase was extracted five times with 
ethyl acetate The collected organic layers were washed with brine 
and dried (Na^O^, and the solvent was evaporated m vacuo The 
residue was recrystallized from methanol/water to give 20 87% 
yield mp 124-125 "C, R, 0 23 (solvent system A), NMR (CD3OD) 
δ 1 41 (β, 9 Η, í-Bu), 2 85 (d, 2 H, CH2S), 3 46-4 05 (m, 3 H, 
CHCH2C», IR (KBr) 3360, 3600-3100, 1685, 1525 cm l Anal 
Caled for C,eH32N2OeS2 C, 46 58, H, 7 82, N, 6 79 Found С, 
46 78, H, 7 92, Ν, 6 87 
4-[(tert Butoxycarbonyl)amino] 1,2-oxathialane 2-Oxide 
(21a,b). A solution of iV-chlorosuccimmide (4 01 g 30 mmol) in 
150 mL of glacial acetic acid was added dropwise to a solution 
of iV-(ieri-butoxycarbonyl)-L-cystinol (20, 4 12 g, 10 mmol) and 
pyridine (2 4 g, 30 mmol) in 100 mL of glacial acetic acid By 
use of the procedure as described for 14a and 14b, 21a and 21b 
were isolated in a 1/1 ratio (86% yield) 
21a mp 127 "С (СНгСЬ-СОД Я, 0 43 (solvent system Β), Ή 
NMR δ 1 44 (s, 9 H, t-Bu), 3 14 and 3 45 (AB part of ABX 
spectrum, J « = 2 9 Hz, J B X = 6 0 Hz, J^B = 13 9 Hz, 2 H, CHjS), 
4 33-4 98 (m, 2 H, CH20), 4 79 [m, 1 H (covered by СН20), 
CHCHjO], 5 05 (br, 1 H, NH), IR (KBr) 3325, 1683, 1530, 1102 
cm"
1
, "C NMR (CDüCy δ 28 4 (СН
э
)зС), C-N covered by CD2C12 
signals, 67 4 (CS), 80 7 (СН3)эС), 77 6 (COS(O)), 155 2 (C(O)N), 
exact mass caled for CHuNO^S (M+ CH,) 206 139, found 
206139 Anal Caled for C8H15N04S C, 43 42, H, 6 83, N, 6 33 
Found C, 43 46, H, 6 90. N, 6 13 
21b mp 135-136 "С (CH2C12) R/ 0 64 (solvent system Β), Ή 
NMR δ 1 43 (s, 9 H, Í-Bu), 2 94 and 3 22 (AB part of ABX 
spectrum, ^ = 13 Hz, JBX = 6 6 Hz, J
№
 = 9 7 Hz, 2 H, CHß), 
4 59 and 4 76 (AB part of ABX spectrum, JAX = 1 9 Hz, JBX = 
5 5 Hz, JAB = 9 7 Hz, 2 H, CH20), 4 85 (m, 1 H, CHCH20), 6 06 
(br, 1 H, NH), 13C NMR (CD2C12) δ 28 5 ((СНзЬО, SO 9 (С Ν), 
62 8 (CS), 80 2 (СН
э
)зС), 83 0 (COS(O)), 155 2 (C(O)N), IR (KBr) 
3325,1725,1525,1115 cm ', exact mass caled for C7Hi2N04S (M+ 
- CH3) 206 139, found 206 139 Anal Caled for CeH15N04S C, 
43 42, H, 6 83, N, 6 33 Found C, 43 56, H, 6 85, N, 6 29 
A M B e n z y l o x y c a r b o n y l ) - S oxo S [ (methy l th io ) 
methyl] L cysteinol (22a,b) and N-(tert Butoxy 
carbonyl) S-oxo-S [(methylthio)methyl] L-cystemol (23a,b). 
The anion of dimethyl sulfide was prepared m a manner analogous 
to the method described by Peterson et al 2 ' TMEDA (0 70 g, 
0 91 mL, 6 0 mmol), freshly distilled dimethyl sulfide (0 37 g, 0 44 
mL, 6 0 mmol), and 2 mL of freshly distilled THF, respectively, 
were brought via a syringe into a 50-mL, cooled (0 "С), round-
bottomed flast (equipped with a septum) containing 3 75 mL of 
a 1 6 M solution of η butylhthium in hexane (6 mmol) The 
resulting solution was stirred at room temperature for 4 h, cooled 
to -30 eC, and added dropwise to a cooled (-78 "С) solution of 
the sultine 14a,b (510 mg, 2 0 mmol) m 6 mL of freshly distilled 
THF Subsequently, the reaction mixture was stirred at -70 "C 
for 30 mm and at room temperature for 30 min, and then rapidly 
quenched at 0 °C with 5 mL of a saturated aqueous solution of 
KHS0 4 Immediately thereafter the pH of the mixture was 
adjusted to 6-8 by addition of solid sodium carbonate Ethyl 
acetate was added, and then the aqueous layer was extracted four 
times with ethyl acetate The combined organic layers were dried 
(Na^O^, and the solvent was evaporated in vacuo The residue 
was chromatographed under slightly elevated pressure (10 mmHg, 
eluant MeOH/CH2Cl2, 5/95 v/v) to give 22a (46% yield) and 22b (33% yield), respectively Compounds 23a and 23b were obtained 
in 71% and 70% yields, respectively, after preparative HPLC 
(solvent system C) and were identical in every aspect with the 
corresponding compounds obtained earlier * 
22a mp 93 "C (C^Clj-hexane), R/ 0 35 (solvent system A), 
NMR (CD2C12) δ 2 27 (s, 3 H, SCH3), 2 96 and 3 33 (AB part of 
ABX spectrum, J A X = 4 9 Hz, J B X = 5 8 Hz, J A B = 13 4 Hz), 
3 60-3 95 (m, 2 H, CH2OH), 3 71 and 3 84 (AB spectrum covered 
by CH2OH, 2 H, JAB = 13 5 Hz, S(0)CH2S), 4 26 (m, 1 H, 
CHCH20), 5 09 (s, 2 H, CeHjCHj), 5 94 (br d, 1 H, NH), 7 34 (s, 
5 H, CeHs), IR (KBr) 3335,1680,1530,1006 cm ', exact mass caled 
for σΐ3Η1 9Ν0432 317 256, found 317 256 Anal Caled for 
CuH^NOiSfr C, 49 19, H, 6 03, N,4 41 Found C, 4915, H, 6 03, 
N,4 34 
22b mp 162 "C (CH2Cl2-hexane), Rf 0 32 (solvent system A), 
NMR (CD2C12) δ 2 29 (s, 3 H, SCH3), 2 97 and 3 21 (AB part of 
ABX spectrum, JAX = 7 0 Hz, J B X = 6 4 Hz, JAB = 13 2 Hz, 2 H, 
CHCH2S(0)), 3 73-4 00 (m, 4 H, СНСНгО and SíOCHüS), 4 16 (m, 1 H, CHCH20), 5 09 (s, 2 H, C6H5CH2), 5 70 (br, 1 H, NH), 
7 35 (s, 5 H, C6H5), IR (KBr) 3330, 1695, 1538,1025, 1015 cm"1, 
exact mass caled for Ci3H19N04S2 317 256, found 317 257 Anal 
Caled for C^H^NOA С, 49 19, H, 6 03, Ν, 4 41 Found С, 
49 16, Η, 5 95, Ν, 4 16 
2 Oxo 4 [[[(methylthio)methyl]eulfoxo]methylene]oxa-
zolidine (27a,b). The ring-opening reaction of the sultine 14a 
or 14b was carried out as described above for the preparation of 
22a and 22b with a slightly different workup Instead of being 
quenched with a saturated aqueous solution of KHSO4, the re­
action mixture was stirred overnight with solid KHS04 Methanol 
was then added and the mixture stirred for another 2 h at room 
temperature After removal of the salts by filtration, the filtrate 
2 9 
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was concentrated to dryness, and the residue chromatographed 
on silica (eluant MeOH/CHjCl* 5/95 v/v) to give 27a (19%) and 
27b (11%), respectively. 
27a: R, 0.24 (solvent system A); NMR (CDjCl.,) S 2.31 (β, 3 Η, 
SCHa), 2.89-3.29 (br d, 2 H, CHCHjS), 3.77 and 3.90 (AB spec­
trum, JAB = 13.8 Hz, 2 H, SÍOJCHÜS), 4.10 and 4.69 (s, 3 H, 
CHCHjO), 6.40 (br s, 1 H, NH); IR (Nujol) 3250,1745,1710,1040 
cm"1; mass spectrum m/e 209 (M+). 
27Ь: Д/ 0.22 (solvent system A); NMR (CD2C12) « 2.32 (s, 3 H, 
SCH3), 2.94-3.29 (m, 2 H, CHCHÌS), 3.78 and 3.86 (AB spectrum, 
JAB = 13.6 Hz, 2 H, StOCHjS), 4.17-4.69 (m, 3 H, CHCHjO), 
6.84 (br s, 1 H, NH); IR (Nujol) 3240,1760,1710,1045 cm"1; mass 
spectrum, m/e 209 (M+). 
ЛГ-(Вепгуloxycarbonyl)-S-OKO-S-o -butyl-L-cysteinol (24) 
and JV-(<ert-Butoiycarbonyl)-S-oio-S-D-butyl-L-cyeteinoI 
(25). A cooled (C02/2-propanol) solution of the n-butyllithium-
TMEDA complex, prepared by adding TMEDA (523 mg, 0.68 
mL, 4.5 mmol) to a solution of n-butyllithium in hexane (4.5 
mmol), was added to a stirred, cooled (-78 0C) solution of the 
sultine Ua (383 mg, 1.5 mmol) or 21b (331 mg, 1.5 mmol) in 5 
mL of freshly distilled, dry THF. The reaction mixture was stirred 
at -70 "C for 30 min and at room temperature for another 30 min. 
The workup was carried out as described to the preparation of 
22 and 23. Compounds 24 and 25 were obtained after HPLC 
(solvent system C) in yields of 55% and 37%, respectively. 
24: R, 0.33 (solvent system A); NMR i 0.95 (t, 3 H, СН
г
СЩ, 
1.10-2.0 (m, 4 H, S(0)CH2CH2CH2CHj), 2.52-3.29 (m, 4 H, 
CHjS(0)CH2), 3.57-3.97 (m, 2 H, CHCH20), 3.97-4.40 (m, 1 H, 
CHCH20), 5.09 (s, 2 H, CeH6CH2), 5.88 (br, 1 H, NH), 7.34 (s, 
5 H, СдНц); Ш (KBr) 3430,3200,1715,1510,1060 cm"1; exact mass 
caled for CuH^NOiS 313.225, found 313.226. 
25: R, 0.32 (МеОН/СН2С12, 9/91 v/v); NMR (CD2C12) ί 0.97 (t, 3 H, CH2CH3), 1.42 (β, 9 H, t-Bu), 1.22-1.93 (m, 4 H, S(0)-
СН2СН2СН2СНэ), 2.62-3.21 (m, 4 H, CHjSiOJCHj), 3.78 (t, 2 H, 
CH2OH), 3.87-4.27 (m, 1 H, CHCH20), 5.44 (br, 1 H, NH); IR (KBr) 3430,1710,1530,1060 cm"1; mass spectrum, m/e 222 (M* 
- t-Bu). Anal. Caled for C^H^NC^S: C. 51.59; H, 9.02; N, 5.01. 
Found: С, 51.53; H, 8.97; Ν, 4.99. 
Pf- ( tert -Butoxycarbonyl ) -S -oxo-S- (cyanobenzyl)-L-cy·-
teinol (26a,b). The anion of benzyl cyanide30 was prepared by 
addition of benzyl cyanide (0.72 mL, 703 mg, 6 mmol) to 3.75 mL 
of a cooled (0 °C) 1.6 M solution of n-butyllithium (6.0 mmol) 
in hexane; 15 mL of freshly distilled, chilled THF was then added 
to dissolve the anion. The resulting, yellow-colored solution was 
added dropwise to a stirred, cooled (-78 0C) solution of 21a or 
21b (442 mg, 2 mmol) in 5 mL of freshly distilled THF. Sub­
sequently, the reaction mixture was stirred for 30 min at -70 "C 
and for another 30 min at room temperature. The workup was 
carried out as described for 22 and 23. Compounds 26a and 26b 
were obtained in yields of 69% and 70%, respectively, after HPLC 
(solvent system D). 
26a: R, 0.31 (solvent system A); NMR 6 1.39 and 1.48 (2 s, 9 
H, t-Bu), 3.02-3.59 (m, 2 H, CHCHÜS«} ) ) , 3.59-3.89 (т.г H, 
СНСН20), 4.09 (m, 1 H, СНСН20), 5.22 and 5.37 (2 s, 1 H, 
S(O)CHCN), 5.4 (br d, 1 H, NH), 7.47 (s, 5 H, C
e
H6); IR (KBr) 
3460,2240,1680,1520,1050 cm'1; mass spectrum, m/e 281 (M* 
- а д , ) . Anal. Caled for C^HaNAS: С, 56.79; H, 6.55; Ν, 8.28. 
Found: С, 56.98; Η, 6.62; Ν, 8.28. 
26b: R, 0.28 (solvent system A); NMR δ 1.40 and 1.44 (2 s, 9 
H, t-Bu), 2.87-3.42 (m, 2 H, CHCH^O), 3.78 (br d, 2 H, 
CHCH20), 4.09 (m, 1 H, CHCH20), 4.96 and 5.17 (2 s, 1 H, 
S(O)CHCN), 5.3 (br, 1 H, NH), 7.44 (s, 5 H, Q W ; IR (KBr) 3450, 
2240,1685,1525,1050 cm"1; mass spectrum, m/e 312 (M+ - CN). 
Anal. Caled for СиНщ^О^: С, 56.79; H, 6.55; Ν, 8.28. Found: 
С, 56.82; Η, 6.51; Ν, 8.23. 
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CHAPTER V 
INTERACTIONS OP SPARSOMYCIN WITH THE PEPTIDYL-
TRANSFERASE CENTER OF RIBOSOMES 
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(SACCHAROMYCES CEREVISAE) CELL-FREE SYSTEMS BY 
SPARSOMYCIN AND ANALOGS; PRELIMINARY RESULTS OF 
A STRUCTURE-ACTIVITY RELATIONSHIP STUDY 
STRUCTURE-ACTIVITY RELATIONSHIPS OF SPARSOMYCIN 
AND ANALOGS; OCTYLSPARSOMYCIN: THE FIRST ANALOG 
MORE ACTIVE THAN SPARSOMYCIN 
THE ANTITUMOR ACTIVITY OF SPARSOMYCIN. 
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INTERACTIONS OF SPARSOMYCIN WITH THE PEPTIDYLTRANSFERASE CENTER OF RIB0S0MES 
INTRODUCTION 
There is ample evidence*• that sparsomycin inhibits the protein synthesis by 
interfering with the peptidyltransferase center. For an understanding of 
sparsomycin's site of interaction, this section is devoted to information 
about the peptidyltransferase center. Beside inhibition of the protein 
synthesis, sparsomycin influences the protein synthesis in several other ways. 
First, even in the absence of messenger RNA , it enhances non-enzymatic binding 
of N-acetyl-AA-tRNA(N-Ac-Phe-tRNA) or N-acetyl-AA-tRNA fragments (N-Ac-Leu-
ACCAC) to the donor(peptidyl)site of the ribosome. 
Second, sparsomycin shows a remarkable effect on the ribosome as a whole, 
by preventing ribosomal subunit exchange, which is essential for the contin­
uation of the protein synthesis ' D' 2. Third, sparsomycin causes extensive 
disaggregation of polyribosomes into monomers, 
in vivo but not in vitro2'3. 
that still contain peptides -
THE PEPTIDYLTRANSFERASE CENTER OF RIB0S0MES: FUNCTION AND LOCALIZATION 
The region of the ribosome, that catalyzes synthesis of peptide bonds is 
refered to as the peptidyltransferase center. More precisely it catalyzes 
the transfer of the nascent peptide chain from the peptidyl-tRNA, located 
at the P-site(peptidyl site) of the ribosome, to the aminoacyl(AA)-tRNA, 
located at the Α-site(aminoacyl site). In organic chemical terms the 
peptidyl transfer represents an ester aminolysis (equation 1, Scheme I), 
namely the nucleophilic attack by the amino group of the AA-tRNA-molecule 
on the ester function of the peptidyl group, with as leaving group the 
empty -tRNA-molecule. 
Peptidyl-tRNA + AA-tRNA »-tRNA-3OH + Peptidyl-AA-tRNA (equation 1) 
Scheme I 
tRNA- A tRNA-f 
0 0 0 
-CX A tRNA-f-0 A tRNA-f-0> A 
он V-o—J он V-o^J 
о он AH OH 
H-hT 
4N-H 
OH V - o - J 
Гін (К 
H-N' 
•P-Site -\ \- A-SiteH | P-Site-| |- •A-Site 
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Although the designation 'ase' and an enzyme nomenclature number (E.G. 
2.3.2.124), suggest that peptidyltransferase is an enzyme, it has to be 
treated as a hypothetical enzyme since the aforementioned activity cannot 
be attributed to one or more defined ribosomal protein(s). Therefore we 
favor the use of the term 'peptidyltransferase center'. 
Apart from peptide bond formation the peptidyltransferase center is 
involved in the process of termination by catalyzing hydrolysis of the 
ester bond in the peptidyl-tRNA5 ( Weissbach6) , as is depicted in equation 
2. 
Peptidyl-tRNA + H2O• tRNA-S'OH + Peptide (equation 2) 
Furthermore there is evidence that the course of peptide bond formation is 
connected with the translocation event5, the last stage of the elongation 
cycle consisting of the relative movement along the messenger RNA towards 
its 3' end over a distance of one codon. 
The peptidyltransferase center is localized in the large ribosomal sub-
unit (50S subunit of prokaryotes; 60S subunit of eukaryotes) and cannot be 
separated from this subunit. As is expected from its 'transfer' function 
(equation 1, Scheme I) the peptidyltransferase center should be localized 
somewhere in between the Α-site and the P-site. Therefore the localization 
of the peptidyltransferase center in the simplest model of a ribosome can 
be represented as in Figure 1. 
Fig 1 Representation of the ribosome and localization of peptidyltrans­
ferase center 
Ρ Site 
Peptidyltransferase center 
A Site 
Large Subunît 
mRNA 
Small Subunit 
Considerable information about the three dimensional structure, spatial 
arrangement of ribosomal proteins and - indirectly - the localization of the 
functional domains on the ribosomal surface is derived from immuno-electron-
microscopic studies (M. Stöffler, R. Bald, B. Kastner, M. Luhrmann, M. 
Stoffler-Meilieke, G. Tischendorf6). With the aid of this technique the 
three dimensional representation of the E-ooli ribosome and its functional 
domains were studied. As a result the peptidyltransferase center appears 
to be located in a domain as depicted in Figure 2. In another representation 
of the ribosome8, - also derived from electronmicroscopic studies by Lake8 -
the peptidyltransferase center is suggested to be a domain as depicted in 
Figure 3. However, Lake^ studied only one protein present in the peptidyl-
transferase center, whereas Stöffler et al. have studied several proteins 
present in this center, so that most of the border of the peptidyltransfer-
ase center in the model of Lake is unknown. 
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Fig 2 Shape of the peptidyltvansferase center according to the model of 
Tischendorf'j Zeichhardt and Staffier7 
Fig 3 Shape of the peptidyltransferase center according to the model of 
Lake* 
Peptidyltransferase center 
Small Subunît 
PROTEINS PRESENT IN THE PEPTIDYLTRANSFERASE CENTER AND INVOLVED IN ITS 
ACTIVITY 
In addition to three RNA molecules (5S, 16S and 23S) prokaryotic ribosomes 
contain 50-60 proteins. In Ε-coli the small ribosomal subunit has 21 proteins, 
which are designated Si, S2 etc., while the large ribosomal subunit has 32 
different proteins (Ll, L2, etc.). Eukaryotic ribosomes are considerably 
larger: they contain about 70-80 proteins, and an extra molecule of RNA as 
well9. 
Through use of the method of affinity labeling (Cooperman6 »^) in­
formation has been obtained about the location of functional sites, such 
as the peptidyltransferase center. In these studies radioactively labeled 
compounds, which also contain an affinity label, are used. The affinity 
label enables the molecule to form covalent bond(s) with (a) molecule(s) 
at its site of interaction. 
One should realize that the extensively used method of affinity labeling 
is a topographical technique, i.e. it identifies ribosomal proteins at or 
near the peptidyltransferase center. It is therefore possible that the 
components thus identified may not even include the structural elements 
exerting the peptidyltransferase activity. Analogs of antibiotics 
(chloramphenicol, puromycin, lincomycin), which interfere with the peptidyl­
transferase activity, or analogs of aminoacyl-tRNA (AA-tRNA) have been used 
in affinity label studies of the peptidyltransferase center. Cooperman 
examined critically the affinity labeling studies and drew the conclusion 
that the proteins on the peptidyltransferase site of E-coti ribosome are 
L2, LU, L15, L18, L23, L27 and less securely I<14 and L1610. 
Large Subunit 
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The relative position of ribosomal proteins including the proteins present 
in the peptidyltransferase center can be derived from cross-linking exper-
iments. Figure 4 shows some results of these experiments (R.R. Traut, J.M. 
Lambert, G. Boileau, J.W. Kenny ) . The shaded sferes indicate proteins 
that constitute the peptidyltransferase center. 
crosslinks' 
Beside the method of affinity labeling, partial reconstitution as well as 
chemical modification have been frequently used in the study of the pepti-
dyltransferase center. Although the experiments using the different methods, 
yield partly contradictory results, protein Lll and L16 seem to be important 
in the peptidyltransferase activity^ . 
Much less is known about the proteins, which are involved in the pepti-
dyltransferase center/activity of eukaryotes . Studies with rat liver 
ribosomes lead to partly contradictory results12. 
Finally, the role of the 5S RNA in the peptidyltransferase activity has 
to be discussed*1*'^. Erdmann showed15 that 50S ribosomal subunits recon-
stituted in the absence of 5S RNA possess a strongly reduced peptidyl-
transferase activity. Thus 5S RNA is important but not essential for pepti-
dyltransferase activity (K.H. Nierhaus6). Although the 5S RNA appears to 
be situated in a functionally important part of the 50S subunit, namely at 
the interface within a cluster of proteins, which includes Ll6 - essential -
and Lll - important - for peptidyltransferase activity, it cannot yet be 
assigned a precise function16. 
ASSAY OF THE PEPTIDYLTRANSFERASE ACTIVITY IN VITRO 
The peptidyltransferase activity may be assayed by determination of one of 
both products of the reaction as depicted in equation 1 and Scheme I. 
Often, puromycin is employed, instead of AA-tRNA(analogs), as acceptor 
substrate for the peptidyl chain (vide infra, equation 3). 
Peptidyl-tRNA + Puromycin •>-tRNA-3,0H + Peptidyl-puromycin (equation 3) 
Peptidyl-puromycin + AA-tRNA-^^- tRNA-S'OH + Peptidyl-AA-tRNA (equation 4) 
Puromycin, an inhibitor of protein synthesis in both prokaryotic and 
eukaryotic systems, has some resemblances1013 with AA-tRNA and can therefore 
be used as an analog (Scheme II). The amide bond in puromycin may be an 
essential feature that prevents further chain elongation, once the puromycin 
has been attached to the peptidyl chain to give a peptidyl-puromycin adduct. 
For further elongation the amide bond of the aminosugar has to be cleaved. 
This fission of the amide bond is energetically less favored than the 
fission of the ester bond, which connects the peptidyl chain to the tRNA 
molecule (equation 4). 
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Scheme II Reaction of puromyain with peptidyl-tRNA 
tRNA-f-O. 
OH 
tRNA-P-Q 
OH U-O 
OMe 
A-SiteH I Ρ Site-| h 
Further elongation of the peptidylpuromycin adducts is also prevented 
because the adducts diffuse away from the ribosome. The amount of formed 
peptidylpuromycin adducts is a measure of the peptidyltransferase activity. 
As a donor substrate i.e. the molecule that furnishes the peptidylmoiety, 
peptidyl-tRNA and a range of analogs can be used. To facilitate the deter­
mination of the amount of puromycin adducts, either the peptidyl-tPNA 
(analog) or puromycin is radioactively labeled. Mostly the donor substrate 
(the peptidyl-tRNA analog) is labeled. 
In the frequently used 'fragment' reaction - developed by Vazquez, Monro 
and co-workers 17 an oligonucleotide fragment of the tRNA molecule, 
carrying an N-acetyl (radioactively labeled) amino acid at the 3' end, is 
used as a donor substrate. Another widely used donor substrate is N-acetyl 
M Phe-tRNA 18 or other N-acylated labeled amino acid tRNA's1 ^ This assay of peptidyltransferase activity in which puromycin is used 
is denoted as the 'puromycin reaction' 22 
INTERACTIONS OF SPARSOMYCIN WITH THE RIBOSOME 
Sparsomycin is a competitive inhibitor of puromycin in the 'puromycin 
reaction'. In contradistinction to puromycin, the molecular mechanism under­
lying the action of sparsomycin on the peptidyltransferase center, causing 
an inhibition of the protein synthesis is completely unknown. Before em­
barking on the synthesis of analogs, in order to study the molecular 
mechanism of action, it is sensible to speculate about possible interactions 
of the sparsomycin molecule with the ribosome. 
The inhibition of the protein synthesis caused by sparsomycin may be 
the result of a non-covalent interaction or the formation of a covalent bond. 
In the latter case the covalent bond may be formed either with tPNA molecules 
- as is the case with puromycin - or with essential sites of the peptidyl­
transferase center. In case of a non-covalent interaction, the transfer of 
the peptidyl chain might be blocked either by interaction with the receptor 
site of the peptidyltransferase center or the site(s) of attachement of the 
tRNA molecules. 
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A working-hypothesis for a covalent interaction might be that sparsomycin 
reacts with peptidyl-tPNA's in a similar way as puromycin. One might expect 
the hydroxy function of sparsomycin to enforce a similar nucleophilic dis-
placement on the ester-carbonyl moiety of the peptidyl-tRNA molecule. Support 
for this assumption is found in studies with the hydroxy analogs2^ la, lb 
of puromycin. The hydroxy puromycins react in an N-formylmethionine fragment 
reaction24 to give N-formylmethionyl-oxypuromycin adducts. In section 3 
of this chapter the synthesis of an analog of sparsomycin having an acylated 
hydroxy function, is described. This analog is unable to induce the afore-
mentioned nucleophilic displacement with the peptidyl-tRNA molecule. The 
results presented in section 3 of this chapter indicate that the hydroxy 
function is not involved in the molecular mechanism of action. 
Me. Me 
N ^ 
N 
, , CO M- i — l 
HN 
H 0V 
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 > 0 
0 
R 
OH 
= 0 
la R=H 
I b f l r M e 
Other hypotheses can be formulated in which a reactive species is proposed 
that is generated from sparsomycin, giving rise to the formation of a covalent 
bond with ribosomal components. This reactive species has to be formed by 
metabolic processes involving enzymes or enzyme systems. Because sparsomycin 
also manifests its action in ribosomal systems without additional enzymes 
or enzyme systems present, these hypotheses are improbable. Thus it seems 
that the activity of sparsomycin is not due to formation of a covalent bond. 
So far no satisfactory molecular mechanism can be offered explaining the 
inhibitory action of sparsomycin on the protein synthesis. 
SPARSOMYCIN AND OTHER INHIBITORS OF THE PEPTIDYLTRANSFERASE ACTIVITY 
Other inhibitors^ of the peptidyltransferase activity include gougerotin, 
griseoviridin, althiomycin, actinobolin, amicitin, blasticidin S, chloram-
phenicol, lincomycin, spiramycin III, streptogramin A, anisomycin, tenuazonic 
acid, trichodermin and althiomycin. The first six compounds act in both 
prokaryotic and eukaryotic systems, whereas chloramphenicol, lincomycin, 
althiomycin, spiramycin III and the streptogramin A antibiotics are only 
active in prokaryotes and anisomycin, tenuazonic acid, trichodermin are 
only active in eukaryotes. Of this serie chloramphenicol and lincomycin 
are the best known antibiotics, because they are widely used against 
bacterial infections. Furthermore they have - like puromycin - extensively 
been used for preparing peptidyltransferase affinity label reagents*0. 
Of all the compounds mentioned in this section, beside puromycin, sparsomycin 
is the best known compound interacting with the peptidyltransferase center 
of eukaryotic systems. In addition sparsomycin appears to be the most effec-
tive in these systems . 
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INHIBITION OF THE PROTEIN SYNTHESIS IN YEAST (SACCHAEOMYCES CEEEVISIAE) CELL-
FREE SYSTEMS BY SPARSOMYCIN(l) AND ANALOGS; PRELIMINARY RESULTS OF A STRUCTURE-
ACTIVITY RELATIONSHIP STUDY ~ 
The contents of this section and that of section 3 of this Chapter consist 
of the first results of a planned, extensive study on the relationships 
between the structure of sparsomycin and analogs on one hand and the mode 
of action as well as the antineoplastic activity on the other hand. 
The inhibition of the protein biosynthesis by natural sparsomycin (la), 
synthetic sparsomycin (lb) and seven of the analogs listed in Table I was 
determined in the fragment reaction, which is described in section 1 of this 
Chapter. In addition, the inhibitory activity of the same compounds in a 
polyphenylalanine synthesizing system was measured. In the latter system 
phenylalanine-tRNA is used as the acceptor substrate instead of puromycin, 
whereas N-acetylphenylalanine-tRNA is used as the donor substrate (see section 
1) . The assays were carried out by Dr D. Vazquez and Dr J.P.G. Ballesta*" . 
The concentration of sparsomycin or an analog causing 50% inhibition of the 
protein synthesis relative to the control cell-free system is denoted as 
ED5o. 
There is a close resemblance between the results obtained with cell-free 
systems (Table I) and those obtained from testing the compounds against 
intact cells (leukemia L1210 cells) as listed in Table I of section 3. 
From the results of the fragment reaction the following conclusions can be 
drawn. Comparison of the ED50 values of la and lb shows that synthetic 
sparsomycin (lb) is practically as active as natural sparsomycin (la). This 
is not surprising since la and lb are chemically identical. The necessity 
of an S configuration of sparsomycin's chiral carbon atom for an optimal 
activity can be concluded unambiguously from a comparison of the inhibitory 
activities of 1 and 4. Conformation of this conclusion is found in the ED50 
values of 12 and 13; compound 12 - having an S configuration of the chiral 
carbon atom - is about three times as active as its enantiomer 13. Compound 
3, which differs only from sparsomycin (la and lb) in having the opposite 
chirality of the sulfoxide-sulfur atom, has about one fourth of the activity 
of the natural product; from this we conclude that the R configuration of 
the sulfoxide-sulfur atom is important but not a requisite for the activity. 
The importance of the oxidation state of the α sulfur atom can be derived 
from a comparison of the ED50 values of 1 and 3 on one hand and 12 on the 
other hand. The compounds having a sulfoxide function at the α-position are 
three to ten times more active than the compound having a bivalent sulfur 
atom at this position. Conroarison of the activities of 1 and 14 demonstrates 
that the proper position of the sulfoxide moiety in the cysteinol side 
chain - i.e. in a-position - is of importance too. 
Finally, the relatively low ED50 value of the mixture of lb and 16 (ratio 
2/5) suggests that isosparsomycin (16) has a considerable activity; the 
ED50 value, that is calculated from the ED50 value of the mixture, amounts 
to 14 pg/mL. This is in contrast with the results from the assay with L1210 
cells, where isosparsomycin (16) showed a very low activity, if any (see 
Table I, section 3). In the polyphenylalanine synthesizing, cell-free 
yeast system, only sparsomycin (l_a and lb) and the mixture of 16 and lb 
showed appreciable activity. 
* Centro de Biologia Molecular, Instituto de Bioquimica de Macromoleculas, 
Universidad Autonoma de Madrid, Facultad de Ciencias, Canto Bianco, 
Madrid-34, Spain. 
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Apparently, this cell-free system does not discriminate between the activity 
of the various less active analogs at the concentrations tested. So far, we 
have no explanation for this observation, the more so as the results of the 
fragment reaction assay show a good correlation with the results obtained 
in intact cell systems. 
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Abstract. The analogs 2-4, 12-17 and 20 of sparsomycinU) were synthesized 
and their cytostatic activity was studied in an in vitro clonogenic L1210 
assay, by measuring the inhibition of colony formation. The activity of 
an analog, expressed as an ID50 value was compared to that of sparsomycin 
(Table I). Each analog possesses not more than two structural modifications 
of the sparsomycin molecule 1. This enabled us to determine unambiguously 
the structural and stereochemical features that are required for an optimal 
biological activity in this assay. It is shown that the S configuration of 
the chiral carbon atom and the presence of an oxygen atom on the (a) sulfur 
atom are essential for an optimal activity, whereas the R chirality of the 
sulfoxide-sulfur atom of sparsomycin is of importance. Isoraerization of the 
E-double bond into the Z-doüble bond yields isosparsomycin(16), which has 
a drastically decreased activity. This finding is noteworthy as we observed 
that authentic sparsomycin(1) is contaminated by isosparsomycin(16). The 
hydroxy function is probably not involved in the molecular mechanism of 
action, as acylation of this function does not affect the activity of 
sparsomycin. In addition, the cytostatic activity seems to be related to 
the lipophilicity of the effector molecule; octylsparsomycin 19 was shown 
to be three tiroes as effective as sparsomycin. In our assay, this analog 
has a comparable activity to that of the clinically used antitumor agents 
5-fluoro uracil and adriainycin. 
INTRODUCTION 
The development of a flexible synthesis or synthetic methodologies for (a) 
structural fragment(s) of a particular molecule possessing an interesting 
or important biological activity, is a prerequisite for thorough studies 
on the biological activity and/or biochemical mechanism of interaction. 
An outstanding example, which underlines this view, is sparsomycin 1. 
The structure activity relation studies, which have appeared so far 4, 
were hampered by the absence of a total synthesis. As a consequence they 
concern analogs, in which several structural parameters had been varied 
simultaneously5, thus allowing only a limited interpretation of the results 
with regard to the role of the various structural fragments. 
The interpretation and comparison of the available information on 
structure activity relationships of sparsomycin encounters another difficulty: 
the biological activity of the analogs has been determined in different 
systems in vitro: KB cell culture and cell-free ribosomal systems3, 
in vivo: P-388 system and Walker 256 system . This hampers comparison of 
the results. 
Sparsomycin* 1 has attracted widespread attention because of its 
biological activity. 
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This activity is primarily due to a strong inhibition of the protein bio­
synthesis resulting in a decline of the protein synthesis and concomitant 
biological effects. There is ample evidence6 that зрагзогаусіл has its site 
of interaction in the large ribosomal subunit, where it prevents peptide 
transfer by interfering with the peptidyltransferase center. Sparsomycin 
manifests its action in intact prokaryotic cells', eukaryotic cells8 -
including transformed2'9 and/or virus infected cells10 - and in various 
cell-free systems11. The behavior of sparsomycin with regard to its inhibitory 
action and its influence on the polyribosomes has also been investigated in 
vivo^2. Since sparsomycin had been shown to be active against transformed 
cells vide supra and various tuioors9a , it has been investigated as a 
potential cytostatic compound. A clinical trial of sparsomycin, however 
revealed eye toxicity13. 
J ^ R = H : Sparsomycin ( S c - R s ) 
17 R= ^ A M e : O-Acetyl sparcomycm (Sc-Rs) 
Recently, both we 1 5» 1 6 and Helquist and Shekhani17 succeeded in developing 
a total synthesis of sparsomycin. In addition we were able to synthesize 
analogs15 in order to carry out structure-activity relation studies. 
The synthesis of analogs also seems promising for studies of the molecular 
mechanism of action of sparsomycin. Moreover attempts will be made to 
develop a molecule with more selective biochemical and pharmacological 
properties, while determining the minimum structural and stereochemical 
requirements for the anti-tumor activity. 
As a first contribution to the realization of these aims, we wish to 
report here the synthesis of a number of relevant analogs and the investi­
gation of their activity against lymphocytic leukemia L1210 cells in vitro'-1*. 
RESULTS and DISCUSSION 
Choice and synthesis of the analogs 
One of the synthetic routes, which we have developed earlier1' for the 
preparation of sparsomycin I 1 8 and analogs 2-4 (Table I), features the em­
ployment of the cysteinol a-chlorosulfoxide (6a-b, 7a-b) as a crvucial 
synthon (Scheme I). This synthon is prepared in three steps starting from 
BOC-D-cystine methylester S
c
 5a or BOC-L-cystine methylester R
c
 5b (Scheme 
I). As was described earlier13 reaction of the resulting stereoisomers 6a, 
7a, 6b and 7b with sodiummethylmercaptide leads - after deprotection with 
trifluoroacetic acid and coupling with the uracil acrylic acid fragment 11 -
to sparsomycin 1 and its stereoisomers 3, 4 and 2 respectively. The analogs 
2-4 allow us to study the dependence of the biological activity on the 
absolute configuration of the chiral carbon atom as well as the sulfoxide 
sulfur atom. 
Compounds 12, 13, 14 and 15 (Table I) were included in order to evaluate 
the role of the oxidation state of the sulfur atom, as well as the influence 
of the position of the sulfoxide iioiety:S(a) or S(0). 
Scheme I 
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To circumvent partial racemization of the chiral carbon atom during the 
synthesis of the S-deoxo analogs 12 and 13, we first reduced 8a and 8b to 
the corresponding amino alcohols with lithium borohydrate (Scheme II). The 
proton at the chiral carbon atom in the amino alcohol is less acidic; as 
a result the chiral carbon atom is less prone to racemization. Subsequently, 
the BOC group was removed by TFA and amino alcohols 9a and 9b (Scheme II) 
were coupled to the uracil acrylic acid fragment 11 to give 12 and 13 in 
31% and 28% yield, respectively. 
We prepared 14 and 15 starting from 8a and 8b in four steps (Scheme II). 
Oxidation with sodium metaperiodate of 8a and 8b, resulted in formation of 
the regio isomer containing an (ß)sulfoxide in excess over the (a)sulfoxide 
regio isomer (ratio ß/a ca. 4/1). These regioisomers were separated by 
HPLC after reduction of the ester function. Removal of the N-protecting 
group led to 10a and 10b respectively, which were coupled in a mixed 
anhydride procedure with 11 to give 14 (54%) and 15 (47%) respectively. 
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In the course of the synthesis of sparsomycin15, we invariably noticed a 
by-product, which appeared after the last step - i.e. the coupling procedure 
in the total synthesis. The by-product - albeit present in a small amount -
is hardly to remove from sparsomycin, by chromatography or gelfiltration. 
43 
By 1H-NMR it was shown that this product was the cis-isomer of sparsomycin, 
i.e. 16 (Scheme III) . As perusal of the NMR spectrum of an authentic sample 
of sparsomycin2" showed also the presence of a significant amount of the 
cis-isomer we decided to investigate this phenomenon more extensively. It 
has been shown before by Wiley and MacKellar , that irradiation of sparso-
mycin with a fluorescent desk lamp for a long period (7 days) resulted in 
the formation of cis-isomerized sparsomycin ('isosparsomycin') 16 in 20% 
yield. In repeating the irradiation experiment with some modification of the 
experimental conditions, we found, by monitoring the trans-cis conversion by 
NMR, that irradiation for 20 minutes with a 300nm lamp is sufficient to 
produce a mixture of isosparsomycin and sparsomycin in a ratio of 4/1. 
Longer periods of irradiation did not result in complete conversion to iso-
sparsomycin. Although isosparsomycin is likely to be thermodynamically less 
stable than sparsomycin, it is present in large excess in the irradiation 
mixture at the photo-equilibrium situation (Scheme III). This is probably due 
to a change in the UV spectrum in going from sparsomycin to isosparsomycin: 
the Xmax changes from 300nm to 290nm; in addition, the molar absorbance 
decreases to about one third. In order to avoid isomerization, sparsomycin 
should be preferentially stored as a solid in the dark, because we noticed 
that the compound in solution isomerizes slowly when exposed to daylight or 
laboratory TL-light22. In addition, we noticed that alkaline solutions of 
sparsomycin always contain a higher percentage of isosparsomycin. This result 
is in accordance with the finding that upon irradiation in the presence of 
base sparsomycin isomerizes more rapidly to isosparsomycin. We suppose that 
this base catalyzed isomerization involves an intermediate as depicted in 
Scheme III. 
To study the biological activity of isosparsomycin23, we prepared a 
mixture of 40% sparsomycin(1) and 60% isosparsomycin(16), by irradiation23. 
The (base-catalyzed) radiation induced isomerization is also observed 
with the stereoisomers 2-4 of sparsomycin, the S-deoxy analogs 12 and 13, 
and the pseudo-sparsomycin analogs 14 and 1^ 5. 
Scheme III 
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The inclusion of compound 17, the O-acylated derivative of sparsomycin also 
deserves further comment. The reason for assigning a possible role to the 
hydroxy function originates from the vast amount of work on an other inhibitor 
of the protein biosynthesis namely, puromycin24 (18). Puromycin and sparsomycin 
interact on the same site of the ribosome. In addition,they share some 
structural features. Both contain a nucleotide base residue, enabling them to 
interact with ribosomal and/or messenger RNA. Furthermore, both contain a 
modified amino acid part, which is the structural feature ultimately respon-
sible, for preventing the continuation of the protein synthesis as has been 
proven for puromycin. 
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The molecular mechanism underlying the blocking of the protein synthesis 
by puromycin features a S^Z like nucleophilic attack of the amino group of 
this molecule on the carbonyl moiety of the peptidyl-tRNA, resulting in the 
formation of peptidyl-puromycin adducts. Analogs of puromycin, which contain 
a hydroxy group instead of an amino function, also display a nucleophilic 
reaction with the peptidyl-tRNA , to form peptidyl-oxypuromycin adducts25. 
1Θ puromycin 
Sparsomycin might enforce a similar nucleophilic displacement as the hydroxy 
puromycin analog. This proposed mode of molecular action can be studied by 
blocking the hydroxy group of sparsomycin. 
The O-acetyl analog 17 was prepared by treatment of sparsomycin(1) with 
acetylchloride and triethylamine in 30% yield. 
Beside the aforementioned modifications of sparsomycin, variations leading 
to a less polar molecule are important. It has been shown ° that sparsomycin 
displays no activity against intact reticulocytes. This has been ascribed" 
to the inability of sparsomycin to penetrate into these cells, which might be 
due to its polar character. 
Therefore the octyl analog of sparsomycin 20 has been chosen to study 
whether an increased lipophilicity will result in an increase of the biolo­
gical activity, because diffusion of the effector molecule into the cell 
might be facilitated. Furthermore, we observed27 in pharmacokinetic experiments 
in the dog, that sparsomycin has a short half life of elimination (70 
minutes). A more lipophilic compound might have a longer half life and thus 
may be used in smaller quantities to reach a certain plasma level. The octyl 
analog 20 was prepared using the a-chlorosulfoxide ба, which was converted to 
the cysteinol mono-oxodithioacetal with sodiumoctylthiolate (Scheme IV). 
Deprotection with trifluoroacetic acid at 0 0C and subsequent deprotonation 
with an ionexchange resin gave the amino alcohol 19 in 85% yield, which was 
coupled thereafter to the uracil acrylic acid fragment 11 to give 20 in 37% 
yield. 
Biological activity 
Colony assays are widely used to measure the response of established lines 
of animal and human tumor cells treated with cytotoxic agents. Recently, for 
example, the Raji cell culture line of Burkitt's lymphoma2" has been used to 
determine the effect of several anticancer drugs on the ability of these 
cells to form colonies in soft ager. The results also suggest that established 
human tumor cell lines may be useful for the screening of new anticancer 
drugs. 
45 
Scheme IV 
1 На5(СН
г
)7СНз ^ он 
H 
6a|S
c
-R
s
) 19 
The growth of tumor colonies in soft agar from primary human tumor explants29 
is even more promising. Preliminary results indicate that the assay is 90-
95% accurate in predicting clinical resistance and 60-65% in predicting a 
clinical response30-^^. Furthermore, this assay is of potential importance 
as a screening test for new antitumor agents32. 
For a first evaluation of the relation between structure and antitumor 
activity of sparsomycin and analogs, we used an in vitro clonogenic assay 
of leukemia L1210 cells. Study of the activity of sparsomycin and relevant 
analogs against tumor cells derived from primary human tumors is under present 
investigation33. The leukemia L1210 in vivo system (in the mouse) is generally 
used in standard screening of compounds of potential interest32'3^. However, 
for certain (semi)quantitative studies the L1210 in vitro system is more 
sensitive and more practical. This system has been used in suspension 
culture35 and in soft agar medium3"'^7. 
In this study we used leukemia ІЛ210 cells in soft agar medium (0.3%) 
in an in vitro clonogenic assay. It has been observed before (P. Lelieveld, 
unpublished observations), that there is a good correlation between the 
in vitro and in vivo activity of the drugs tested. Thus, the in vitro system 
is of predictive value for the in VÌVO system. Inhibition of L1210 colony 
formation by sparsomycin and analogs was determined for several concentra-
tions and the dose causing 50% inhibition of colony formation ID50 relative 
to untreated control cells was calculated. The results are collected in 
Table I. 
DISCUSSION 
Comparison of the ID50 value of 1 with that of 4 unambigeously demonstrates 
the necessity of a S configuration of the chiral carbon atom (Sc) for an 
optimal biological activity). This has been suggested earlier by Vince et 
αΖ·
3
 and by Lin and Dubois2. However, their conclusion was based on experi­
ments with analogs containing more than one modification. Confirmation of 
this conclusion is found in the ID5Q values of the S-deoxy analogs 12 and 
13 and of the pseudo analogs 14 and 15: compounds having an S configuration 
of the chiral carbon atom have a significantly lower ID50 value. 
The higher ID50 value of the analog 3, which only differs with sparsomycin 
in having the opposite chirality of the sulfoxide-sulfur atom, clearly 
demonstrates the importance of an R configuration of the sulfoxide-sulfur 
atom (R
s
). A similar difference in biological activity between molecules, 
which only differ in chirality of the sulfoxide-sulfur atom has been 
observed - although evaluated in VÌVO - with Amanita toxins38. 6-Methoxy-
a-amanitin, having a sulfoxide-sulfur atom with the R configuration, is at 
least ten times more toxic than the corresponding compound with the S 
configuration. 
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JÇ The highest dose tested was 100 pg/mL; no value is reported for compounds 
showing no activity at this dose. 
Χ Χ A mixture of 40% sparsomycin(1) and 60% isosparsomycin(161 was tested in 
the assay. 
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The importance of the presence of the oxygen atom on S(α) can be derived 
from a comparison of the ID50 values of 1 and 3 on one hand and 12 on the 
other hand. This is in accordance with the findings of Lin and Dubois , 
who demonstrated that the biological activity - if any - of the syntheti­
cally more accessible monosulfide analogs (R=cysteinol-S-alkyl) is invariably 
lower than the biological activity of the corresponding sulfoxide analogs 
(R=cysteinol-S{0)-alkyl). 
The importance of the proper position of the sulfoxide moiety in the 
cysteinol side chain of 1, is demonstrated by comparing the ID50 values of 
1 and 14: when the positions of the sulfoxide function and the sulfur atom 
are reversed,the biological activity is markedly reduced. In addition, the 
pseudo-sparsomycin analog 14 possesses a diminished activity compared to 
the corresponding S-deoxy-analog 12, suggesting an adverse effect of a 
sulfoxide function at this position of the molecule. 
Although study of the biological activity of the separate diastereomers 
of 14 might give additional insight into the role of the stereochemistry 
of the (β)sulfoxide function, no attempts were made to separate these dia­
stereomers as this would not lead to a more active antitumor agent. Comparison 
of the ID50 value of 14 with those of 1 and 3 shows that the mono-oxodithio-
acetal moiety as such does not determine the biological activity. Apparently 
a bivalent (β)sulfur atom is preferable for an optimal activity. 
The ID50 value of the mixture of 1 and 16 (ratio 2/3) is about two times 
the ID50 value of pure 1. This suggests that isosparsomycin(16| has a very 
low activity, if any. However, this result should be interpreted with 
caution, because of the error present in this biological assay. It will only 
be regarded as indicative and future experiments will be necessary to clarify 
the activity of sparsoinycin ( 16) itself2 . 
The ID50 value of the octyl-analog of sparsomycin i.e. 20 is three times 
lower than that of sparsomycin itself. This result supports our assumption 
that an increase of sparsomycin's lipophilicity, facilitates cell penetration. 
The high activity, expressed as a low ID50 value, demonstrated in this L1210 
clonogenic assay, is comparable to those found for the clinically used 
cytostatic compounds 5-fluorouracil and adriamycin which have ID5Q values 
of 0.04 yg/mL and 0.03 yg/mL respectively in the same assay. (P. Lelieveld, 
unpublished observations). 
At first glance a comparison of the ID50 value of 1 and the O-acetyl-
analog 17 suggests that the hydroxy function of sparsomycin is not involved 
in the molecular mechanism, underlying the inhibitory action of sparsomycin 
on the protein synthesis {vide supra). However, this result has to be 
confirmed by cell-free experiments, because in this clonogenic assay the 
compound is in continuous contact with the L1210 cells and the components 
of the medium. This continuous contact may lead to (metabolic)hydrolysis 
of the O-acetyl-analog to give sparsomycin, so that the observed activity 
may be partly due to the presence of - liberated - sparsomycLn. In cell-
free experiments the compound to be tested is present in the reaction 
mixture for a shorter period and no metabolism is likely to take place. 
Under present investigation is the antitumor activity of sparsomycin and 
octylsparsomycin in mouse against leukemia L1210 as well as solid tumors. 
The results will indicate whether the in vitro prediction of the higher 
activity of octylsparsomycin compared to sparsomycin (vide supra) reflects 
the (in vivo) situation. 
EXPERIMENTAL РАНГ 
Biological activity 
The L1210 in vitro clonogenic assay used in this study is an improved 
variant of the method described earlier^6'" for the growth into colonies 
of L1210 cells in soft agar medium. 
48 
From a suspension culture, 100 L1210 cells were plated into 35 mm culture 
dishes (Falcon), containing 1 ml of soft agar growth medium and the compound 
to be tested in appropriate concentrations. The soft agar growth medium 
consisted of Dulbecco's medium supplemented with 20% horse serum, 60 pmol 
2-mercaptoethanol, 20 mg/ml L-asparagine, 75 mg/ml DEAE dextran (molecular 
weight 2xl06) and 0.3% bacto agar (Difco). The culture dishes were incubated 
at 37 0C in an atmosphere of 10% CO2 in humidified air for θ days. After 
this period of continuous drug exposure, colonies were counted and dose-effect 
curves were made. From these curves the drug dose causing 50% inhibition of 
colony formation (ID50) relative to untreated control cells was calculated. 
Synthesis 
^-NMR spectra were measured on a Varian Associates Model T-60 or a Bruker 
WH-90 spectrometer with МегЗі or МезЗіСВгСПгСС^а as an internal standard. 
UV spectra were measured on a Perkin-Elmer spectrophotometer. Model 555. 
For determination of the specific rotation, a Perkin-Elmer 241 Polarimeter 
was used. The irradiation experiments were carried out in a Rayonet RPR 100 
or RPR 200 photochemical reactor, fitted with 300 nm lamps,in pyrex tubes. 
Thin-layer chromatography (TLC) was carried out by using Merck precoated 
F-254 plates (thickness 0.25 mm). Spots were visualized with a UV lamp, 
ninhydrin and TDM. For column chromatography, Merck silica gel H type 60 
was vised. A miniprep LC (Jobin Yvon) was used for preparative HPLC. 
Spars amy ein(V ; sparsomyain enantiomer 2; sparsomyain diastereomer 3; 
sparsomyain diastereomer 4 
Compounds 1 , 2 , 3 and 4 were prepared as descr ibed e a r l i e r 1 5 . However, the 
r e a c t i o n s were c a r r i e d out under the exc losure of l i g h t and the p u r i f i c a t i o n 
of the end-product was changed: the crude products were chromatographed over 
s i l i c a gel by HPLC (e luent МеОН/СНгСІг^Ні+ОН, 80/20/0.2 v/v) .followed by 
g e l f i l t r a t i o n over Sephadex LH 20 (e luent НгО/МеОН, 15/85 v / v ) . 
S- [(methylthio)methyl]-D-oysteinol(9a); S-[(methylthio)methyІ]-L-
cysteinol(9b) 
The e s t e r funct ion of 8a and 8b (885 mg, 3 mmol) was reduced with l i t h i u m -
borohydrate as has been descr ibed e a r l i e r 1 5 . The N-protected c y s t e i n o l 
d e r i v a t i v e was p u r i f i e d by HPLC (e luent МеОН/СНгСІг, 5/95 v / v ) . Subsequently, 
the BOC group was removed by t r i f l u o r o a c e t i c ac id as d e s c r i b e d for the 
p r e p a r a t i o n of 19 (vide infra) t o give 9a (40%) and 9b (50%) , r e s p e c t i v e l y . 
9a and 9b: R f 0.56 ( e l u e n t sec-BuOH/NH^ÖH, 5/2 v/v);~ÑMR (CD2CI2) δ2.18 
Ts, ЗН, ІСНз), 2.73-2.93 (m, 2Н, СНСНгЗ), 3.67 ( s , 2Н, SCH2S), 3.69-3.89 
(m, зн, сненгон). 
S- [(methylthio-oxcjmethylj -Ό-cysteinol(10а)І S-iCmethylihio-oxcjmethyîj -
L-cyste inol(10b) 
Compounds 8a and 8b (932 mg, 3 mmol) were oxidized wi th sodium metaper iodate 
followed by reduc t ion with l i th iumborohydrate according t o procedures 
descr ibed e a r l i e r 1 5 . The r eg io isomers con ta in ing an ($)sul foxide were 
sepa ra t ed from those with an (o)sulfoxide funct ion by HPLC (e luent MeOH/ 
CH2CI2, 5/95 v / v ) . The d e s i r e d compounds had a lower Rf value on TLC than 
the corresponding r eg io i somers . No at tempts were made to sepa ra t e the 
N-protec ted d ias te reomers of 10a (SCRS-SCSS) or 10b (RCRS-RCS ) . Deprotec-
t i o n of the aminofunction was achieved by t rea tment with t r i f l u o r o a c e t i c 
ac id , as i s descr ibed for the p repa ra t ion of 19 (vide infra). The products 
were obta ined in 85% y i e l d . 
10a and 10b: Rf 0.42 (e luen t sec-BuOH/NHi+OH, 5/2 v / v ) ; NMR (CD2CI2) 52.6 
7s7 3H, SCH3), 2 .67-3.20 (m, 2H, CHCH2S(0)), 3.20-3.62 (m, 3H, CHCH2OH), 
3 .20-3.98 (AB spectrum p a r t l y covered by CHCH20H s i g n a l s , 2H, S(0)CH2S). 
S-dBOxo-(S0)sparsomyoin(12); S-deoxo-(Rc)sparsomycin(13). 
Compounds 12 and 13 were obta ined by coupling of (E)-3- (2 ,4-d ioxo-6- ine thyl -
5 -pyr imidy l ) ac ry l i c ac id ( l l ) 1 5 wi th 9a and 9b, r e s p e c t i v e l y (each 250 mg, 
1.5 mmol), i n a mixed anhydride procedure as has been descr ibed e a r l i e r 
for the p r e p a r a t i o n of 1-4. 
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The yields were 31% and 28% respectively after HPLC (eluent МеОН/СНгСІг, 9/91 
v/v) . 
12: Rf 0.51 (eluent МеОН/СНСІз, 1/4 v/v); [dg
5
 + 82 (c 0.205, water); NMR(D20) 
62.18 (s, 3H, SCH3), 2.42 (s, 3H, С(б)СНэ), 2.76 and 3.03 (AB part of ABX 
spectrum, 8 lines, J A X = 8 Hz, J B X = 5 Hz, J A B = 14 Hz, 2H, CHCH2S(0)), 
3.59-3.88 (m, 2H, CH2OH), 3.78 (s, 2H, SCH2S), 4.07-4.37 (br. IH, CHCH2OH), 
7.08 and 7.41 (AB spectrum, J A B = 15.5 Hz, 2H, HC=CH). 
13: was identical in every aspect with 12, excepting Ы п 5 ' which had a 
value of -76° (c 0.225, water). 
S
c
-pseudosparsomycbn(14_) ; R
c
-pseudosparsomycin (15). 
Compounds 14 and 15 were obtained by coupling of 11 with 10a and 10b, respec­
tively (each 275 mg, 1.5 mmol) in a mixed anhydride procedure as has been 
described earlier^. The yields of 14 and 15 were 54% and 47% respectively. 
14: Rf 0.14 (eluent МеОН/СНСІз, l/4~v/v), [a]£5 + 89° (c 0.218, water); 
NMR (D2O) 62.42 (s, ЗН, С(б)СНз), 2.77 (s, ЗН, 5(0)СНз), 2.77-3.27 (m, 2Н, 
CHCH2S(0)), 3.60-3.90 (AB part of ABX spectrum, 2H, СНгОН), 3.91-4.16 (AB 
spectrum or two doublets, 2H, SCH2S(0)), 7.09 and 7.40 (AB spectrum, Jftg = 
15.5 Hz, HC=CH). 
Compound 15 was identical with 14 in every aspect excepting O[Q , which 
had a value of -82° (c 0.174, water). 
Isosparsomyoin(16) 
A solution of sparsomycin(l) (30 mg, 0.08 mmol) in 20 ml of water was 
irradiated at 300 nm in a pyrex tube for 50 minutes. Subsequently, the 
solvent was removed by freeze-drying. The isosparsomyoin(16)/sparsomycin(l) 
ratio was shown to be 3/2, as was determined by NMR, from the ratio of 
integration of the signals due to the cis HC=CH protons (6 6.26 and 6.55) 
on one hand, and the signals due to the trans HC=CH protons (6 7.07 and 
7.41) on the other hand. This ratio corresponds to the ratio of integration 
of the С(6)СНз (δ 2.17) signal in isosparsomyoin and the С(6)СНз (δ 2.40) 
signal in sparsomycin. Except for these signals, the remaining signals in 
the ^H-NMR spectrum of 16 and 1 coincide. Rf 0.17, for comparison Rf 1 : 0.21 
(eluent, МеОН/СНСІз, l/4~v/v);~Rf 0.22, for comparison Rf 1 : 0.35 (eluent 
n-BuOH/EtOH/H20, 70/27/3 v/v). 
0-aae ty l-spœcsomycin ( 17) 
To a solution of sparsomycin(1) (46.8 mg, 0.13 mmol) in 5 ml of dry pyridine 
was added 3 ml (0.39 mmol) of a 0.13 M solution of acetylchloride in dichloro-
methane. The reaction was stirred overnight at room temperature. After 
completion of the reaction as was monitored by TLC (eluent МеОН/СНСНз, 1/4 
v/v), 2 ml of dry ethanol was added. Subsequently the solvent was evaporated 
in vacuo and the crude product was chromatographed over silica gel 60 H 
(HPLC, eluent МеОН/СНгСІг, 12/88 v/v). The product was obtained after final 
purification over Sephadex LH20 (eluent НгО/МеОН, 15/85 v/v) in 30% yield. 
No attempts were made to improve the yield. Rf 0.64 (eluent МеОН/СНСІз, 1/4 
v/v); NMR (D2O) 62.13 (s, ЗН, С(О)СНз), 2.31 (s, ЗН, SCH3), 2.43 (s, ЗН, 
С(б)СНз), 3.07-3.46 (AB part of ABX spectrum, 2H, CHCH2S(0)), 3.96 and 
4.18 (AB spectrum, J A B = 14 Hz, 2H, S(0)CH2S), 4.20-4.44 (m, 2H, CHCH2O), 
4.44-4.70 (m, IH, CHCH2O), 7.04 and 7.43 (AB spectrum, J A B = 15.5 Hz, 2H, 
HC=CH). 
S-oxo-S- f(oatylthio)methyiJ-D-at/ste-Lnol(19) 
A solution of sodium octylthiolate " (353 mg, 2.1 mmol), of which the purity 
was checked as described earlier*^ in 10 ml of dry ethanol was added at once 
to a stirred solution of the chloro-sulfoxide 6a (542 mg, 2 mmol) in 10 ml 
of dry ethanol. The preparation of 6a has been reported earlier15. Argon 
had been passed through both solutions for 15 minutes. The reaction mixture 
was stirred overnight at room temperature. After completion of the reaction, 
as was monitored by TLC (eluent МеОН/СНгСІг, 1/9 v/v), the solvent was 
evaporated, and water (5 ml) and dichloromethane (30 ml) were added. 
Removal of the turbidness, due to finely divided sodium chloride, could be 
achieved by stirring with ЫагБОц for about 1 h. Filtration and removal of 
the solvent afforded the BOC-protected S-oxo-S (octylthio)methyl -D-cysteinol 
in 85% yield. 
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Rf 0.45 (eluent МеОН/СНгСІг, 1/9 v/v); NMR(CDCl3) 6 0.67-2.16 (m, 15H, 
(СН2)бСНз), 1.44 (s, 9H, t-Bu), 2.56-2.82 (m, 2H, ЗСНг(CH2)6СНз), 2.96 and 
3.22 (AB part of ABX spectrum, 8 lines, Jp^ = JBX = 6 Hz, J A B = 14 Hz, 2H, 
CHCH2S(0)), 3.71-3.97 (m, 4H, СНгОН, 3(0)0123), 3.97-4.23 (br, IH, CHCH2OH), 
5.22-5.33 (br, IH, NH); Anal. Caled, for C17H35NS2O4: С, 53.53; Η, 9.29; Ν, 
3.67. Found: С, 53.68; Η, 9.31; Ν, 3.70. For removal of the BOC group, the 
compound (190 mg, 0.5 mmol) was dissolved in 10 ml of trifluoroacetic acid. 
The solution was stirring for 30 minutes at 0 0C, after which the trifluoro­
acetic acid was evaporated in vacuo at room temperature. The residue was dried 
in vacuo over for 1 h and then dissolved in a minimal amount of water. The 
solution was placed on a ion-eocchange column (Amberlite IRA-410, 20-50 mesh 
OH- form). Elution with water and removal of the solvent by freeze-drying 
gave 19 in 90% yield. Rf 0.40 (eluent МеОН/СНСІз, 1/4 v/v); NMR(CD2Cl2) & 
0.70-2.20 (m, 15H, (СНгЭбСНз), 2.60-2.85 (m, 2H, ЗСНг(СНг)6CH3), 2.95 and 
3.23 (AB part of ABX spectrum, 8 lines, ¿Гду = Jgx = 6 Hz, Лдв = 14 Hz, 2H, 
CHCH2S(0), 3.70-3.98 (m, 4H, CH2OH, S(0)CH2S), 3.98-4.35 (br, IH, CHCH2OH). 
Octylsparsomyoin 20 
Compound 20 was prepared by a mixed anhydride procedure as follows. To a 
stirred, cooled (0 0C) solution of the acid 11^  (112 mg, 0.66 mmol) and tri-
ethylamine (86 mg, 0.86 mmol) in 5 ml of THF/DMF (1/1 v/v) was added 
ethylchloroformate (103 mg, 0.86 mmol). Stirred was continued at 0 0C for 
4 h. Subsequently a solution of the amino alcohol 19 (140 mg, 0.5 mmol) 
in 5 ml of THF/DMF (1/1 v/v) was added dropwise. The reaction was stirred 
at room temperature for 48 h, under the exclosure of light. The solvents 
were removed in vacuo at room temperature. The crude product was chromato-
graphed over silica gel 60H by HPLC (eluent МеОН/СНгСІг, 1/4 v/v), followed 
by gelfiltration over Sephadex LH-20 (eluent НгО/МеОН, 15/85 v/v). 20 was 
obtained in 17% yield. Rf 0.43 (eluent МеОН/СНСІз, 1/4 v/v), [a]¿5 3.3° 
(с 0.095, МеОН/НгО, 1/1 v/v); NMR(D20/K2C03) fi 0.58-2.33 (m, 15H, (СН2)бСНз), 
2.35 (s, ЗН, С(б)СНз), 2.55-2.84 (m, 2Н, ЗСНг(СНг)бСНз), 2.84-3.49 (m, 2Н 
СНСНг5(0)), 3.49-3.87 (m, 2Н, СНСНгОН), 3.87-4.16 (br, s, 2Н, S(0)CH2S), 
4.40-4.67 (m, IH, СНСНгОН), 6.95 and 7.61 (AB spectrum, J A B = 16 Hz, HC=CH). 
ACKNOWLEDGEMENT 
Parts of the investigations were supported by the Netherlands Foundation 
for Chemical Research (SON) with financial aid from the Netherlands Organi­
zation for the Advancement of Pure Research (ZWO) and the Netherlands Cancer 
Foundation, Koningin Wilhelmina Fonds. 
REFERENCES and FOOTNOTES 
1. Sparsomycin is a metabolite of Streptomyces sparsogenes: A.D. Argoudelis, 
R.R. Herr, Antimtcrob. Agents Chemother. (1962), 780; and of Strepto­
myces cuspidosporus: E. Higashide, T. Hasegawa, K. Mizuno, H. Akaide, 
Takeda Kenkyusho Nempo (1966), 25, 1; Chem. Abstr. (1967), 66, 54328. 
2. C.-C.L. Lin, R.J. Dubois, J. Med. Chem. (1977), 20_ 337. 
3. R. Vince, J. Brownell, C.K. Lee, Bioahem. Biophys. Res. Corrm. (1977), 
75, 563; C.K. Lee, R. Vince, J. Med. Chem. (1978), 2Л_, 177. 
4. R.J. Dubois, C.-C.L. Lin, B.L. Michel, J. Pharm, Soi. (1975), 64, 825. 
5. The authors were obliged to have recourse to more easily accessible 
analogs, because no synthetic route to the unique structural features 
of the cysteinol mono-oxodithioacetal was available2- . 
51 
6. S. Pestka in Ann. Rev. Miarob. (1971), 25^ 488, C.E. Clifton, S. Raffel, 
M.P. Starr, Eds.; D. Vazquez, FEBS Lett. (1974), 40^ , S63; D. Vazquez, 
'Inhibitors of protein synthesis' in Molec. ВъоЪ. Biochem. Biophys. 
(1979) , 30. 
7. L. Slechta, 'Antibiotics I', D. Gottlieb, P.D. Shaw, Eds. Springer Verlag 
New York, (1967), 410; R.E. Bannister, D.E. Hunt, R.F. Pitillo, Can. J. 
Microb. (1966), 12_, 595. 
8. I.H. Goldberg, K. Mitsugi, Biochem. Biophys. Res. Corrm. (1966), £3, 453; 
A. Contreras, D. Vazquez, L. Carrasco, J. Antibiot. (1978), 3^ _, 598; 
R.S. Gupta, L. Siminovitch, Biochem. (1977), l£f 3209. 
9. a. S.P. Owen, A. Dietz, G.W. Camiener, Antimicrob. Ag. Chemother. (1962), 
772,-
b. M. Kuwano, K. Takenaka, M. Ono, Biochem. Biophys. Acta, (1979), 563, 
479; 
c. B.K. Bhuyan, L.G. Scheidt, I.J. Fraser, Cancer Res. (1972), 32^ , 398. 
10. A. Contreras, L. Carrasco, J. Virol. (1979), 2£, 114; L. Thiry, J. Gen. 
Virol. (1968), Ij, 143. 
11. C. Baglioni, Biochem. Biophys. Acta, (1966), 129, 642; B. Emmerich, H. 
Hoffmann, V. Erben, J. Rastetter, Biochem. Biophys. Acta, (1976), 447, 
460; S. Pestka, Froc. Natl. Acad. Sci. USA, (1968), 61_, 726; L. Carrasco, 
M. Fresno, D. Vazquez, FEBS Lett. (1975), 52^ 236. 
12. A.C. Trakastellis, Froc. Natl. Acad. Sci. USA, (1968), 59, 854; H. 
Sidransky, E. Vemey, J. Natl. Cancer Inst. (1979), 63/ 81; D.S. Sarma, 
C.N. Murty, H. Sidransky, Biochem. Pharmacol. (1974), Z3, 857. 
13. H.P. Close, J.R. McFarlane, Cancer Chemother. Rep. (1969), £3, 29. 
14. Investigation of the activity in a cell-free ribosomal system will be 
subject of a future report. 
15. H.C.J. Ottenheijm, R.M.J. Liskamp, S.P.J.M. van Nispen, H.A. Boots, 
M.W. Tijhuis, J. Org. Chem. (1981), 46^ 3273. 
16. R.M.J. Liskamp, H.J.M. Zeegers, H.C.J. Ottenheijm, J. Org. Chem. (1981), 
46, 5408. 
17. P. Helquist, M.S. Shekhani, J. Am. Chem. Soc. (1979), 101, 1057. 
18. The chiral carbon atom in sparsomycin possesses the S absolute configu-
ration denoted as Sc, whereas the absolute configuration of the 
sulfoxide sulfur19 is R, denoted as Rg. 
19. H.C.J. Ottenheijm, R.M.J. Liskamp, P. Helquist, J.W. Lauher, M. Shekhani, 
J. Am. Chem. Soc. (1981), 103, 1720. 
20. We are grateful to Dr P.F. Wiley (Upjohn Co.) for supplying us with a 
sample of authentic sparsomycin. 
21. P.F. Wiley and F.A. MacKellar, J. Org. Chem. (1976), 41_, 1858. 
22. The uv detector of the HPLC or gelfiltration equipment is probably 
also responsible for contamination of the trans-isomer with the cis-
isomer. 
23. It should be emphasized here that several of the reported biological 
and biochemical studies have probably been carried out with sparsomycin 
containing variable amounts of isosparsoniycin( 16). 
24. R.H. Symons, R.J. Harris, D. Greenwell, D.J. Eckerman, E.F. Vanin, in 
'Bio-organic Chemistry' E.E. van Tamelen, Ed. (1978), A_, 81. 
25. S. Fahnestock, H. Neuman, V. Shashoua, A. Rich, Biochem. (1970), 9, 2477. 
52 
26. В. Colombo, L. Felicetti, С. Baglioni, Biochem. Biophys3 Acta, (1966), 
119, 109. 
27. B. Winograd, M. Oosterbaan, R. Liskamp, E. van der Kleijn, H. Ottenheijm, 
Th. Wagener, manuscript in preparation. 
28. P.-C. Wu, R.F. Ozols, M. Hatanaka, C.W. Boone, J. Natl. Cancer Inst. 
(1982), 6£, 115. 
29. This method was originally described by V.D. Courtenay, I.E. Smith, 
M.J. Peckham, G.G. Steel, Nature, (1976), 263, 771 and A.W. Hamburger, 
S.E. Salmon, Science, (1977), 197, 461. 
30. S.E. Salmon, A.W. Hamburger, B. Soehnlen, B.G. Durie, D.S. Alberts, Т.Е. 
Moon, N. Engl. J. Med. (1978), 298, 1321. 
31. D.S. Alberts, S.E. Salmon, H.S. Chen, Lancet, (1980), 2_, 340. 
32. A. Goldin, J.M. Venditti, J.S. MacDonald, F.M. Muggia, J.A. Henney, V.T. 
Devita Jr., Europ. J. Cancer, (1981), Г7, 129. 
33. C. Herman, personal communication. 
34. H.E. Skipper, F.M. Schabel Jr., W.S. Wilcox, Cancer Chemother. Rep. 
(1964) , 35., 1. 
35. L.H. Li, S.L. Kuentzel, L.L. Murch, L.M. Psichigoda, W.R. Kruger, H. 
Martin, Cancer Ees. (1979), 39^ 4816. 
36. P. Himmelfarb, P.S. Thayer, H. Martin, Cancer Chemother. Rep. (1967), 
51_, 451. 
37. A.A. van der Huizen, J.C. van de Сгащреі, W. Akkerman, P. Lelieveld, 
Α. van der Meer-Kalverkamp, H.B. Lamberts, submitted for publication. 
38. Η. Faulstich, T. Wieland, 'Peptides 1971'; H. Nesvadba, Ed. North Holland 
Publishing Co. Amsterdam, (1973), 343; H. Faulstich, M.Bloching, S. 
Zobeley, T. Wieland, Ехреггепіга, (1973), 343; T. Wieland, M.P.J, de 
Urries, H. Indes, H. Faulstich, A. Giren, M. Sturm, W. Hoppe, Justus 
Liebig Ann. Chem. (1974) , 1580; A. Buku, R. Altmann, T. Wieland, Ibid., 
(1974), 1580. 
39. P. Lelieveld, L.M. van Putten, Cancer Treat. Rep. (1976), 60^ , 373. 
40. Sodiumoctylthiolate was prepared from octylthiol and sodiumhydride. 
53 
THE ANTITÜMOB ACTIVITY OF SPARSOMYCIN 
EVALUATION OF THE AVAILABLE DATA 
Clinical Phase I Study 
In 19641 sparsomycin was selected for a Phase I clinical study on the basis 
of its activity against KB cells (the KB cell culture is a cell line derived 
from human epidermoid carcinoma of the mouth) as well as its moderate inhi-
bitory activity in a number of in VÌVO tumor systems2. In this study, sparso-
mycin was daily administered i.v. for an intended period of 42 days to 5 
patients who had all far advanced carcinoma for which no specific therapy 
was available. The total dose given ranged from 0.085 to 0.24 mg/kg. Two 
patients noted difficulty of vision, one after 13 days of treatment (total 
dose 12 mg) and one after 15 days of treatment (total dose 7.5 mg), where-
after treatment was stopped. 
The complaints consisted of ring scotomas, i.e. ring shaped blind spots. This 
impaired vision and the wide spread degeneration of retinal pigment epithe-
lium observed at necropsy indicated a severe ocular toxicity1'3. 
Necropsy of other organs of the 5 patients revealed no changes related to 
drug toxicity1. 
Ocular changes have not been observed in laboratory animals including rat, 
dog and monkey. These results have been referred to by MacFarlane et al.; 
however, neither references nor detailed information are given in this report. 
The Phase I Study was terminated pending additional preclinical studies. 
It was expected that determination of the structural formula of sparsomycin 
in conjuction with animal studies might further define the pathophysiology 
of this ocular toxicity. In addition, it was stated1 that preclinical studies 
of sparsomycin's activity should include studies of ocular toxicity. However, 
to our best knowledge the number of publications concerning additional pre-
clinical studies, that have appeared ever since, is limited. We have no 
conclusive explanation for this sudden decline of interest in sparsomycin 
as an antineoplastic agent. We are inclined to assume that further research 
was hampered because of two reasons: first, the reported ocular toxicity 
and second, a possible lack of sufficient material. The sparsomycin used 
had been obtained through tedious isolation procedures from a fermentation 
broth4-7. 
IN VITRO AND IN VIVO EXPERIMENTS 
In vitro experiments 
Sparsomycin has attracted much attention because of its activity against 
transformed cells8»9'11 as well as its activity against various tumors2»9'10. 
For 50% inhibition of KB cell growth 0.08 pg/mL of sparsomycin is suffi-
cient2 »β»9. Experiments with normal cells from a Chinese hamster fibroblast 
line showed12 that sparsomycin was most cytotoxic to cells in the S-phase. 
During the S-phase DNA synthesis takes place. Beside inhibiting the protein 
synthesis, sparsomycin inhibited markedly the DNA synthesis. This has been 
ascribed to an interruption of the histone synthesis, which is tightly 
coupled to DNA synthesis12. Although it has been shown that sparsomycin is 
active against transformed and normal cells (Chapter I, general introduc­
tion) , no information is available on the selectivity of sparsomycin against 
transformed cells as compared to normal cells. 
In vivo experiments 
As mentioned above sparsomycin showed a moderate inhibition in a number 
of in vivo tumor systems2. In these experiments with laboratory animals 
having implanted tumors sparsomycin manifested its effects at a dose level 
of 0.5 mg/kg. 
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In the in VÌVO systems p-388 lymphocytic leukemia9 and Walker carcinoma 256^ 
sparsomycin showed its activity at a dose level of 0.3-0.8 mg/kg. In a study^ 
with rats bearing intra hepatically transplanted hepatomas, the responses 
to sparsomycin, in terms of changes in the polyribosome pattern and inhi-
bition of protein synthesis [in vitro and in vivo) were evaluated relative 
to the responses in the host livers. In general, the host livers responded 
much more than the hepatomas did, which might be partly attributed to a 
difference in blood supply to the transplanted hepatomas1 . 
Toxicity 
An acute LD50 value (lethal dose for 50% of the animals) of 2.4 mg/kg in mice 
has been reported for sparsomycin. However, new experiments ° indicate 
recently a considerable lower toxicity; the observed LD50 value is about 20 
mg/kg. Sparsomycin, when administered intraperitoneally to mice (20 yg/20 g 
of body weight), induced marked disaggregation of hepatic polyribosomes and 
inhibited incorporation of [_ CJ -leucine into hepatic proteins by 90%lt*. 
Disaggregation was not observed in vitro^-1*. These results, the aforementioned 
ocular toxicity and effect on normal cells indicate that sparsomycin is toxic. 
Its toxicity is a consequence of its ability to inhibit the protein synthesis. 
In general, toxicity is an intrinsic property of antineoplastic agents. The 
question to be answered by further research is whether the therapeutic 
index of sparsomycin is large enough for clinical studies. 
PRESENT AND FUTURE INVESTIGATIONS ON THE ANTITUMOR ACTIVITY OF SPARSOMYCIN 
AND ANALOGS 
An interesting aspect of the activity of sparsomycin is, that it inhibits 
the protein synthesis (Chapter I and this Chapter, sections 1 and 2), where-
as all clinically used antitumor agents act more or less on the DNA or RNA 
level. Therefore, sparsomycin might be a valuable antineoplastic agent for 
use in multiple drug schedules. We suppose that the mode of action of sparso-
mycin features another aspect; many of the clinically used antitumor agents 
have also carcinogenic properties. We expect that this adverse effect is 
absent with sparsomycin. The syntheses developed for sparsomycin enable us 
to prepare sufficient quantities for further biomedical studies. In addition, 
more elaborate structure-activity relationship studies will be performed 
to develop compounds with more selective biochemical and pharmacological 
properties while determining the minimum structural and stereochemical 
requirements for the biological activity. 
Now that it has been shown that sparsomycin as well as octylsparsomycin 
possess a high activity in an in vitTO L1210 clonogenic assay (this Chapter, 
section 3), we and others15-17 decided that renewed investigations on the 
antitumor activity of sparsomycin are called for. The following experiments 
are planned. Sparsomycin and octylsparsomycin will be tested against 
primary human turaor cells in the human tumor cell assay . 
Furthermore the compounds will be tested in mice against implanted leukemia 
L1210 and solid tumors 18. 
For further preclinical studies of sparsomycin and analogs evaluation of 
their pharmacological properties in laboratory animals is essential. No 
data of pharmacokinetics or metabolism of sparsomycin have been published 
so far. A first pharmacokinetic study in the dog showed that sparsomycin 
has a short half-time of elimination 1 , namely 70 min. In addition, the 
recovery of sparsomycin is only 25% in 24 h, although sparsomycin is rather 
soluble in water. Octylsparsomycin is more active in the L1210 clonogenic 
assay (this Chapter, section 3) and might have the advance of a longer 
half-time of elimination, because of an increased lipophilicity. This is 
under present investigation15»17. 
For closer examinations of the pharmacological properties (metabolism, 
distribution, excretion, mass balance) and ocular toxicity of sparsomycin2", 
we have planned to prepare radio-actively labeled sparsomycin. 
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Radio-actively labeled sparsomycin derivatives will also be used to study 
the penetration of these compounds into transformed cells as compared to normal 
cells. This might give information on the selectivity on the cellular level. 
Finally, based on results of these experiments and further preclinical 
investigations in laboratory animals, it will be decided whether sparsomycin 
will be reintroduced into clinical studies*5. 
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Abstract. The solid state conformation of an N-protected sultine 2 was 
determined by X-ray crystallography, which allowed also the assignment of 
the R configuration of the sulfinate sulfur atom. In addition the conforma­
tion of compounds 1 and 2 in solution is reported. This conformational ana­
lysis was based on the application of a new, empirical generalization of the 
classical Karplus equation. Application of equation 1 and 4 allowed the 
expression of vicinal coupling constants - obtained by 500 MHz NMR spectros­
copy - in proton- proton torsion angles фцн· Using the concept of pseudo-
rotation (equation 1, 2a-d) the puckering and conformation of the sultine 
ring of 1 and 2 was quantitatively described. 
It was shown that in CDCI3 at 2 33K or 300K compound 1 is present as a 
twist chair conformer, which can be denoted as ^Ts (Scheme I). In Me2SO-d6 
compound 1 is engaged in an equilibrium between this T5 conformer and a 
|T conformer. Compound 2 in CDCI3 at 233K is engaged in two conformational 
equilibria, a slow and a fast one on the NMR time scale. The slow equilibrium 
between a major component and a minor component is due to hindered rotation 
in the urethane side chain. 
In the fast equilibrium the five-membered ring is engaged in an equili­
brium between a twisted chair conformer (^ Т) and an envelope shaped con-
former (χΕ, see Scheme II). The slow equilibrium is not observed in Me2SO-dD 
at 300K or in C2D2C1I+ at 3Θ3Κ. The effects that might play a role in deter­
mining the conformations of 1 and 2 in solution are the gauche effect (Figure 
7), the anomeric effect (Figure 8) and hydrogen bonding. The solid state 
conformation of 2.which is governed by hydrogen bond formation (see Figure 1), 
can be described as 3E (Figure 3). Thus, a comparison of both the solution 
conformer and the solid state conformer of 2 (Scheme II and Figure 3, 
respectively) shows a remarkable difference. 
INTRODUCTION 
Recently, we reported2 an efficient route leading to the functionalized, 
five-membered cyclic sulfinate esters - γ-sultines - 1-3. It was concluded 
that nucleophilic ring-opening reactions of these sultines proceed with 
inversion at sulfur2. To draw this conclusion, the absolute configuration 
of one of the sultines had to be established rigorously. 
Here we report a detailed discussion of the X-ray crystallographic, 
configurational and conformational analysis of 2. 
We noticed that the chiral sulfur atom causes asymmetric induction in 
ring-opening reactions with a prochiral nucleophile . For a fundamental 
understanding of this chiral induction, insight into the conformation of 
the sultines in solution is a prerequisite. 
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Therefore, beside the crystallographic analysis of the solid state 
conformation, an analysis of the conformation of 2 and 3 in solution will 
be given. This analysis is a new application of a generalized form of the 
Karplus equation, which has been formulated by one of us1* and which has been 
used successfully5. 
/ S 4 . 
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METHODS 
Pseudorotation Апаіувів of the Sultine Ring. The conformation of a five-
membered ring in general is conveniently described by using the concept of 
pseudorotation6''. The endocyclic torsion angles Ф. of a five-membered ring 
are interrelated via the pseudorotation equation 1. 
Φ
α
 = Φ cos (Ρ + 4 1j/5) in which j = 0-4 {\) 
J m 
The puckering and conformation of the sultine ring may thus be quantita­
tively described by two parameters: Ρ - the phase angle of pseudorotation 
and Φ - the puckering amplitude. The endocyclic torsion angle opposite 
to the sulfur atom is defined as the reference angle Фд, the remaining 
torsion angles Ф^, $2> Ф3 and Φι» are designated counterclockwise along 
C4-C5, C5-S1, Sl-02 and 02-C3, respectively (see structure 5). 
Ç5 2? 
00 
By application of a new empirical generalization of the classical Karplus 
equation (vide infra, equation 4), experimental vicinal 1H-NMR coupling 
constants can be correlated with proton-proton torsion angles Ф
н н
. These 
torsion angles are intimately related to the endocyclic torsion angles Ф^, 
which, on their turn determine the pseudorotation parameters Ρ and Φ 
(equation 1). Therefore, in order to determine the conformation of the 
sultine ring in terms of the pseudorotation concept, correlations between 
the pseudorotation parameters (P and Φ ) and the proton-proton torsion 
angles are called for. 
A complication arises however, because this pseudorotation equation 1 
can only be regarded as near-exact for equilateral five-membered rings 
such as cyclopentane. 
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In heterocyclic systems with varying endocyclic bond distances, as is 
pertinently the case for the sultine ring under study (bond distances 
of 1.40-1.83 A , Table 1), equation 1 is expected to reproduce the 
endocyclic torsion angles - and hence the exocyclic proton-proton torsion 
angles - only with limited accuracy. This expectation is indeed borne out 
by experiment as the torsion angles recalculated from the pseudorotation 
parameters for the sultine ring in the solid state {vide infra) show 
deviations up to 2.5 when compared with the experimentally observed 
torsion angles. This situation was only recently remedied by de Leeuw et alQ 
by applying two correction factors to the pseudorotation equation 1. 
This corrected pseudorotation equation yields the following correlations 
between the proton-proton torsion angles φ and the pseudorotation para­
meters governing the conformation of the sultine ring: 
Фзі_і» = -3.9 + 1.0033 Ф
т
соз(Р-2.48) (2a) 
Фзг-ц = -123.3 + 1.0033 Φ COS(P-2.48) (2b) 
φ^-δΐ = 4.0 + 1.0206 $mcos(P+140.72) (2c) 
Φι»-52 = 1 2 3 · 2 + 1.0206 фтсоз(Р+140.72) (2d) 
Obviously, by combining equations 1 and 2a-2d, it will suffice - at least 
in theory - to determine two vicinal coupling constants in order to give 
a full description of the five-membered ring in terms of Ρ and Φ . When 
more coupling constants and hence more torsion angles are known, the system 
is overdetermined and 'best' values for Ρ and Φ may be obtained either by 
averaging or, preferably, by least-squares fitting of the data. 
A complication may arise when the five-membered ring under study is 
engaged in a fast equilibrium between two distinct conformers; then the 
experimental coupling constants 3J represent time-average values that are 
linearly related to the coupling constants of the individual conformers J(I) 
and J(II) and their populations as expressed by equation 3. 
3J
e x p = xJ(I) + (l-x)J(II) (3) 
where χ is the mole fraction of conformer I. 
In this case the complete conformational analysis entails the determination 
of five independent parameters P d ) , Φ (I), Ρ (II), Φ (II) and χ from the 
observed coupling constants. This objective was realized by an iterative 
least-squares computer program (written in PASCAL) devised to obtain the best 
fit of the equilibrium parameters to the experimental coupling constants. 
At this point it should be mentioned that for the sultine ring under study 
the system is in fact underdetermined as only four observables - i.e. 
coupling constants - are available from experiment for the calculation of 
Φ (I), P(I), Φ (II)/ P(II) and x. Therefore, within each minimization one 
m m 
or more parameters must be constrained to reasonable values. In the 
following sections it will be demonstrated that the procedure outlined 
above yields a consistent conformational analysis of the sultine rings in 
solution. 
Determination of the Proton-Proton Torsion Angles. To obtain the proton-
proton torsion angles, necessary for the pseudorotation analysis of the 
sultine ring (eqs 1, 2a-2d), a new emperical generalization1* of the clas­
sical Karplus equation was used. 
In this generalized equation the standard Karplus equation is extended 
with a correction term in order to describe the influence of electro­
negative substituents on vicinal coupling constemts in an explicit way. 
Each H-C-C-H fragment in the ring of compounds 1 and 2 carries three non-
hydrogen substituents in which case the generalized equation takes the form: 
3jHH = 1 3- 2 2 с о з 2Ф _ 0' 9 9 с о зФ + ΣΔχ.{0.87-2.46οο32(ς.φ + 19.9|Δχ.|)} (4) 
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The first two terms describe the dependency of the vicinal coupling constant 
(3J ) in the H-C-C-H fragment under study on the Klyne-Prelog signed 
proton-proton torsion angle' (4). The remaining terms account for the 
dependency of J p H on the electronegative substituents S.; these terms 
depend on the torsion angle φ,on the difference in electronegativity between 
the substituents S and hydrogen on the Huggins scale10 (Δχ.), and finally 
on the orientation of the substituent S. with respect to the coupling 
protons и
А
) . 
RESULTS 
X-Ray Crystallographic Configurational and Conformational Analysis of 2. 
So that the configuration of the sulfoxide atom and the solid state con­
formation of the ring could be determined, a single crystal X-ray structure 
determination of 2 was performed (see also experimental section). This 
compound crystallized from dichloromethane/carbon tetrachloride as monoclinic 
needles with two crystallographically independent molecules in the unit 
cell, see Figure 1. 
Bond distances (Table 1) and angles of these two molecules agree with 
each other without significant differences. The structure of the molecules 
is shown in Figure 2. By reference to the chiral carbon atom having the R-
configuration (see experimental section), the chiral sulfur atom can readily 
be seen to possess the R-configuration1* too. 
Fig 1 Stereoscopie view of 2 in the unit cell 
The C5-S1 bond is, as expected, the longest bond in the ring of both mole­
cules in the unit cell; its values (1.780A and 1.833A) are similar to 
th se reported for non-functionalized sultines12'13 . 
In Figure 1 the presence of intermolecular hydrogen bonds between NH and C=0 
is indicated. The observed O-N distances are 2.88A and 2.93Ä and the 
corresponding N-H-0 angles are 156 and 150 , respectively. Consequently, 
the hydrogen bonds can be classified as moderately strong11*. Due to 
these hydrogen bonds the molecules form straight chains throughout the 
crystal. 
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Table 1 BOND DISTANCES (ft) OF 2 
Atoms d <d> Atoms d 
SI -06 
SI -02 
SI -C5 
02 -C3 
C3 -C4 
C4 -C5 
C4 -N7 
N7 -C8 
C8 -Oil 
C8 -09 
09 -CIO 
C10-C12 
C10-C13 
C10-C14 
1.466(7) 
1.586(7) 
1.780(7) 
1.426(11) 
1.524(11) 
1.525(11) 
1.402(9) 
1.356(7) 
1.189(7) 
1.332(7) 
1.484(7) 
1.503(9) 
1.491(10) 
1.513(10) 
1.460 
1.592 
1.807 
1.415 
1.515 
1.534 
1.418 
1.355 
1.195 
1.327 
1.483 
1.495 
1.512 
1.502 
SI' 
SI' 
SI' 
02' 
C3' 
04' 
C4· 
N7' 
C8* 
08' 
09' 
CIO' 
CIO' 
CIO' 
-06' 
-02' 
-C5' 
-C3· 
-C4' 
-C5' 
-N7' 
-C8' 
-Oil' 
-09' 
-CIO' 
'-сіг· 
'-СІЗ' 
'-CM' 
1.453(7) 
1.598(6) 
1.833(9) 
1.403(8) 
1.505(11) 
1.543(10) 
1.434(9) 
1.354(7) 
1.201(7) 
1.321(8) 
1.482(7) 
1.487(10) 
1.533(11) 
1.490(11) 
Fig 2 X-ray analysis of 2 showing the R -R configuration 
Ρ =334.7° Ρ =332.7° 
Φ = 44.6° Φ = 44.7° 
m m 
The conformation of the ring of 2 in the .jinit cell can be described in 
terms of pseudorotation as has been outlined above (eq 1). As a result 
the two sultine rings have phase angles of pseudorotation (Ρ) of 334.7 
and 332.7 with puckering-amplitudes (Φ ) of 44.6 and 44.7 , respectively. 
Both conformations are almost envelope shaped, with C3 out of the plane, 
pointing into the direction opposite to the C4-N bond, a conformation which 
is denoted15 by 3E (Figure 3). 
An alternative way to describe the envelope shaped conformation is the 
dihedral angle between the planes through the atoms [c4, C5, Si, 02"] and 
[c4, C3, 02]; this value is 41 for both molecules in the unit cell. 
^H-NMR spectra of 1 and 2. The proton chemical shift values of 1 in CDCI3 
at 233K are collected in Table 2. The corresponding observed coupling 
constants are listed in Table 3. 
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Fig 3 Representation of 2 in the solid state showing the envelop •¡E shape 
t-Bu-0 
Table 2 CHEMICAL SHIFT DATA (PPM) OF 1 IN DIFFERENT SOLVENTS AND AT 
DIFFERENT TEMPERATURES 
Proton 
CDCI3 
233 К 
CDCI3 
300 к 
Me2SO-db 
300 К 
нзі 
н32 
Нц 
н51 
HS2 
HN 
Ht-Bu 
4.659 
4.810 
4.955 
3.021 
3.294 
6.154 
1.438 
4.623 
4.749 
4.899 
2.972 
3.201 
6.012 
1.437 
4.572 
4.511 
4.433 
3.481 
2.994 
7.040 
1.390 
Table 3 COUPLING DATA (Hz) OF 1 IN DIFFERENT SOLVENTS AND AT DIFFERENT 
TEMPERATURES 
Coupling 
H3I-4 
Н32-Ч 
H51-4 
H52-4 
Ηι,-ΝΗ 
H31-32 
H51-52 
CDCI3, 233K 
J J . Δ, 
exp. cale. J 
5.82 5.80 0.02 
1.52 1.48 0.04 
7.00 7.05 -0.05 
0.90 1.22 -0.32 
9.9 
-9.67 
-13.14 
CDCI3, 300K 
J J , Δ, 
exp. cale. J 
5.93 5.96 -0.03 
1.74 1.54 0.20 
7.21 7.18 0.03 
0.99 1.22 -0.23 
8.2 
-9.67 
-13.15 
Me2SO-d6, 
J 
exp. 
6.68 
5.22 
8.21 
3.53 
6.0 
-8.92 
-13.41 
J* . 
cale. 
6.72 
5.26 
8.12 
3.50 
300K 
Δ
σ 
-0.04 
-0.04 
0.09 
0.03 
Calculated for a conformational equilibrium (see text) 
The 500 MHz spectra of 2 deserve some comment; the spectrum in CDCI3 at 
300K is depicted in Figure 4 and shows the simultaneous presence of both 
sharp and broad resonances. 
The broad resonances at δ 3.47 and 4.48 were taken indicative for chemical 
shift exchange phenomena. This conception was indeed confirmed by experiment; 
at lower temperature (233K), the broad lines sharpen up to give two sets 
of signals with em integration ratio of about 9:1 (Figure 4). The gaussian 
enhanced spectrum of 2 at 233K is represented in Figure 5. 
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Fig 4 500 MHz 1H-NMR speatmm of 2 in CDCl3 at 22SKt at SOOK and in 
С
г
02С1ц at 383K 
T:383K 
50 'в 4 ~П ' ïr* Ti ' Ti-
Τ 233Κ 
Ί№; 
J 
—ι 1 г 1 1— •ЛЛг- ïW? 
Perusal of this spectrum shows that the sharp resonances are also 
splitted into sets of signals, displaying a similar integration 
ratio; however, the chemical shift differences are very small (0.01 ppm). 
From these observations we concluded that 2 is engaged in a slow equi-
librium between two conformers; the conformer with the larger integration 
values for all resonances is called the major component and the second 
conformer is called the minor component. 
We have solid evidence that the bipartition of 2 in these two components 
originates from different conformations in the side chain and not from 
different ring conformations (vide infra). The chemical shift data and 
coupling data for the major and minor component of 2 are collected in 
Tables 4 and 5. 
These data and those presented in Tables 2 and 3 were obtained from 
computer simulated spectra. As an example the simulated spectrum of the 
major and the minor component of 2 in CDCI3 at 233K is shown in Figure 5. 
The assignment of the signals in the spectrum of 2 at 233K (Figures 4 
and 5) to individual protons is based on the following rationale. The 
urethane proton is easily recognized by its broad doublet appearance at 
5 ppm and the fact that it exchanges after the addition of D2O/TFA to 
the sample. The singlet at high field is due to the t-butyl protons. The 
signals in the 3.20 - 3.60 ppm region originate from the protons H51 and 
H52; each proton gives rise to a doublet of doublets. 
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Fig S Gaussian enhanced experimental spectrum of 2 at 233K in CDCl^ 
and the corresponding simulated spectra of the major and minor 
component 
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Table 4 CHEMICAL SHIFT DATA (ppm) OF 2 IN DIFFERENT SOLVENTS AND AT 
DIFFERENT TEMPERATURES 
proton 
H31 
H32 
Hi» 
H5I 
H52 
HN 
Ht-Bu 
CDC13, 
minor 
4.869 
4.475 
4.717 
3.216 
3.443 
5.259 
1.495 
233K 
major 
4.865 
4.554 
4.798 
3.920 
3.590 
4.994 
1.445 
CDCI3 
300K 
4.847 
4.474 
4.78 
3.176 
3.461 
1.445 
сгОгсіі^ 
383K 
4.746 
4.323 
4.660 
3.062 
3.256 
4.581 
1.383 
Me2SO-d6 
300K 
4.626 
4.332 
4.566 
3.067 
3.432 
7.327 
1.388 
The doublets of doublets In the 4.55 - 4.87 ppm region are due to the 
protons H31 and H32; in this region are also located the multiplets due 
tothe Нц proton in the major and minor component. This global assignment 
is in accordance with the chemical shift data reported for the closely 
related compound 1,2 oxathiolane 2,2-dioxide (propane-sultone) and, 
moreover, consistent with all observed geminai and vicinal coupling 
constants reported in Table 5. 
Assignment of the individual geminai protons at C3 and C5 is based 
on coupling constant considerations. 
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Table S COUPLING DATA (Hz) OF 2 IN DIFFERENT SOLVENTS AND AT SEVERAL 
TEMPERATURES 
CDCI3, 233K СгОгСі^, з зк мегзо-а6, зоок 
coupling minor component major component J J . Δ_ 'J J , Δ, J J . Δ, J J . Δ, 
exp cale J exp cale J ejtp cale J exp cale J 
H31-4 
H 3 2-it 
H51-«t 
H52-4 
H4-NH 
H31-32 
H51-52 
H32-52 
4.83 
2.27 
6.61 
3.59 
7.94 
-10.00 
-13.82 
5 
2 
6 
3 
13 
27 
47 
39 
-0 
-0 
0 
0 
32 
00 
14 
20 
-
-
4.34 
1.25 
6.69 
2.25 
7.95 
10.16 
14.23 
0.99 
4 
1 
6 
2 
35 
71 
59 
01 
-0 
-0 
0 
0 
01 
46 
10 
24 
5.16 
2.61 
6.71 
4.03 
6.00 
-9.82 
13.67 
5.47 
2.62 
6.58 
3.91 
-0.31 
-0.01 
0.13 
0.12 
-
5.17 
2.82 
6.79 
4.30 
4.99 
-9.25 
-13.66 
5.62 
2.86 
6.60 
4.12 
-0.45 
-0.04 
0.19 
0.18 
Using the appropriate equations 1 and 2a-2cl together with the equation 4 the 
dependency of each of the four vicinal coupling constants on the phase angle 
of pseudorotation Ρ is easily computed for two values of the puckering ampli­
tude, viz. 35 and 45 1 7. The resulting coupling constants profiles are 
shown in Figure 6. 
Fig 6 Calculated aoupling constant profiles 3сШЯ (Hz) for 1 and 2 as a 
function of the pseudorotation phase angle P. Solid curves:^ 35° 
dashed curves:i 45° m 
m 
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Figure 6 allows an asaignmenL of the C3 and the C5 protons; only the H32 
and H52 protons can adopt - for certain ranges of Ρ - coupling constants values 
less than or equa] to 2 Hz. Consequently, those signals that correspond 
to a vicinal coupling constant of 2 Hz (see Table 5) can be assigned to 
the protons H32 and H52. 
The same line of reasoning can be used to assign the signals in the 
spectra of l,(see Tables 2 and 3),with the exception of the spectrum in 
Me2S0-d^ at 300K. In the latter solvent protons H31 and H32 display vicinal 
coupling constants of roughly the same magnitude (^6 Hz). In this case 
we had recourse to a solvent-mixture technique : by recording the NMR-
spectra in mixtures of CDCI3 and Me2S0-d of varying composition it was shown 
that the H31 and H32 protons as well as the H51 and H52 protons interchange 
position in the spectrum upon increasing Me2SO-d content in the solvent 
mixture. No other assignment leads to acceptable structures in the conformatio­
nal analysis [vide infra). 
Solution conformation of 1. The results of the pseudorotation analysis of 1 
in CDCI3 at 233K show that the five-membered ring is best described in terms 
of a single conformation characterized by P=25 , Φ_=34 (^ Ts) Scheme I 
Scheme I 
 
m 
Solution conformers of 1 present in CDCI3 at 233K (la) in CDCl^ 
¿t 300K (lb) and in Ме
г
30-<3!°, at 300K (lo and Id) 
t-Bu-0 
la.lb,1ç 
t-Bu-Q 
see a l s o Table 6 (conformer l a ) . Raising the temperature t o 300K hard ly 
a f f e c t s the experimental coupling c o n s t a n t s : again a comparable conforma-
t i o n a l system descr ibed by P=26 , $ =33 (Table 6 , conformer lb) i s found. 
S u b s t a n t i a l changes in the v i c i n a l coupling cons tan t s are induced, however, 
when 1 i s d i sso lved in Me2SO-d6 (300K). In t h i s c a se , the observed couplings 
cannot be r a t i o n a l i z e d in terms of one conformation for the five-membered 
r i n g , as p i l o t - c a l c u l a t i o n y ie lded unacceptably high d i f fe rences between 
observed and c a l c u l a t e d coupling cons tan ts (up to 1 Hz) for the u l t ima te ly 
' b e s t ' s i n g l e conformer. Therefore , the p o s s i b i l i t y of a conformational 
equ i l ib r ium (see 'Methods') was cons idered . In order t o reduce the number 
of parameters to be e x t r a c t e d from the coupling cons tan t d a t a , the involved 
puckering amplitudes Φ (I) and Φ (II) were fixed t o the a r b i t r a r y value of 
3 5
0 1 8
-
 m m 
Indeed, the c o n s t r a i n e d c a l c u l a t i o n s t r o n g l y i n d i c a t e s the e x i s t e n c e 
of a conformational e q u i l i b r i u m c h a r a c t e r i z e d by P(I)=17 , P(II)=148 and 
x=0.54 (x=molefraction of conformer I ) . Moreover, good agreement between 
c a l c u l a t e d and observed coupl ing c o n s t a n t s i s noted ( a l l AJ's < 0.1 Hz). 
The correspondence between one of these conformers (P(I)=17 , Φ(Ι)=35 , ^Е) 
and the s o l u t i o n conformation la in CDCI3 (P=25 , Φ =34 , Тц) i s s t r i k i n g , 
—— m 
the geometr ica l d i f fe rences between both five-membered r i n g s are d i f f e r e n c e s 
of degree, not of kind. 
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Therefore, it is not very surprising that introduction of the latter con­
formation la as one of the components of the conformational equilibrium 
yields - after pseudorotational analysis - an equilibrium of 1c (TO and 
Id (^ T) characterized by P(I)=250, Φ (1)=34 , Ρ(II)=146°, Φ (Ξϊ)=40 and 
x=0.56 (Table 6). This reproduces the observed coupling constants well 
(Table 3) . 
Table 6 PSEUDOEOTATION PARAMETERS OF 1 IN DIFFERENT SOLVENTS AND AT 
DIFFERENT TEMPERATURES 
P(I) m P(II) Φ (II) m 
CDC13 
CDC13 
Me2S0-d6 
233K 
300K 
ЗООК 
la 
lb 
le 
•is 
4
т 5 
25 
26С 
25С 
34 
зз
с 
34С 
1 
1 
0.56 ld: |т 146 40 
Solution conformation of 2. The ^-NMR spectrum of 2 in CDCI3 at 233K shows 
the presence of a major component and a minor component {vide siqpra) . The 
major and the minor component are proposed to be characterized by a trans 
urethane bond (^ T-Z and χΕ-Ζ, Scheme II) and a ois urethane bond (^ T-E and 
jE-E, Scheme II), respectively. 
Scheme II Solution L:onformers of 2 present in CDClj at 233K (2a-2d)3 in 
Me2S0-ds at 300K (2e and 2£) and in СгОгЫц at Z83K (2£~ 2hJ 
t-Bu-0 
t-Bu-0 
2Ь.2Л, 2h 
.E-Z 
/ 
t-Bu-0 
T-E 
2c 
г 
/ 
^ ^ 
1 Ε · Ε 
2d 
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Indirect evidence can be offered for this presumption: 
a. calculations showed (vide infra) that nearly the same conformers of the 
sultine ring were present both in the major and the minor component. 
This indicates that the sultine ring itself can be excluded as the 
cause for the chemical exchange phenomena 
b. the bipartition in a major and a minor component does not originate 
from different conformations about the C4-N bond, as in both components 
vicinal proton-proton couplings H14-C-N-H on one hand and geminai 1 '3C4-NH 
coupling constants on the other hand are very alike 
с the occurence of a major and a minor component is intimately related 
to the presence of a urethane-bond. The NMR-spectra of the N-benzyl 
oxycarbonyl-sultine 3 at 233K and 300K display similar features. However, 
no chemical exchange phenomena evinced from the corresponding spectra of 
4 which is a 'carbon-analogue' of 3 
d. several examples of molecules containing a urethane bond are known, which 
due to the C-N-C(O) bond can exist as a pair of rotamers (see 'Discussion'). 
Attention is now drawn to the sultine ring of the minor component. Model 
calculation in which the sotid—state pseudorotation parameters of 2 
(P=334 , Φ =44.7 , vide Sbcpra) were introduced as a constraint did not yield 
satisfactory results; the residual r.m.s. deviations between the observed 
couplings and those calculated for the ultimately 'best' conformational 
equilibrium remained unacceptably high (>1 Hz). Therefore, the experimental 
coupling constant data of the minor component were subjected to a pseudoro-
tational analysis along the lines described for 1 in Me2S0-d (vide siqpra). 
The phase-angles of pseudorotation and molefractions in the conformational 
equilibrium were optimized for arbitrary puckering amplitudes, after which 
the puckering amplitudes were optimized. This was followed by a re-optimization 
of the phase-angles and mole-fraction. 
This procedure resulted in the following description of the conformational 
equilibrium between conformers 2c and 2d: P(I)=7 , Φ (I)=45 , P(II)=270 , 
0 —— —— m 
Φ (II)=54 , and x=0.76 (Table 7). Calculated values for the coupling constants 
οΓ the ring protons in this equilibrium are listed in Table 5 and show 
indeed good agreement (residual rms-deviation between calculated and observed 
couplings = 0.2 3 Hz). 
Similar pseudorotational analyses were carried out for the coupling 
constant data of the major component. Again, when guided by the solid-state 
conformation of 2, no satisfactory solution was reached. However, upon 
introduction of the most populated conformer 2d of the minor component 
(vide supra) , the analysis smoothly optimized to a biased equilibrium of 
2a and 2b (Scheme II) characterized by P(I)=50I Фт(І)=45
0
, P(II)=2620, 
Ф
т
(ІІ)=45 and x=0.91 (Table 7). Subsequently, the effect of raising the 
temperature on the equilibrium between the major and minor component was 
studied, since the ^H-NMR spectrum in CDCI3 at 300K shows coalescence pheno­
mena. In order to record the ^-NMR spectra at elevated temperatures, the 
compound was dissolved in di-deuterotetrachloroethane (СгОгСІ^). At 383K, 
the minor and major component are rapidly interconverting, yielding a 'time-
averaged' spectrum, see Figure 4. 
A description of the five-membered ring in terms of an equilibrium between 
two conformers 2g and 2h (Scheme II) represented by the parameters Ρ (I)=5 , 
Ф
т
(І)=45 , Р(ІіГ=2б 0,~Ф
т
(ІІ)=54О and x=0.71 matches the experimental 
couplings constants very well (nns=0.20 Hz, see Table 7). 
Remarkably, no coalescence phenomena or separation into two components 
could be observed when the NMR spectrum of 2 was recorded in Me2SO-d6 at 
300K (Tables 4 and 5). Either the ais-trans isomerization of the urethane 
bond is fast on the NMR time-scale under these conditions (of the situation 
in C2D2CI4 at 383K) or the equilibrium is completely one­
sided in favour of one of the aforementioned isomers. No unambiguous choice 
between these two possibilities can be made from the data at hand. 
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Apart from this, the pseudorotational analysis of the sultine ring in this 
solvent appeared to be rather straightforward, yielding an equilibrium 
between conformers 2e and 2f (see Scheme II) with Ρ(I)=5 , Φ (I)=45 , 
P(II)=2650, Ф
т
(ІІ)=500 and~x=0.68 (see Table 7). m 
Table 7 PSEUDOROTATION PARAMETERS OF 2 IN DIFFERENT SOLVENTS AT DIFFERENT 
TEMPERATURES 
cods 
Me0SO-d6 
СгОгСі^ 
233K 
300K 
383K 
2a: 
2c: 
2R: 
lb 
^T-Z 
|T-E 
^
T 
3 T 
P(I) 
5° 0 
7 
.SU 
5° 
Ф
т
( І ) 
45° 
о 
45 
45° 
45° 
χ 
0.91 
0.76 
0.68 
0.71 
2b: 
2d: 
2f: 
2h: 
lE-Z 
lE-E 
iE 
iE 
P(II) 
262° 0 
270 
265° 
268° 
•
m
(II) 
45° 0 
54 
50J 
54° 
RMS 
0.23 
0.30 
0.30 
0.20 
DISCUSSION 
Although the results reported in this study allow only a qualitative insight 
into the specific intramolecular interactions that govern the conformational 
behaviour of the five-membered sultine-ring, the data at hand reveal several 
interesting points. The molecular model constructed for the Ts-conformer of 
1 (г.е. the solution conformation in CDCI3, la. Scheme I) suggests the facile 
formation of an intramolecular hydrogen-bond between the NH proton and the 
oxygen atom of the syn S-Ю moiety. Sundry experimental findings support thi? 
concept : 
a. the N-H absorption-bond in the IR-spectrum of 1 in CHCI3 is found at 30 cm-1 
lower frequency with respect to the corresponding bond in the IR-spectrum 
of 1 having the C-N and S-Ю bonds in an anti-arrangement (Figure 2). A 
similar difference in IR-absorption frequency (+ 40 cm-*) has been observed 
in the case of 5-hydroxy-l,3-dioxane^9 and has been assigned to the presence 
of an intramolecular hydrogen-bond 
b. the NH proton in the 500 MHz NMR-spectrum of 1 in CDCI3 resonates at 
significant lower field (ca. 1 ppm, cf Tables 2 and 4) compared to the 
corresponding proton in 2 
c. the proposed intramolecular bond in 1. in CDCI3 requires an anti-periplanar 
position of the C4-H and N-H protons. The vicinal coupling constant be­
tween these protons (3J (Hit-NH)=9,9 Hz) even exceeds the maximum value 
(9.45 Hz) predicted by the Karplus equation for H-C-N-H fragments given 
by Ramachandran et al20. This indicates a complete anti-periplanar 
position at 233K of the protons under discussion. 
Upon raising the temperature to 300K the magnitude of the latter coupling 
constant diminishes to 8.2 Hz, concomitantly the urethane-amide proton 
shifts to higher field. These observations betoken a certain amount of 
disruption of the intramolecular hydrogen-bonding2* according to the 
pseudorotational analysis given in the preceding section', however, the 
change in temperature has virtually no effect on the conformation of the 
sultine-ring, inferring that the formation of the intramolecular hydrogen 
bond does not play a dorcinant role in determining the conformation of 
the five-membered ring. 
Thus, although the intramolecular hydrogen bond stabilizes the Ts-conforma-
tion of the sultine-ring of 1 to a certain extent, we seek the main driving 
force for this conformation in the so-called gauche-effect. This is the 
well-documented22 preference for gauche over anti-geometry in X-C-C-Y 
fragments in which X and Y represent electronegative substituents. It has 
been pointed out that the conformational behaviour of five-membered ring 
sugars in nucleosides and nucleotides as well as in the five-membered 
protine ring " can be rationalized by assuming a predominant gauche 
stabilization between the endocyclic hetero-atom and exocyclic substituents. 
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We propose that the conformational behaviour of the sultine ring of 1 can be 
understood on the same grounds; as in the ^Ts-conformation of the sultine 
ring the exocyclic C-N-bond occupies a gauche orientation with respect to 
the ewdbcyclic C-S and C-0 bonds. From the observation that in chloroform 
no other conformation than the ^T5-conformer could be detected (vide infra), 
it follows that the (double) gauche stabilization in the sultine-ring amounts 
to >2 kcal/mole. This lower limit estimate is in accordance with data5'·' 
available for the gauche effect in N-C-C-0 fragments (2.0 kcal/mole), to 
which the gauche stabilization for the N-C-C-S(O) fragment should be added. 
This conformational behaviour of 1 changes drastically when the compound 
was dissolved in Me2SO-d6: next to the aforementioned le- T5 conformer a 
second(Id)(¿T) conformer becomes populated to approximately an equal extent. 
This finding may be explained in terms of a diminished gauche effect2^ in the 
more polar solvent МегЗО. 
In addition, the anomeric effect was taken into account. In Figure 7 the 
Newman projections along the 02-S1 bond of the conformers la-d are depicted. 
It is noted that in the fT-conformation (Id) the S-K) bond of the sultine 
ring approaches an antiperiplanar orientation with respect to one of the 
ring-oxygen lone-pairs, suggesting a stabilization on the basis of the 
anomeric effect25»26. In Figure 8 this anomeric effect is visualized. Finally, 
Me2SO is a strong hydrogen bond accepting solvent capable of competing with 
the intramolecular hydrogen bond-accepting sulfinyl function. Indeed, a 
reduced intramolecular hydrogen bonding tendency is reflected by the 
- relatively - low 3J (H1+-NH) value (Table 3) . 
In the discussion of the conformational analysis of 2 an additional 
observation has to be taken into account, i.e. the occurrence of a minor 
{'cis* , Ε-configuration) and a major ('trans', Z-configuration) component 
at low temperature (233K). Molecules like 1-3, containing a urethane 
moiety can indeed exist as a pair of rotamers of the C-N-C(O) bond. This 
9 7 — 4? 
has been observed earlier with urethanes in general and more partic­
ularly with urethanes derived from amino acids 3 1 - 3 5, amino acid esters33'38'3' 
and peptides33-3' containing the BOC or Cbo group as N-protecting group. 
Often the rotamers were found to be present in unequal amounts ' 3 1 ' 3 ' 3 
as is the case in this study too. The trans rotamers (Z-configuration) is 
expected to be more stable and is therefore present in excess over the 
CÏs-rotamer (E-configuration). 
The equilibrium between the major and minor component of 2 is slow on 
the NMR time scale at 233K, so that the separate rotamers can be observed 
(Figure 4). At 300K a situation near coalescence is observed and at 383K 
in СгОгСІіі the interconversion of rotamers is rapid. Assuming that 300K is 
about the temperature of coalescence a rough estimate for the activation 
energy for rotation around the C-N-bond (ΔΟ*) gives a value of 15 kcal/mole. 
9 7 9 R 
This compares favourably with studies on several urethanes ' °. (The major 
as well as the minor component consist of an equilibrium between a twist-
chair 2a,2b (^ T) and envelope 2b,2d (iE-)conformer (Scheme II). The twist-
chair conformer is present in excess in the minor as well as in the major 
component (mole fraction 0.76 and 0.91, respectively, see Table 7). We 
attribute the stabilization of this conformer JT to a double gauch effect: 
the C-N bond has a gauche position to the endocyclic C-0 and C-S bonds. 
In the Ε-conformer the only stabilization that is remarked at first glance 
is the anomeric effect (Figure 7). 
Finally, a comparison of the conformations of 2, which are present in 
solution (Scheme II) with the solid state conformation (Figure 3) shows 
that the latter differs from the conformers in solution. The solid state 
conformation is almost envelope shaped with the C3-atom as the most 
puckered atom. In contradistinction the conformations in solution are of 
twist-chair shape (2a,2e,2g,2c) or envelope shaped (2b,2f,2h,2d) with the 
S-atom as the puckered atom. Obviously the interroolecular interactions in 
the solid state - especially the intermolecular hydrogen bonding (Figure 1) 
force the molecule into a certain conformation, which does not need to be 
the most stable one in solution. 
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In summary: both diastereomers 1 and 2 behave in a remarkably consistent 
way: in CDCI3 the presence of the exocyclic C-N-bond dominates the con­
formational behaviour by exerting a (double) gauche stabilization which 
leads to a ^ Тз conformation for 1 and to a (predominant) 3 T~ c o nf o r m ation 
for 2. In MeaSO-d6 this gauche effect is counterbalanced by the anomeric 
effect and/or the gauche effect diminished in this more polar solvent. 
This study adds a new example1*0 to the growing row of molecules showing 
that solid state and solution conformers can differ. Work is in progress 
to evaluate the influence of the conformation of functionalized sultines on 
ring-opening reactions1 and reactions of the o-sulfinyl carbanion with 
electrophiles. 
Fig 7 Newman projection along the 02-S1 bond of the conformers of 
compounds 1 and 2 
0 0 
* C-5 
la , lb , 1c Id 2a , 2ç , 2e , 2c| 
Fig 8 Visualization of the anomeric effect 
2b , 2d , 2f , 2_h 
R' H. 
/ 
i 0 
<Ъ = s*' 
EXPERIMENTAL PART 
Synthesis 
Compounds 1, 2 and 3 were synthesized as has been described before2. 
2R-4R-4[(3-phenylpropanoyl)amino]-1,2-oxathiolane 2-osride (4) 
This compound has been prepared from N-(3-phenylpropanoyl)-L-cystine 
methyl ester as described for the preparation of 1 and 2 from the cor­
responding N-protected cystine ester. R^ 0.19 (МеОН/СНгСІг, 5/95, v/v). 
500 MHz ^ -NMR (CDCI3) at 300K: 62.455 (m, 2H, CH^CÍO)), 2.938 (t, 2H, 
C6H5CH2) , 7.158-7.305 (m, 5H, CgHs); 4.309 (H32) , 4.763 (Hsj), 4.913 (Ηι+) , 
3.084 (HSJ), 3.258 (H52) and 5.977 (H N). 
Coupling constants (Hz): Нзі_ц: 4.60, Нзг-і»: 1.69, Н5і_ц: 6.74, H52-4: 2.89, 
H 4-N H: 7.20, Нзі_32: -9.98, H5i_52: -14.06. 
lH-NMR spectroscopy 
^-NMR spectra at 500 MHz were recorded in the Fourier Transform mode 
on a Bruker WM500 spectrometer interfaced with an ASPECT-2000 computer for 
data-accumulation (Э2К datapoints). 
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The spectrometer was field-frequency locked on the deuterium resonance of the 
solvent (CDCI3, СгОгСІ^ог Me2S0-d6), the sancle temperature was regulated 
with a VT-1000 temperature controller. If necessary, a Lorentz Gauss trans­
formation was carried out before a Fourier transformation, yielding Gaussian 
enhanced spectra41' . All relevant spectra were analyzed by standard 
iterative simulation techniques using the LAOCOON-III-like PANIC program1*3 
for the abovementioned ASPECT computer. 
Chemical shift data (relative to tetramethylsilane as internal reference) 
and coupling constants for the investigated compounds are presented in Tableí' 
2-5. Based on the excellent agreement between observed and simulated spectra, 
the accuracy of the values of the chemical shifts and of the coupling 
constants can be considered better than 0.001 ppm and 0.1 Hz, respectively. 
X-ray erystallography 
A crystal of about 0.05x0.05x0.40 mm was used for X-ray measurements. 
The colourless crystals are monoclinic. Unit cell and space group data were 
obtained from diffractometer measurements. Accurate unit cell dimensions 
were determined by a least-squares method from 25 general reflections, 
measured with CuKa radiation (graphite crystal monochromator, λ=1.5418Α). 
Crystal data are listed in Table 8. 
Table 8 CRYSTAL DATA 
Molecular formula CeHisNO^S 
FW 221.275 
Crystal system monoclinic 
Space group P2i 
a 9.604(1)£ 
Ь 11.652(1)Ä 
с 9.949(1)Ä 
β 90.93(1)° 
V 1113.ЗА3 
Z C 4 
D
c
 1.32 gem-3 
F(OOO) 471.9 
v(CuKa) 24.74 cm-1 
The intensities of B098 reflections, the full sphere with sin θ/λ<0.600, 
were measured on a CAD4 diffractometer, using the ω-2θ scan with a scan 
range of 0.80 + 0.14 tan 6°. 
Intensity and orientation control reflections were measured every 30 
min. and used to correct the data for primary beam intensity fluctuations 
and crystal decay (^20%). Synmetry equivalent reflections were averaged 
resulting in 4068 independent reflections, 2341 of which were considered 
'observed', I > 3σ(Ι) counting statistics. Lorentz and polarization 
corrections were applied but no absorption correction. The structure was 
solved by direct methods (MULTAN) using the PDP-8/CSP1*1* programs and 
refined by full-matrix least-squares to an R-value of 0.08. Then, based on 
the anomalous dispersion of S, the absolute configuration was established 
by comparison of the observed and calculated Bijvoet differences4 . 
Refinement was continued; hydrogen atoms could be located in a difference 
Fourier synthesis but were included at calculated positions. Anisotropic 
thermal parameters were used for all non-hydrogen atoms. The quantity 
minimized was Ζ W([FJ-K[FJ ) 2 with 2=(σ2 + 0.0025 F^) - 1; a2 from counting 
statistics. The final R-value is 0.051 for 252 variables and 2341 contri­
buting reflections. A final difference map showed no significant resulting 
density. 
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The atomic scattering factors for S, 0, N and С were those of Cromer and 
Mann1*6 and for those of Stewart et αΛ 7. CSP1*1* and X-RAY1*8 programs were 
used for the calculations. The molecular structure and the atomic numbering 
are shown in Figure 2. The final atomic parameters are giver in Table 9. 
Table 9 FINAL POSITIONAL PARAMETERS ( 10ц for non-hydrogen-, 103 for 
H-atoms) AND THERMAL PARAMETERS 101 
Molecule -1- Molecule -2-
Atom 
SI 
C5 
C4 
C3 
C8 
CIO 
C12 
C13 
C14 
06 
02 
on 
09 
N7 
H51 
H52 
H4 
H32 
H31 
H7 
H121 
H122 
H123 
H131 
H132 
H133 
H141 
H142 
H143 
X 
1192 
2178 
2075 
784 
4131 
6376 
7343 
7045 
5852 
-70 
844 
3888 
5224 
3265 
325 
174 
198 
-16 
76 
348 
824 
681 
772 
630 
793 
742 
528 
671 
514 
У 
7241 
7168 
8334 
8876 
9236 
10176 
10811 
9124 
10968 
6560 
8562 
8955 
9837 
9019 
694 
650 
826 
852 
980 
935 
1114 
1155 
1027 
862 
932 
853 
1171 
ИЗО 
1054 
ζ 
9819 
8323 
7631 
3239 
6760 
6315 
7256 
5768 
5212 
9571 
9624 
5631 
7209 
7792 
852 
764 
654 
773 
807 
872 
676 
775 
811 
519 
518 
659 
562 
464 
451 
% 
8, 
7, 
7, 
10. 
4 
4, 
7, 
8 
7 
10 
9 
5 
5 
6 
.9(1) 
.2(2) 
.1(2) 
.1(4) 
.8(1) 
.9(2) 
.0(2) 
.7(3) 
.8(3) 
.6(3) 
.1(2) 
.9(2) 
.4(2) 
.6(2) 
Atom 
SI' 
CS' 
C9' 
C4 , 
C8' 
CIO' 
C12' 
C13· 
C141 
06' 
02' 
011' 
09' 
N7' 
H51· 
нбг· 
H32' 
НЗІ' 
114' 
H7' 
H121' 
11122' 
H123' 
H131' 
H132' 
H133' 
H141' 
11142' 
H143' 
χ 
888 
1003 
2477 
2244 
4338 
6617 
7551 
6089 
7276 
-334 
2279 
4157 
5412 
3450 
127 
6 
175 
353 
195 
366 
853 
780 
706 
694 
550 
539 
752 
825 
662 
Y 
10558 
9487 
11102 
9864 
8888 
7988 
7366 
7170 
9051 
11221 
11197 
9155 
8313 
9170 
865 
941 
1167 
1138 
980 
890 
715 
792 
660 
678 
646 
759 
962 
885 
952 
ζ 
4705 
3362 
2873 
2500 
1776 
1445 
2404 
343 
920 
4316 
4262 
620 
2275 
2767 
386 
284 
230 
259 
143 
70 
194 
328 
277 
-17 
84 
-35 
180 
46 
25 
% 
8.4(1) 
8.9(3) 
6.9(3) 
6.2(2) 
5.0(2) 
5.0(2) 
7.1(3) 
10.0(3) 
9.5(3) 
12.3(3) 
7.5(2) 
7.7(2) 
6.1(2) 
5.8(2) 
1. The numbering of the non-hydrogen atoms is as indicated in Figure 2. The 
numbering of the hydrogen atoms (not shown in the Figure) is determined 
by the atoms to which they are attached e.g. Ηΐ2ΐ# Hi22 an<3 H123 denote 
three protons attached to atom 12, a C-atom 
2. Η atoms were assigned a fixed y-value of 9.00A. E.s.d.'s are between 
2χ10_1* and Э.хЮ-1* for non H atoms. 
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FLASH VACUUM THERMOLYSIS OF FUNCTIONALIZED y-SULTINES 
Rob M.J. Liskamp, Henk J. Blom, Rutger J.F. Nivard and 
Harry C.J. Ottenheijm 
Department of Organic Chemistry3 University of Nigmegen^ 
Toernooiveld, 6S25 ED NIJMEGEN, The Netherlands. 
Abstract. The flash vacuum thermolysis (FVT) of the 4-(benzamido)-γ-
sultines 5a and 5b is shown to lead to a mixture of the allylamide 6 and 
enamides 7 and 8, the allylamide being the main product. This reaction 
involves a novel migration of the benzamido group, which is proposed to 
proceed as depicted in path £, Scheme IV. 
This proposed mechanism features heterolytic bond fission, accompanied 
by neighbouring group participation. Support for this proposal has been 
found by FVT of 5â-d2 (Scheme IV). 
INTRODUCTION 
During the last decade several aspects of the chemistry of cyclic sulfinate 
esters (sultines) received incidental attention, but all those studies*»2 
concerned sultines containing only phenyl or simple alkyl substituents or 
sultines condensed with aromatic rings. Recently, we reported3 for the first 
time an efficient route to functionalized cyclic sulfinate esters, viz. the 
N-protected β-άΐηΐηο-γ-ευΐtines, and showed that nucleophilic ring-opening 
reactions can be performed by selective cleavage of either the S-O or the 
C-0 bond. 
Durst et a I. have studied the photochemical and thermolytic5 breakdown 
of non-functionalized γ-sultines 1. Photolysis was only observed with 
sultines having a γ-phenyl substituent and gave phenylcyclopropanes 2 
(Scheme I). Thermolysis gave the alkenes 3a and 3b beside 2°. 
Scheme I 
R^CeHs 
so2 
Ri- S02 
The authors assumed that thermolysis of 1 proceeds via an intermediate 
diradical by consecutive cleavage of the C-O and C-S bond5. It seemed worth­
while to investigate whether thermolysis of N-protected B-amino-y-sultines 
leads to functionalized analogs of 2 and 3. 
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RESULTS and DISCUSSION 
The N-protected amino γ-sultines 5a and 5b were prepared from N-benzoyl-L-
cystinol 4 by treatment with N-chîorosuccïnimide and AcOH3 (Scheme II). The 
two diastereomers 5a and 5b were readily separated by silica gel chromato-
graphy. Their thermolytic behaviour was studied by flash vacuum thermolysis 
(FVT) at 0.05 mmHg through a quartz tube heated by a tube furnace. The 
products were collected on a cold finger and analysed by thin layer 
chromatography, ^H-NMR spectroscopy and mass spectroscopy. 
Scheme II 
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Interestingly, the sultines 5a and 5b epimerise at the sulfur atom at 130 C, 
which is the preheating temperature of the samples . As a consequence, 
thermolysis of 5a and 5b gave identical reaction mixtures. At 700 С the 
compounds fragmented as shown in Scheme III. At higher temperatures a 
considerable amount of unidentifiable products was formed whereas at 650 0C 
the starting material was not completely converted. Other variations in 
reaction conditions yielded invariably the allylamide б as the main 
product: when the reaction tube was filled with quartz wool (600 0 C , 0.05 mmHg) 
or quartz chips (625 0C, 0.09 mmHg, N2 flow) compound б was isolated in 
yields of 45% and 50%, respectively. 
In variation with the results of Durst et al5 (Scheme I), we could not 
detect cyclopropane derivatives. 
Scheme III 
5a 0 
II 
5b 
• C 6 H s ^ N ^ s ^ • C e H s ^ N ^ . C H e ^ N ^ " . CeHs^NH, 
6(40·/.) 7(2·/.) 8(7·/.) (25·/.) 
The formation of б via an intermediate biradical .9 and a cyclopropane 
derivative 10 , as proposed by Durst et al. for non-functionalized γ-sultines 
(Scheme I), could be ruled out by the following experiment. 
Thermolysis of benzamidocyclopropane 10 at 700 0C yielded a mixture of 7 
and ; none of the allylamide 6 could be detected. Conclusive evidence which 
allowed us to rule out pathway a for the formation of 6 as well as of 7 and 
θ was obtained by thermolysis of the labelled sultine 5a-d2 (Scheme IvT. 
Thermolysis of 5a-d2 at 700 0C gave the compounds 6-d2, 7-d2 and 8-d2, all 
having the label at the terminal carbon atom. These structures were secured 
by 1H-NMR spectroscopy. Pathway a fails to explain these results, as the 
intermediacy of 10 would inevitably lead to scrambling of the label in 
6-d2, 7-d2 and 8-d2. 
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Apparently, the formation of 6-8 by thermolysis of 5 involves migration of 
the ami de function. Pathways b and с (Scheme IV) might explain this re­
arrangement. Path b features intramolecular nucleophilic attack by the amide 
nitrogen on the C-S bond leading to the aziridine intermediate J_l_; expulsion 
of SO2 gives 6-d2. Alternatively, intramolecular nucleophilic attack on the 
C-0 bond by the amide oxygen (path c) gives the oxazoline intermediate 12. 
Extrusion of SO2 from the latter yields 13, which gives 6-d2 via a Claisen 
type rearrangement9. Compounds 7.-d2 a n^ §7^2 m aY have been formed on their 
turn from .6-d2 by a Η-shift. This could be substantiated as follows: 
thermolysis of .6-d2 at 700 0C gave a mixture of 2.~^2 ànà 8-d2, beside starting 
material. 
At present we have no conclusive evidence permitting a choice between 
pathways b and с However, we are inclined to favour pathway с for two 
reasons. First, in 5 the C-O bond is more polarized than the C-S bond, and 
thus more susceptible to a nucleophilic attack. Second, attack by the amide 
nitrogen on the C-S bond (path b) would lead to a strained transition state, 
in which the nucleophile and the leaving group hardly can take apical 
positions. 
The formation of benzamide (Scheme III) can be explained as depicted in 
Scheme V. This mechanism is analogous to the well-documented10 thermolytic 
fragmentation of amides having a C(0)-N-C-C-H moiety. As this fragmentation 
is in competition with path с and/or path b, the occurence of benzamide 
explains the relatively low yields of compounds 6-Θ. 
Scheme V 
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The mechanisms as depicted in paths b and с (Scheme IV) deserve some further 
comment. First, one might argue that - prior to attack by N or 0 - the 
sultine 5a-d2 rearranges to the sulfone 14 or the sulfoxylate 15. However, 
the formation of 6-d2 excludes the intermediacy of these structures in any 
conceivable mechanism, as they would lead to an allylamide б having a 
scrambled label11. 
СбНб
 н- ч0 
H 15 
Second, the proposed mechanistic pathways b and с (Scheme IV) involve 
heterolytio bond fissions, whereas radical pathways are rather generally 
encountered in pyrolytic reactions15. However, there is limited evidence 
for the occurence of charged intermediates in thermolysis f 1. These 
examples concern polar molecules containing moieties which are able to 
acconmodate charge, as is the case with j> too. Heterolytic bond fission is 
expected to take place primarily at the polar surface of the reaction tube17. 
Loss of deuterium, when observed in pyrolytic reactions, can be expected 
also to occur in a surface process. 
We argued that as a consequence, loss of deuterium in the conversion of 
5a-d2 into 6-d2 might be indicative of the reaction to take place - at least 
partly - at the surface and would thus support the proposed polar mechanism. 
Therefore, we determined by mass spectroscopy the percentage of mono-deuterated 
(dj) and non-deuterated (d ) compounds 5a-d2 and 6-d2 relative to the cor­
responding dideuterated (d2) compounds. For 5a-d2 and 6-d2 the ratios 
d2/di/d0 were found to be 100/26/2 and 100/41/6, respectively. This loss of 
deuterium is significant and suggests that the mechanism for the conversion 
of 5 into 6 is a polar one. 
concLuswm 
The above findings suggest that thermolysis of 5a or 5b involves a novel 
migration of the benzamide group to yield 6-8. The proposed mechanisms 
(Scheme IV) feature neighbouring group participation by the amide nitrogen 
(path b) or amide oxygen (path c) in the heterolytic fission of the C-S or 
C-O bond, respectively. We favor pathway с above pathway b for the afore­
mentioned reasons. Support has been found for the heterolytic nature of the 
bond fission. 
Whereas thermolysis of non-functionalized γ-sultines led to cyclo-
propanes among other products5, we could not detect benzamidocyclopropane 
in the reaction mixture. Experiments to refine the proposed mechanism are 
being sought. 
In addition, we plan to study the FVT of other functionalized sultines 
and sultones. Presently, the influence of the N-protecting group on the 
behaviour of sultines in FVT is under investigation. Also synthetic appli­
cations of this route to allylamides 6 are being studied1 . Finally, the 
synthesis of sparsomycin starting from a sultine3/19 can be optimized now, 
by making use of the finding that sultines 5a and 5b undergo a clean 
epimerization at 120-130 •'c'. 
so 
EXPERIMENTAL PART 
^-NMR spectra were measured on a Varian Associates Model T-60 or a BruJcer 
WH-90 spectrometer with МецЗі as internal standard. IR spectra were measured 
with a Perkin-Elmer spectrophotometer, Model 997. Mass spectra were obtained 
with a double-focusing Varian Associates SMI-B spectrometer and with a 
Finnigan 3100 Gas chromatograph/mass spectrometer. 
Melting points were taken on a Kôfler hot stage (Leitz-Wetzlar) and are 
uncorrected. Thin layer chromatography (TLC) was carried out by using Merck 
precoated silicagel F254 plates (thickness 0.25 mm). Spots were visualized 
with an UV lamp.ninhydrin or CI2-TDM20. For column chromatography Merck silica 
gel H (type 60) was used. The Miniprep LC (Jobin-Yvon) was used for prepa-
rative HPLC. 
Flash Vacuum Thermolysis (FVT) was carried out in standard equipment in 
a horizontal assembly as described in Chapter II of ref. 15. The quartz tube 
(outer diameter 1.75 cm) was heated over a length of 17.5 cm. The products 
were collected on a cold finger cooled with isopropanol/C02. The preheating 
temperature was 130 0C. The reported yields are after HPLC column chroma-
tography . 
N-benzoyl-L-cystinol (4) 
N-benzoyl-L-cystine methylester (10.0 g, 21 mmol) was reduced with 
lithium borohydrate [sodium borohydride (4.75 g, 125 mnol) and lithium 
iodide (21.34 g, 125 mmol)] in 500 ml of DME as described earlier^ for the 
preparation CbO-L-cystinol. The work-up had to be slightly modified, 
however, due to the poor solubility of the reaction products in DME. The 
pH was adjusted to 5 by addition of an aqueous IN HCl solution to the stirred 
and cooled (0 0C) solution. DME was evaporated -in Vacuo, the residue dis-
solved in 500 ml of methanol/water (1/1, ν/ν), and then oxidized with 
iodine as described for CbO-L-cystinol. Subsequently, the methanol was 
evaporated in vacuo, and water and dichloromethane were added. The aqueous 
phase was extracted five times with 400 ml portions of dichloromethane. 
The collected organic layers were dried (Na2SOi») and residual iodine was 
removed by stirring with N322205. The residue was recrystallized from 
methanol/water to give 4: 56% yield; m.p. 194 0C; Rf 0.27 (eluent МеОН/СНгСІг, 
1/9, v/v); NMR (СОзОО)бЗ.ОО (ABX, 2H, СНСНдЗ), 3.63 (d, 2Η, СНгОН), 
4.11-4.52 (m, IH, CHCH2OH), 7.20-7.89 (m, 5H, CeHs); IR (KBr)'3380, 3300, 
1640, 1530 cm1. Anal. Caled for С2^2^2
0
Ч
52'· c · 57.12; H, 5.75; N, 6.56. 
Found: С, 56.75; H, 5.79; Ν, 6.51. 
N-benzoyl-L-dideuterocystinol (4-d2) 
This compound was prepared as has been described for the preparation of 
4. Instead of sodiumborohydride, sodiumborodeuteride was used. The compound 
was obtained in 60% yield and was identical in every aspect with 4, except 
for the CH^OH signal in the NMR spectrum, due to residual protons (ca 18% 
by integration). Anal. Caled, for Сго^НгоМгО^Зг: С, 56.58; Ν, 6.60. Found: 
С, 56.58; Ν, 6.46. 
4-(Benzamido)-l}2-oxothiolane-2-oxide (5α, Sb) 
Compounds 5a and 5b were prepared from N-benzoyl-L-cystinol 4 (3.50 g, 
8.3 mmol) and N-chlorosuccinimide (3.34 g, 25 mmol) in 150 ml of glacial 
acetic acid as has been reported earlier3 for other N-protected aminosultines. 
HPLC (eluent МеОН/СНгСІг, 5/95, v/v) gave 5a (43%) which was homogeneous by 
TLC (МеОН/СНгСІг, 1,9 v/v). Compound 5b thus obtained was still contaminated 
with succinimide; both compounds have nearly identical R^ values on TLC. 
Purification was achieved by repeated extraction of a dichloromethane 
solution of the mixture with 0.1 N NaHCOa solution. After drying (N32300 
and evaporation of the solvent, sultine 5b was obtained in 32% yield. 
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5a: Rf 0.77 (eluent МеОН/СНгСІг, 1/9, v/v); NMR (CDCla) 63.06 and 3.32 
(AB~part of ABX spectrum, J A X =1.2 Hz, J B X = 6.3 Hz, J^ = 13.2 Hz, 2H, 
CHaS), 4.67 and 4.84 (AB part of ABX spectrum, J A X = 1.7 Hz, J B X = 5.4 Hz, 
JAB = 9 · 9 ^ 2' 2 H' CH20)» 5.22-5.60 (m, IH, CHCHçO), 7.17-8.11 (m, 6H, CeHs 
and NH) ; IR (Юг) 3280, 1640, 1535 and 1060 cm-1 ; mass spectrum: m/e 225 (Μ*) , 
161 (-SO2) ; Anal. Caled, for СюНцЮзЗ: С, 53.32; H, 4.92; Ν, 6.22. Found: 
С, 53.12; Η, 4.86; Ν, 6.19. 
5b: Rf 0.40 (eluent МеОН/СНгСІг, 1/9, v/v); NMR (CDCI3), 63.24 and 3.60 
(AB part of ABX spectrum, J A X = 3 Hz, Jgx = 6.6 Hz, J A B = 14 Hz, 2H, СНгЗ), 
4.60 and 4.89 (AB part of ABX spectrum, J ^ = 1.5 Hz, Jgx = 4.6 Hz, іТдд = 
10 Hz, 2H, CH2O), 5.00-5.29 (m, ІН, CHCH2O), 6.87 (d, ІН, NH), 7.16-7.84 
(m, 5H, C6H5); IR (KBr) 3300, 1650, 1530 and 1030 cm
-1
; mass spectrum: 225 
(M+) , 161 (-SO2); Anal. Caled, for С Ю Н І 1NO3S: С, 53.32; Η. 4.92; Ν, 6.22. 
Found: С, 53.26; Η, 4.90; Ν, 6.22. 
4-(Benzamtdo)-5yS-dideutero-l32-охо±Ыо1<те 2-oxide (δα-άζ, Sb-dz) 
The synthesis of 5a-d2 and 5b-d2 from 4-d2 vas carried out as described 
above for 5a and 5b, yielding the compounds in 43% and 29%, respectively. 
5a-d2: Rf 0.77-7eluent МеОН/СНгСІг, 1/9, v/v); NMR (CDCI3), 63.06 and 3.32 
(AB part of ABX spectrum, J A X =1.2 Hz, J B X = 6.3 Hz, J^ = 13.2 Hz, 2H, 
CH2S) , 4.55-5.02 (residual protons CH2O; 15% by integration), 5.44 (d of t, 
IH, CHCH2O), 7.17-8.11 (m, 6H, C6H5 and NH); mass spectrum: m/e 227 (M+), 
163 (-SO2) ; Anal. Caled, for СюВгНдЖЗзЗ: С, 52.85; Ν, 6.16. Found: С, 52.67 
Ν, 6.08. 
5b-d2: Rf 0.40 (eluent МеОН/СНгСІг, 1/9, v/v); NMR (CDCI3), 63.24 and 
3.60 (AB part of ABX spectrum, J A X = 3 Hz, J B X » 6.6 Hz, JÄB = 14 Hz, 2H, 
CH2S). 4.59 and 4.89 (residual protons CH2O; 15% by integration), 5.14 (d 
of t, IH, CHCH2O), 6.82 (d, IH, NH), 7.16-7.84 (m, 5H, C6H5); mass spectrum 
m/e 227 (M+), 163 (-SO2). Anal. Caled, for C10D2H9NO3S: C, 52.85; N, 6.16. 
Found: C, 53.03; N, 6.28. 
3-Benzamido-propene-l (6)3 Z-benzamido-Z--pTopene-2 (7)t 3-benzamido-E-
propene-2 (8) 
The FVT of 5a or 5b (0.5 g, 2.2 mmol) was carried out as described above. 
The products were separated by HPLC (eluent CH2CI2) to give 6, 7 and 8 in 
yields of 40-50%, 2% and 7%, respectively. 
6: Rf 0.66 (МеОН/СНгСІг, 1/9, v/v); NMR (CDCI3), 64.08 (Y2 part of ABXY2-
spectrum J A Y = J ™ = 1.6 Hz, J X Y = Jy_NH = 5.6 Hz, 2H, NHCH^), 5.17 and 
5.24 (AB part of ABXY2 spectrum, J A B = 3.2 Hz, J A X = 17.2 Hz, Jßx = 10 Hz, 
2H, С = СНг), 5.95 (X-part of ABXY2, spectrum IH, CH2CH), 6.16-6.76 (br, 
IH, NH), 7.07-7.93 (m, 5H, C6H5); IR (CHCI3) 3460, 3360, 1660, 1520, 995 
and 930 cm-1; mass spectrum: m/e 161 (M+). 
7: Rf 0.81 (МеОН/СНгСІг, 1/9, v/v); NMR (СОСІз),δ 1.70 (Хз part of ABX3 
spectrum, d of d; J B X = 6.9 Hz, J A X = 1.7 Hz, 3H, CHCH3); 4.95 (B part of 
ABX3 spectrum, JA3 = 8.4 Hz, IH, CHCH3), 6.93 (A part of ABX3 spectrum, 
JA = 1.8 Hz, J A _ N H = 10.0 Hz, ІН, NHCH), 7.30-7.96 (m, 6H, CgHs, NH); mass 
spectrum: m/e 161 (M+). 
8: Rf 0.73 (МеОН/СН2СІ2, 1/9, v/v); NMR (CDCI3), 61.74 (X3 part of ABX3 
spectrum, d of d, JBx = 6.8 Hz, J A X = 1.6 Hz, 3H, CHCH3), 5.31 (B part of 
ABX3 spectrum, J A B = 13.8 Hz, IH, CHCH3), 6.97 (A part of ABX3 spectrum, 
JA-NH = 1 0 · 0 H z' l H' NHCH), 7.30-8.00 (m, 6H, C6H5, NH); mass spectrum: 
m/e 161 (M+). 
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APPROACHES TO THE MARASMIN FRAGMENT OF y-GLUTAMYLMARASMIN 
INTRODUCTION 
More than 70 γ-glutamyl derivatives of amino acids and amines have been 
isolated from plants, including mushrooms (Basidomycetes), during the last 
twenty years . Among these are γ-glutamyl derivatives of sulfur containing 
protein amino acids and γ-glutamyl derivatives of sulfur or selenium con­
taining non-protein amino acids. Six γ-glutamyl derivatives of sulfur and 
two γ-glutamyl derivatives of selenium containing non-protein amino acids 
have been identified so far. 
•
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J_ -glutamyl marasmm 
γ-Glutamylroarasmin^, an Ν-γ-glutamyl-S-substituted cysteine derivative, has 
attracted our interest, because it possesses a mono-oxodithioacetal moiety. 
To our knowledge, 1 and sparsomycin are the only natural products containing 
this moiety. 
γ-Glutamylmarasmin was isolated2 from the Basidomycetes mushrooms, 
Mavasminus alliaceus, M. scorodoniusi and M. prasiosmus, which are known 
for their garlic like odour. Its structure was established2,3 by chemical 
and enzymic degradation studies as well as by spectroscopic methods. 
γ-Glutamylmarasinin is readily soluble in water, giving a slightly 
acidic solution. In solution the compound gradually decomposes what causes 
the typical odour of the parent mushrooms. This odour is ascribed to products 
derived from the sulfenic acid МеБСНгЗОН, which is formed by an acid catalyzed 
ß-elimination reaction4 of 1 (Scheme I, path a), with concomitant formation 
of γ-glutamyl-dehydroalanin 2. In the mushroom a similar degradation takes 
place by the fungal C-S lyase2'^. This reaction takes place at higher pH(8.5) 
and only after cleavage of the γ-glutamyl residue (Scheme II) by γ-glutamyl-
transpeptidase (E.G. 2.3.2.2.), resulting in the formation of marasmin 3. 
In the latter reaction the γ-glutamyl residue is transferred to an acceptor 
e.g. another amino acid6. The C-S lyase induced β-elimination is character-
istic for many S-substituted derivatives11 of γ-glutainyl-cysteine compounds 
and the corresponding sulfoxides. Noteworthy examples are (epi)lentinic 
acid7»" 4,5; γ^1^3πιγ1-5-(ρΓθρ-1-θηγ1) -cysteine-R-sulfoxide9 § and γ-
glutamyl-S-(prop-1-enyl)-cysteine-S-sulfoxide10 7. Via consecutive trans-
peptidation and lyase mediated11 ^-elimination, these compounds also give 
rise to the formation of pyruvic acid, ammonia and a variety of sulfur 
compounds (Scheme III 1 2) . 
Beside the aforementioned acid-catalyzed B-elimination of γ-glutamyl-
marasmin, the compound might undergo an acid-catalyzed decomposition of the 
mono-oxodithioacetal moiety, as depicted in Scheme I, path b. In this 
reaction pathway the sulfoxide is protonated too, but now the protonation 
is followed by cleavage of the other C-S(O) bond. Subsequently the inter­
mediate sulfenate ester is formed, which looses formaldehyde, leaving the 
mixed disulfide 8. This decomposition of the mono-oxodithioacetal moiety13 
- which is of value for the preparation of mixed disulfides1 ' ^ - requires 
the presence of a strong acid. 
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Scheme I acid catalyzed ^-elimination and decomposition of the mono-
oxodithioacetal moiety of 1 
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Scheme III C-S lyase induced ^-elimination of S-substituted-sulfoxide-y-
glutamyI-cysteine derivatives 
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Consequently, the use of strong acids has to be avoided in synthetic 
routes leading to γ-glutamylmarasmin . 
The motive to start an investigation into a total synthesis of γ-
glutamylmarasmin emanated from our experiences, gained in the synthetic 
studies on sparsomycin (Chapter II-IV). We were interested to investigate 
whether the synthetic methodologies developed for the introduction of the 
mono-oxodithioacetal moiety of sparsomycin could be applied to the prepa­
ration of 1. In further studies the construction might be considered of a 
sparsomycin analog, in which the cysteinol mono-oxodithioacetal fragment 
of sparsomycin is replaced by S
c
-marasmin 3. Furthermore, we could expect 
that successful completion of synthetic route of 1, would lead to the 
elucidation of the absolute configuration of the sulfoxide-sulfur atom of 
marasmin. 
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STRATEGY AND SYNTHETIC APPROACHES 
As will be clear from the enzymatic degradation pattern (Scheme II) of 
γ-glutainylinarasniin, this compound can be considered as a dipeptide derived 
from L-glutamic acid and the cysteine-mono-oxodithioacetal fragment, 
marasmin^. We planned the coupling procedure toward the end of the total 
synthesis. Standard methods are available for the preparation of γ-glutamyl 
derivatives1»16. The most suitable method for the preparation of Y-glutamyl-
marasmin seems to be coupling of marasmin with N-phtaloyl-L-glutamic anhydride, 
which is known to react predominantly at the γ-carbonyl function. The N-
protecting group can be removed by hydrazinolysis. 
More challenging is the synthesis of the marasmin fragment. Several 
approaches can be envisaged for its preparation (3, Scheme IV). The four 
approaches depicted in Scheme IV are discussed here in succession. 
Scheme IV 
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ROUTE A 
As was described earlier (Chapter III17) oxidation of the dithioacetal 
(Chapter III, compounds 23-26) failed to yield predominantly the regio 
isomer, occuring in sparsomycin. A conceivable route to obtain the desired 
regio isomer from the dithioacetal 9 is depicted in Scheme V. This syn­
thetic route proceeds via the intermediate 10, in which the ß-sulfur atom 
is protected intramolecularly by the amine nitrogen as a sulfilimine18 
moiety. As the ß-sulfur atom is protected, it will no longer be susceptible 
to oxidation and therefore the α-sulfur atom might be oxidized. Subsequently 
the ß-sulfur atom can be deprotected with hydrogen sulfide or a thiol 
(vide •infra) to give marasmin. 
The proposed synthesis of the six-membered ring sulfilimine 10 is based 
on the well documented19 synthesis of the corresponding five-membered 
ring sulfilimines 13 (Scheme VI). These compounds have been prepared from 
methionine or other S-substituted homo cysteine derivatives 12 (Ri=Me,Etf 
CgHsjCeHsCHa; R2=COOH) in an oxidation reaction with iodine at neutral 
to slightly alkaline pH. Especially the preparation and chemistry of de-
hydromethionine 13 (R^Me, R2=COOH) have found attention19'20. Treatment 
of 13 with hydrogen sulfide200, a thiol19'21 or KI in the presence of acid 
yields the starting material, whereas treatment with aqueous base or acid 
gives the corresponding sulfoxides 1419. 
Scheme V elaboration of route A 
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Compound 10 was obtained from 9 - which was prepared as described earlier 
(Chapter III17) - by treatment with one equivalent of iodine. During the 
reaction an aqeous solution of sodium hydroxide was added, to maintain a 
pH of 7 - 8.5. Addition of a second equivalent of iodine did not result 
in the formation of the sulfoxide 11. The use of other oxidizing agents 
(sodium metaperiodate, hydrogen peroxide) failed also to yield 11. These 
failures were partly attributed to the poor solubility of 10. In order to 
obtain a sulfilimine derivative with an increased solubility, we decided 
to prepare the t-butyl ester of 9, i.e. 15. However, so far we have not 
been able to develop a satisfactory synthesis of 15 (Scheme VII). 
Treatment of 9 with isobutylene/sulfuric acid22 or t-butyl acetate/ 
perchloric acid2^gave compound 16 beside the desired t-butyl ester 15, 
both isolated as hydrochloric acid salts. Attempts to separate the free 
amino esters of 15 and 16 were unsuccessful. 
Another approach to 15 is outlined in the second entry of Scheme VII: 
the t-butyl ester i.e. 18 was prepared from the commercially available 17 
with isobutylene/sulfuric acid, according to the procedure of Anderson25. 
Subsequently, we studied the simulteneous removal of the N- as well as 
the S-protecting group by treatment with sodium in liquid ammonia2 . It was 
expected that subsequent addition of chloromethyl methyl sulfide would 
yield 15. 
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Scheme VII a: ratio 1 
b: ratio 2 
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Unfortimately deprotection gave rise to a mixture of products, among which 
ß-elimination products were present. In a final attempt to prepare 15, we 
tried to reduce the t-butyl ester of cystine - prepared according to the 
aforecited methods22»" _ with sodium borohydride in methanol or ethanol, 
followed by treatment of the formed thiolate with chloromethyl methyl 
sulfide. However, beside some ß-elimination product, the starting compound 
was recovered. 
In view of these poor results, this - albeit at first glance elegant -
route for the preparation of marasmin was abandoned temporarily. 
ROUTE В 
We had recourse to a route, which we had developed earlier (Chapter III17) 
for the synthesis of the cysteinol mono-oxodithioacetal moiety of sparso-
mycin. An adaptation of this route to the synthesis of γ-glutamylmarasmin 
is represented in Scheme VIII. It is obvious that for the synthesis of 22 
according to this scheme, the amino group as well as the carboxylic func­
tion26 of 19 have to be protected; the required protecting groups are 
denoted as Pj and P2, respectively. These protecting groups have to be 
removed selectively and in succession, as appears from Scheme VIII. 
Furthermore, to avoid base induced racemization and ß-elimination, the 
protecting groups have to be acid-labile or removable under neutral condi-
tions, without affecting the mono-oxodithioacetal moiety. Finally, as a 
matter of course the protecting groups must be stable to the conditions 
used for the introduction of the mono-oxodithioacetal moiety. 
Therefore the t-butyloxycarbonyl (BOC) group and the 2-trimethylsilyl-
ethyl (Tmse) group were chosen for Pj and P2 respectively (Scheme LX). 
The BOC-group can be removed by treatment with HCl in trifluoroethanol 
without affecting the Tmse group; the Tmse group is removed by treatment 
with fluoride ions, also in the presence of the BOC-group2". 
The cystine derivative 19a (Scheme IX) was prepared from cystine by 
subsequent introduction of the BOC-group with di-tert-butyl-pyrocarbonate2^ 
and the Tmse group in a DCC coupling procedure of N-BOC-cystine28a with 
2-trimethylsilylethanol. Treatment of 19a with chlorine and acetic an-
hydride, followed by reaction with diazomethane afforded 21a in 48% yield. 
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Reaction of 21a with sodimn methylmercaptide in ethanol to substitute the 
chlorine atom, resulted in the formation of 24 instead of the desired 22a. 
24 is the product of a ß-elimination and a transesterification reaction. 
Reaction of 21a with sodium methylmercaptide in DMF instead of ethanol also 
led to ß-elimination. This apparent inclination to ß-elimination must be 
ascribed to the presence of an ester function; the С(a) proton is acidic, 
which in combination with the leaving group character of the S(0)CH2C1 
moiety facilitates the observed ß-elimination. To circumvent ß-elimination 
we decided to remove the ester function prior to the reaction with sodium 
methylmercaptide, because the α-proton in the carboxylic acid is less acidic. 
By treatment with a large excess of tetra-n-butylamraonium fluoride the 
Tinse group was slowly removed. However, during the working-up procedure 
the BOC-group was largely removed from 25. So far we have no satisfactory 
explanation for this observation. Treatment of the crude reaction mixture, 
that resulted from the desylilation procedure with excess sodium methyl­
mercaptide failed to yield the mono-oxodithioacetal. 
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In view of the apparent lability of the BOC-group in 25, during or after 
the procedure for removal of the Tmse group and the ß-elimination caused 
by sodium methylmercaptide, it seemed sensible to reconsider the sequence 
of reactions. In Scheme X an altered sequence is depicted that takes these 
problems into account. The sequence of reactions 21ά—*·2£—~21—*·2ίί has 
been realized so far. First, the BOC-group of 21a was removed to yield 26. 
Subsequently the more stable Z-group was introduced to give 27, whereafter 
the carboxylic acid is deprotected to give 28. This compound is a suitable 
model compound to study the substitution of the chlorine atom by the methyl-
thiolate anion. If this substitution reaction succeeds, the route will be 
repeated using N-phthaloyl-L-glutaraic anhydride instead of N-o3cy-(benzyloxy) 
carbonyl-phthalimide. This route features introduction of the y-glutamyl 
fragment prior to completion of the marasmin fragment. 
The substitution reaction of the chlorine atom in 28 is under present 
investigation. 
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ROUTES С AND Ό 
Two other possible routes are depicted in Scheme IV. Both routes have in 
common the use of the anion of dimethylsulfide. This anion has been used 
earlier (Chapter IV3") in a ring-opening reaction of a functionalized 
sultine, in order to complete the cysteinol mono-oxodithioacetal fragment 
of sparsomycin. In the routes С and D the anion might also be used for the 
synthesis of the mono-oxodithioacetal moiety. Route С (Scheme IV) features 
the employment of a sulfinate ester, whereas the synthetic intermediate 
in route D is an carboxylic-sulfinic anhydride. For the preparation of the 
sulfinate ester 29 from 19a, wet chlorine, instead of dry chlorine in the 
preparation of 21, was used. The resulting sulfinic acid 30 was esterified 
with diazomethane to the sulfinate ester 31 (Scheme XI). Attempts to complete 
the mono-oxodithioacetal moiety in the aforecited30 way with the anion of 
dimethyl sulfide resulted in the formation of a ß-elimination product. 
Removal of the Trase group from 29 in order to obtain a better substrate viz. 
a compound with a less acidic α-proton, gave rise to similar problems as 
encountered in the removal of the Tmse group from 21a (vide supra) . 
Scheme XI 
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In the proposed route D the preparation of the substrate 33 for the ring-
opening reaction with the anion of dimethyl sulfide turned out to be the 
bottle-neck. Attempts to synthesize the carboxylic-sulfinic anhydride 33 
from Z- or BOC-cystine 32, either with chlorine26»27 or with N-chloro-
succinimide under varying conditions failed. 
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In summary, experiences gained in the synthesis of the cysteinol mono-oxo­
dithioacetal fragment of sparsomycin cannot be simply used for the prepa­
ration of marasmin. Although we have not yet completed the synthesis of 
marasmin, we expect that at least one of the approaches discussed in this 
chapter will lead to a total synthesis in due time. Route A seems the most 
promising one, as for completion of the synthesis of marasmin by this route 
only the last step, namely the substitution of the chlorine atom, has to 
be successful. 
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EXPERIMENTAL PART 
The used equipment and materials have been described in Chapter III. Thin 
layer chromatography was carried out on Merck, precoated silica gel F254 
plates (thickness 0.25 mm), unless stated otherwise. 
Compound W 
Compound 10 was prepared analogous to the procedure, vised for the preparation 
of 13, by Lambeth and Swank19. 
A solution of iodine (1.27 g, 5 mmol) in methanol was added in aliquots to a 
suspension of 5-(methylthio)methyl -L-cysteine 917, in 20 mL of methanol/water 
(1/1 v/v). The pH was kept between 7.0 and 8.5 by the dropwise addition of 4N 
NaOH. After completion of the reaction (3-4 h), the methanol weis evaporated 
and the remaining solution placed on an ion-retardation resin column (50-
100 mesh, Biorad), to remove the sodium iodide. The column was eluted with 
water and the fractions containing 10 were combined and evaporated to dryness. 
Residual water was removed by dissolving the compound in dry ethanol, fol-
lowed by evaporation of the solvent. After repeating this procedure the 
compound was dried in vacuo over P2O5. 
The compound was obtained as a mixture of diastereomers in 90% yield. TLC: 
Rf 0.27 and 0.31 (Merck cellulose plates, thickness 0.1 mm; eluent acetoni-
tri le-ethy lene glycol-0.1 M ammonium acetate, 70/15/15, v/v); R£ 0.11 
(eluent п-ВиОН-НОАс-НгО, 4/1/1 v/v). The spots were visualized by spraying 
with a 10% solution of potassium iodide in 0.5 N HCl. 
Compound 10 did not give a colour reaction with ninhydrin. NMR(D20) δ 2.4-3.1 
(m, 2H, CHCH^S), 3.1-3.5 (m, IH, CHCH2S), 3.3 (two s, 3H, SCH3), 3.65-4.25 
(m, 2H, SCH2S). Compound 10 could be converted again to 9 by passing hydrogen-
sulfide through a solution of 10 in methanol for 15 min. The resulting 
precipitate was filtrated and washed with ether. 
Compounds 15 and 16 
The t-butyl esters 15 and 16 were prepared according to procedures described 
earlier22/23 for the preparation of the t-butyl esters from free amino acids. 
Relative yields of 15 and 16 are based on the ratio of integration of the 
O-t-Bu (δ 1.7) and the S-t-Bu (δ 1.5) signals. 
N-^benzyloxy)carbonytJ-S-benzyl-L-cysteine-tert-butyl ester(18). Compound 
18 was obtained according to the procedure described earlier2 in 95% yield. 
Rf 0.90 (eluent ethylacetate/hexane, 1/1 v/v); NMRÍCDCla) δ 1.45 (s, 9H, 
t-Bu), 2.8 (d. 2H, СНСНг), 3.7 (s, 2Н, C6H5CH2S), 4.15-4.7 (m, IH, CHCH2S), 
5.1 (s, 2Η, С6Н5СН20), 5.5 (br. d, IH, NH), 7.2 (s, 5H, C6H5CH2O), 7.25 
(s, ЪК, C6H5S). 
Ν-Иtert-butyloxy)aarbony Ij -L- ays tine(2- trime thyIsilyl)ethyl es ter(19a) 
Compound 19a was prepared from cystine by subsequent introduction of the 
BOC-group and Tmse-group: N-BOC-cystine was prepared from cystine (9.61 g, 
40 mmol) according to the procedure described earlier29 with di-tert-butyl-
pyrocarbonate. However, the reaction period was adapted in order to increase 
the yield. The yield is 70% after a reaction period of four days. The Tmse 
protecting group was introduced analogous to the procedure of Sieber 
a solution of N-BOC-cystine (8.79 g, 20 mmol) in 40 mL acetonitrile and 40 mL 
DMF, was added 6.4 mL pyridine followed by the addition of 6.8 mL of 2-
trimethylsilylethanol. Subsequently the mixture was cooled (0 0C) and after 
10 min. 9 g of DCC was added. The reaction and work-up procedure were car­
ried out as described283. The crude product was chromatographed over silica 
gel 60 H (eluent ethylacetate/hexane, 1/4 v/v) and obtained in 67% yield. 
Rf 0.57 (eluent ethylacetate/hexane, 1/3 v/v); NMRÍCDCla) δ 0.04 (s, 9H, 
ЗІМез), 0.82-1.16 (m of t, 2H, СНгЗіМез), 1.43 (s, 9H, t-Bu), 3.16 (d, 2H, 
CHCH2S), 4.04-4.38 (mof t, 2H, ОСНдСНгЗі), 4.38-4.70 (m, IH, CHCH2S), 5.37 
(br. d, IH, NH) . 
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N-[(tert-butyloxy)carboni/ÎJ -S-oxo-S(chloromethyl)-L-cysteine( 2- trì-
methylsilyl)ethyl es ter(21a) 
Compound 21a was prepared from 19a (4.48 g, 7 mmol) according to the procedure 
described earlier (Chapter I I I ' 7 ! for the preparation of Ν-, O-protected 
cysteine a-chlorosulfoxides. The product was purified Ъу HPLC (sil ica gel 
60 H, eluent ethylacetate/hexane, 2/3 v/v) and obtained as a colourless semi­
solid oi l in 48% yield. ЫМК(СОСІз) δ ΟΌ4 (s, 9H, ЗіМез) , 0.84-1.18 (m of t , 
2Н, СН23л.Мез), 1.44 (s, 9H, t-Bu), 3.29 and 3.57 (AB part of ABX spectrum, 
J A X = 5.1 Hz, JBx = 6.3 Hz, J A B = 13.2 Hz, 2H, CHCH2S(0)), 4.07-4.42 (m of t , 
2H, OCH2CH2SÌ), 4.42-4.73 (m, 3H, CHCH2S(0) and S(0)CH2C1), 4.59 (part of 
AB spectrum of S(0)CH2C1), 5.56 (far. d, IH, NH). 
Ethyl-N-[(tert-butyloxy)carbonyl] -2-aminoaarylate(24) 
Treatment of compound 21a (386 mg, 1 mmol) with sodium methylmercaptide, 
analogous to the procedure described earlier for substitution of cysteinol 
a-halosulfoxides (Chapter I I I 1 7 ) , afforded 24 in quantitative yield. Rf 0.92 
(eluent ethylacetate/hexane, 1/1 v/v); ЫМН(сБсіз) δ 1.3 (t, Зн, СН2СН3), 1-45 
(s, 9H, t-Bu), 4.25 (q, 2H, CH2CH3), 5.65 (d, IH, C=CH), 6.05 (s, IH, C=CH), 
7.0 (br, IH, NH). 
S-oxo-S-(chloromethyl)-L-cysteine(2- trt-methylsilyl)ethyl ester hydro­
chloride (26) 
The BOC-group was removed from 21a (256 mg, 0.66 mmol) with HCl in trif luoro 
ethanol analogous to the procedure of Sieber ° a. The product thus obtained 
was used without purification for the next experiment. Rf 0.66 (eluent 
acetonitrile/H20, 9/1 v/v); NMR(CDCl3), δ 0.05 (s, 9H, ЗіМез), 0.8-1.35 (br, 
2Н, СЕ^ЗіМез), 3.05-4.05 (br, 2Н, СНСНгЗ(О)), 4.05-4.65 (br, 2Н, OCH2CH2SÌ), 
4.65-5.15 (br, ЗН, SÍOCHoCl and CHCH2S (О) ) . 
Ν- [(benzy loxy ) carbony у -S-oxo-S- (ah lorome thy I) -L-cys teine (2-trime thy Isi ly I) 
ethyl ester(27) 
Starting from 26, we introduced the (benzyloxy)carbonyl group using i t s N-
hydroxyphthalimide derivative^ 1 . Compound 27 was obtained after HPLC puri­
fication (eluent, ethylacetate/hexane, 2/3 v/v) in 60% yield. Rf 0.37 
(eluent ethylacetate/hexane, 1/1 v/v); NMR(CDCl3) δ 0.04 (s, 9H, ЗіМез), 
0.74-1.15 (m of t , 2H, СНСНгЗі), 3.29 and 3.51 (AB part of ABX spectrum, 
JAX = S · 1 H z ' JBX = 6 · 3 H z ' JAB = 1 3 · 2 H z / 2Hf CHCH2S(0)), 4.04-4.36 (m of t , 
2H, OCH2CH2SÌ),4.36-4.49 (m, 2H, S(0)CH2C1), 4.49-4.88 (m, IH, CHCH2S(0)), 
5.07 (s, 2H, C6H5CH2), 5.83 (br. d, IH, NH), 7.28 (s, 5H, C6H5)-
N-[ (tert-butyloxy) carbony ÎJ -S-oxo-S-methoxy-L-cysteine( 2- trimethylsilyl) 
ethyl ester(Zl) 
The aforecited procedure, used for the preparation of 21a was adapted in 
order to prepare the sulfinate ester 31. Wet chlorine instead of dry chlorine 
was used. The sulfinate ester 31 was obtained after treatment of 2.Q. with 
diazomethane and subsequent chromatography (eluent, ethylacetate/hexane, 1/3 
v/v) in 56% yield. Rf 0.77 (eluent, ethylacetate/hexane, 1/1 v/v), NMRÍCDCls) 
δ 0.05 (s, 9Н, ЗіМез), 0.7 -0.8 (m of t , 2H, CH2CH2SÌ), 1.4 (s, 9Н, t-Bu), 
2.95-3.35 (m, 2H, CHCH^SÍO)), 3.75 (s, ЗН, 5(0)ОСНз), 3.8 (s, ЗН, С(О)ОСНз) 
4.0 -4.4 (mof t, 2H, OCH^C^Si) , 4.40-4.85 (m, IH, CHCH2S(0)), 5.4 (br. d, 
ІН, NH). 
N- [(benzyloxy )carbonyц-S-oxo-S-(chloromethyl)-L-cysteine(28) 
A solution of 28 (63 mg, 0.15 mmol) in 2 mL of trifluoroacetic acid was 
stirred for 2 h at room temperature. After removal of trifluoroacetic acid 
in Vacuo compound 28 was obtained. Rf 0.27 (eluent, toluene/ethylformiate/ 
formic acid, 10/7/3~v/v) ; NMR(CDCl3) δ 3.35-3.85 (m, 2H, СНСНгЗШ)), 4.4-
5.1 (m, 5Н, CHCH2S(0), S(0)CH2C1), 5.2
x
(s, 2H, C6H5CH2), 7.4 (s, 5H, C6H5). 
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SAMENVATTING 
Syntheses en biologische activiteit van sparsomycine en analoga. De chemie 
vein chirale gefunctionaliseerde sulfoxides en sultines afgeleid van cysteine. 
In hoofdstuk I werd een kort overzicht gegeven van het tot nu toe bekende 
over de biologische activiteit van sparsomycine. Tevens werden de motieven 
uiteengezet die geleid hebben tot onderzoek aan sparsomycine en analoge 
verbindingen. Deze algemene inleiding werd gevolgd door een inleiding op de 
hoofdstukken. 
In hoofdstuk II werd de absolute configuratie van het sulfoxide-zwavel 
atoom beschreven. Immers de structuur van sparsomycine werd in 1970 door 
Wiley en MacKellar opgehelderd met uitzondering van de absolute configuratie 
van het sulfoxide-zwavel atoom. Deze kon door ons opgehelderd worden met 
behulp van CD spectroscopie aan de intermediairen die gebruikt werden in de 
synthese van het enantiomeer van sparsomycine (verb. 1 pg 9 ): door uit-
breiding van de Mislow-Snatzke regel kon uit het teken van het Cotton effect 
in de verschillende CD spectra de absolute configuratie van het sulfoxide 
vastgesteld worden. Dit sulfoxide bleek in sparsomycine de R configuratie 
te bezitten. Hetgeen bevestigd werd door een röntgenstructuuranalyse van een 
(verb. 5 pg 9 ) van de bij de synthese van het enantiomeer van sparsomycine 
gebruikte intermediairen. 
In hoofdstuk III werd de eerste totaal synthese van sparsomycine en de 
drie stereomeren beschreven. Men kan sparsomycine beschouwen als een amide 
dat gevormd wordt door koppeling van het 0-6(methyl-uracilyl)acrylzuur 
(verb. 2 pg13 ) en het cysteinol mono-oxodithioacetaal (verb. 3 pg 13). 
Beide synthons werden gesynthetiseerd. 
Uitgangsstof voor het 6-methyl-uracil acrylzuur was het e-methyl-uracil 
(verb. 4 pg 1 3). Hieruit werd het 5-formyl uracil (verb. 19 pg 14 ) bereid, 
dat na koppeling met het ylide van de a-broomazijnzure ethyl ester (verb. 
20 pg 1 4) de uracil acrylzure ethyl ester (Schema III pg14 ) leverde. 
Door verzeping van de ester (verb. 18 pg14) werd vervolgens het uracil 
acrylzuur verkregen. 
De synthese van het cysteine derivaat werd als een bijzondere uitdaging 
gezien vanwege de aanwezigheid van een mono-oxodithioacetaal functie. De 
voor de hand liggende mogelijkheid (n.l. oxidatie van het dithioacetaal 
(route A, Schema II pg 13 verb. 23-26 pg 14)) leidde tot de vorming van het 
niet gewenste regio isoraeer (verb. 27-30, Tabel I pg14). Het bleek echter 
wel mogelijk door reactie van een o-halogeen sulfoxide (route B, Schema 
II pg 1 3 verb. 36-41 pg 15, 53, 54 pg16 ) de mono-oxodithioacetaal functie 
te synthetiseren. De a-halogeen sulfoxides werden bereid met als uitgangs-
stof een cysteine derivaat waarvan zowel de ami no groep als de carboxyl 
groep beschermd was. Uitgaande van een beschermd D-cysteine derivaat kon 
het cysteinol mono-oxodithioacetaal fragment van sparsomycine (verb. 3 pg13) 
naast het diastereoisomere cysteinol mono-oxodithioacetaal fragment (verb. 
60 pg 17) verkregen worden, in een opbrengst van 40% (over 5 stappen, 
Schema VII pg 1 7 ) . Hieruit konden door koppeling met het uracil acrylzuur 
via de gemengd anhydride methode sparsomycine en het Sc Ss diastereoisomeer 
(verb. 67 pg 17) bereid worden. Uitgaande van een beschermd L-cysteine 
derivaat werden op analoge wijze beie andere stereoisomeren van sparsomy-
cine verkregen (verb. 65 en 66 pg 17). 
In de CD spectra (Fig. 1 pg 18) van sparsomycine en de stereoisomeren 
kon het Cotton effect, gerelateerd aan het chirale koolstof atoom, en 
het Cotton effect van het sulfoxide afzonderlijk waargenomen worden. 
Bij de in hoofdstuk IV beschreven tweede benadering (route C, Schema II 
pg 24) van de synthese van het cysteinol mono-oxodithioacetaal gedeelte 
van sparsomycine en de stereoisomeren, werd gebruik gemaakt van het sultlne 
als synthon. Daartoe werd eerst voor de benodigde sultines een synthese 
ontwikkeld. 
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Het bleek mogelijk deze verbindingen te bereiden uit een N-beschermd Cysti­
nol derivaat (verb. 11 en 20 pg 25) met N-chloor succiniraide en azijnzuur 
(Schema III en IV pg 2 5). Vervolgens leidde nucleofiele ring opening van de 
sultines door het anion van de dimethyl sulfide tot de vorming van de ge­
wenste cysteinol mono-oxodithioacetalen (Schema V pg 26). Deze ring opening 
reactie, waarbij de S-0 band verbroken werd kon ook door andere алioneη 
bewerkstelligd worden. (n-BuLi, CgHsCfLi)(H)CN (Schema V pg 2 6)). De ring 
opening is stereospecifiek en verloopt met inversie van configuratie van 
het zwavelatoom. 
De sultine ring kan ook geopend worden door verbreking van de C-O band. Deze 
ring opening leidt, als ze door chloor teweeg gebracht wordt tot het sulfonyl 
chloride (verb. 15, Schema III pg 25). Naast deze intermoleculaire opening 
van de sultine ring door splitsing van de C-0 band is er ook een intermo-
leculaire ring opening zoals beschreven in hoofdstuk VII mogelijk. 
De sultine route bleek aantrekkelijk te zijn vanwege de hoge opbrengsten 
en omdat via deze route analoga van sparsomycine bereid kunnen worden, die 
op een andere wijze moeilijk toegankelijk zijn. 
CD metingen kunnen ook bij sultines gebruikt worden om de absolute configu­
ratie van het sulfoxide-zwavel atoom vast te stellen (Figi pg26). 
Hoofdstuk V is gewijd aan de biologische activiteit van sparsomycine en 
analoga. Voor een goed begrip hiervan werd in de eerste paragraaf van dit 
hoofdstuk achtergrond informatie gegeven over het aangrijpingspunt van 
sparsomycine: het peptidyltransferase centrum van het ribosoom. Interactie 
met dit centrum leidt tot remming van de eiwit synthese. Tevens werden enkele 
methoden beschreven die gebruikt worden om de peptidyltransferase activiteit 
van het ribosoom te meten. 
In de tweede paragraaf werd een van deze methoden gebruikt om de remming 
van de eiwit synthese van sparsomycine en analoga (verb. 1-4, 12, 13, 14, 16, 
Tabel I pg 39) in een cel-vrij systeem van gist te bestuderen. Ook werd de 
remming in een polyfenylalanine (Tabel I pg 39) synthetiserend cel-vrij 
systeem van gist bepaald. 
In de derde paragraaf werd vervolgens de activiteit van deze verbindingen 
tegen intacte leukemie L1210 cellen beschreven. Naast deze sparsomycine 
analoga zijn ook andere analoga (verb. ^ 7 en 20 Tabel I pg 46) onderzocht 
op hyn cytostatische werking tegen leukemie L1210 cellen in vitro door de 
mate van remming van de vorming van celkolonies te bestuderen. De activiteit 
van een analogon werd uitgedrukt in de ED50 (§ 2 Tabel I pg 39) respectie­
velijk de ID50 (i 3 Tabel I pg 46) waarde en werd vergeleken met die van 
sparsomycine. Aangezien ieder analogon niet meer dan twee structuurwijzigingen 
ten opzichte van sparsomycine bevat, was het mogelijk om eenduidig de 
structuur en stereochemische kenmerken te bepalen die vereist zijn voor een 
optimale biologische activiteit. De resultaten verkregen uit experimenten 
met een cel-vrij systeem, waarin de fragment reactie gebruikt werd, lopen 
bijna parallel met die verkregen uit de experimenten met L1210 cellen. Voor 
beide systemen geldt dat de S configuratie van het chirale koolstofatoom 
evenals de aanwezigheid van een zuurstofatoom op het a-zwavelatoom essentieel 
zijn voor de optimale activiteit. Daarentegen is de R configuratie van het 
zwavelatoom, hoewel van belang, niet essentieel. 
Het geisomeriseerde sparsomycine (isosparsomycine (verb. 16 Tabel I pg 39 
en Tabel I pg 46)) bezit in een van beide cel-vrije systemen een aanzien­
lijke activiteit, terwijl deze in het L1210 systeem vrijwel afwezig is. 
Verder werd de rol van de hydroxy functie van sparsomycine in het L1210 
cel systeem bestudeerd. Naar het schijnt is deze functie niet betrokken 
bij de werking van sparsomycine op moleculair niveau op een vergelijkbare 
wijze als de aminofunctie van puromycine (verb. 18 pg 44),aangezien acylering 
van de hydroxy functie de biologische activiteit niet beïnvloedt. 
De cystostatische activiteit in dit systeem neemt sterk toe wanneer de lipo-
filiteit van het effector molecuul toeneemt: octyl sparsomycine is 3-4 maal 
zo actief als sparsomycine zelf (Tabel I pg46). 
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Dit analogon heeft een vergelijkbare activiteit als de in de kliniek ge-
bruikte citostatica fluorouracil en adriamycine. 
In de vierde paragraaf werd de cytostatische activiteit van sparsomycine 
beschreven. Deze is waarschijnlijk grotendeels het gevolg van de remming 
van de eiwit biosynthese. Verder werd het huidig en toekomstige onderzoek 
aan sparsomycine en analoga met betrekking tot de cytostatische activiteit 
nader toegelicht. 
Omdat de chemie van sultines, en met name van de gefunctionaliseerde 
sultines een nagenoeg ongeêxploreerd terrein is, hebben we besloten meer 
aandacht aan deze verbindingen te schenken. Een eerste aanzet hiertoe werd 
beschreven in hoofdstuk VI. De aanleiding tot dit onderzoek was dat bij 
ring opening van het sultine door een prochiraal nucleofiel chirale inductie 
plaats vond (hoofdstuk IV, pg26). Dit vormde o.a. •vroor ons een reden om 
de conformatie(s) van deze verbindingen in oplossing te gaan onderzoeken. 
Van twee sultines (verb. 1 en 2 pg 57) is de conformatie analyse beschreven. 
In deze conformatie analyse werd gebruik gemaakt van een nieuwe empirische 
generalisering van de klassieke Karplus vergelijking (vergelijking 4,pg 58). 
Door toepassing van deze vergelijking en vergelijkingen die gebruikt worden 
voor de beschrijving van 5-ringen (vergelijking 1 en 2, pg57#5^cvmnen vicinale 
koppelingsconstanten, verkregen met behulp van 500 MHz proton NMR spectrosco-
pie, vertaald worden in proton-proton torsiehoeken. Met behulp van het 
pseudorotatie concept kon de conformatie en de 'puckering' van de 5-ring 
quantitatief beschreven worden. 
Aangetoond kon worden dat het BOC-sultine (verb. 1 pg ) waarin het zuurstof-
atoom een syn positie inneemt ten opzichte van de C-N band, in chloroform 
bij -40 0C en bij kamertemperatuur aanwezig is als een 'twist-chair' confor-
meer ( T5, la-c pg65). In DMSO is de conformeer van deze verbindingen in 
evenwicht met een andere'twist-chair' confoniieer( ¡T, ld pg65). Het sultine 
(verb. 2 pg60), waarin de sulfoxide functie een anti positie inneemt ten 
opzichte van de C-N band, verkeert in chloroform bij -40 0C in een op de 
NMR tijdschaal langzaam en snel conformatie evenwicht. Het langzame evenwicht 
behelst een evenwicht tussen een component die in grote overmaat (major 
component) aanwezig is en een andere component die in ondermaat aanwezig is 
(minor component). Dit evenwicht is een gevolg van een belemmerende rotatie 
van de urethaan binding. In het 'snelle' evenwicht zijn een 'twisted-chair' 
conformatie (;JT, 2a, 2c, 2e, 2g pg66) en een'envelop'achtig conformeer 
(iE, 2b, 2d, 2f, 2h рдббУ met elkaar in evenwicht. Het 'langzame' evenwicht 
wordt niet waargenomen in DMSO bij kamertemperatuur en in tetrachloorethaan 
bij HO oc. 
De effecten die een rol zouden kunnen spelen bij het bepalen van de confor-
maties van 1 en 2 zijn het gauche effect, het anomeer effect en de waterstof 
brugvorming. Dit laatste effect bepaalt waarschijnlijk de waargenomen vaste 
stof conformatie die ook in dit hoofdstuk gerapporteerd werd. Vergelijking 
van deze vaste stof conformatie met de conformatie aanwezig in oplossing 
laat duidelijke verschillen zien. 
Naast de conformatie van de sultine ring werd met behulp van röntgenanalyse 
ook de absolute configuratie van het sulfoxide-zwavelatoom bepaald. Dit in 
combinatie met de bovenbeschreven absolute configuratie van de producten 
die ontstaan bij ring opening (hoofdstuk II en IV) leidde tot de conclusie 
dat ring opening reacties van sultine (hoofdstuk IV) stereospecifiek zijn 
en gepaard gaan met inversie van configuratie. 
Een ander facet van de chemie van (gefunctionaliseerde) sultines is de 
in hoofdstuk. VII beschreven flits vacuum thermolyse reactie. Flits vacuum 
thermolyse van de 4-(benzamido)-γ-sultines (verb. 5a en 5b pg77) leidde tot 
een mengsel van producten met als hoofdproduct het allylamide (verb. 6 pg 7 7) 
en verder het Z- en E-enamide verb. 7 en 8 pg 77) en het benzamide. In deze 
reactie verhuist de benzamide groep mogelijk via een mechanisme waarin de 
C-O binding van het sultine heterolytisch gesplitst wordt door een nucleo-
fiele aanval van het amide zuurstof atoom in een nabuurparticipatie reactie. 
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Dit mechanisme kon onderbouwd worden door de flits vacuum thermolyse van een ge-
deutereerde sultine (verb. Sa-dj pg 78 ) uit te voeren. 
In het laatste hoofdstuk van dit proefschrift werden enige voorlopige 
resultaten van het onderzoek naar de synthese van het marasmine gedeelte 
van γ-glutamyl marasmine behandeld. 
γ-Glutamyl marasmine is het enige ander bekende molecuul dat ook een mono-
oxodithioacetaal functie bevat. Vier mogelijke routes die echter tot op heden 
nog niet tot een afgeronde synthese van marasmine hebben geleid, werden be­
schreven. De routes waaraan het meeste onderzoek is verricht zijn die waarin 
een sulfilimide als synthetisch intermediair gebruikt werd, en een route die 
berust op toepassing van de a-chloorsulfoxide benadering van sparsoraycine. 
Omdat deze benadering (Schema X pg 91), die voor de synthese van de mono-
oxodithioacetaal functie gebruik maakt van een α-chloor sulfoxide, als syn­
thetisch intermediair, niet zonder meer gebruikt kon worden voor de synthese 
vein het overeenkomstig fragment in marasmine, dient de laatste stap van 
de synthese van marasmine n.l. substitutie van het chlooratoom door het 
methylthiolaat anion nog verwezenlijkt te worden. 
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